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1. Introductory summary  
1.1 Dendritic cells as orchestrators of immune responses 
 
Dendritic cells (DCs) were initially identified in the adult mouse spleen by Steinmann 
and Cohn, where they were described as stellate cells with high motility 1. Since then, 
they have been recognized as immune sentinels with a multifaceted participation in 
the elicitation and regulation of immune responses 2. Due to this fact, it is not seldom 
for DCs to be seen as a connective link between the innate and the adaptive arm of 
immunity. Featuring as innate immune cells, DCs constantly sample their microenvi-
ronment by engulfing antigenic molecules derived from self or non-self. They possess 
an array of surface and intracellular receptors that enables them to sense the context 
within these antigens are met, and whether they are connected to invading pathogens, 
damaged cells or constitute innocuous antigens. Subsequently, they process these 
antigens and present them to T cells, thereby activating them in an antigen specific 
way. However, the simple initiation of effector immune responses against foreign and 
potentially pathogenic antigens does not guarantee their effectiveness. In order to en-
sure sufficient protection it is of outmost importance that effector responses will be 
tailored according to the pathogen met 3. For example, immune responses against 
intracellular pathogens, like viruses, and extracellular ones, like helminths, while are 
both designed to fight off pathogenic organisms differ substantially in their elicitation. 
Therefore, DCs can integrate information regarding the source and the context that 
foreign antigens are met and polarize the effector responses accordingly through the 
production of cytokines and provision of specific costimulatory signals to T cells 4. This 
has earned them the title of orchestrators of immune responses. On the other hand, 
establishing and maintaining tolerance against self and innocuous antigens is equally 
important and therefore DCs have been described to play a pivotal role in induction of 






1.2 Ontogenetic pathways of cells contributing to the mononuclear 
phagocyte system during development 
 
DCs are part of the mononuclear phagocyte system together with monocytes and tis-
sue resident macrophages 7. According to the current paradigm all members of the 
mononuclear phagocyte system have well defined ontogenetic relationships and dis-
tinct progenitors (Figure 1). Among the members of the mononuclear phagocyte sys-
tem tissue resident macrophages have been documented to arise the earliest during 
embryogenesis. More specifically, together with the first wave of nucleated blood cells 
they originate from extra-embryonic yolk sac progenitors already at embryonic day 
7.25 (E7.25) 8-10. This wave of primitive hematopoiesis has been described to emerge 
from the so-called early erythro-myeloid progenitors (EMPs). Notably, a second wave 
of yolk sac derived progenitors emerges at E8.25. These late EMPs belong to the so-
called transient definitive hematopoiesis and they can give rise to non-nucleated red 
blood cells and a bigger variety of myeloid lineages except for macrophages 11. Inter-
estingly, late EMPs can migrate as precursors to the fetal liver, thereby sustaining 
hematopoiesis until the next wave arises or seed embryonic tissues producing termi-
nally differentiated cells. Among the late EMP progeny are also macrophages that 
colonize most embryonic tissues except the brain, due to the natural obstacle pre-
sented by the blood-brain barrier 9,10. Interestingly, whether the second wave of tissue 
resident macrophages emerges through an intermediate state of fetal monocytes is 
still debated 8,10,12. Similar to other immune cells arising from yolk sac progenitors, e.g. 
masts cells 13, embryonically derived macrophages persist in their tissues of residence 
for extended periods after birth. Their replacement kinetics by cells deriving from the 
definitive wave of hematopoiesis have been described to vary depending on the organ 
they reside in 9,14. At E10.5, definitive hematopoietic stem cells (HSCs) emerge from 
the aorto-gonado-mesonephros region and migrate to the fetal liver where they ex-
pand and differentiate after E12.5 into all lineages of hematopoietic cells in a c-Myb 
dependent process. Shortly after birth hematopoiesis shifts to the bone marrow 9,11. 
Therefore, it is evident that hematopoiesis commences early on during the develop-
ment of a newly formed organism and during embryogenesis takes place in spatially 
and temporally overlapping waves. Each hematopoietic wave is characterized by dif-
ferent potential to produce distinct immune cell lineages that either transiently exist in 
the embryo or even persist after birth.  
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Apart from tissue resident macrophages, also DCs and monocytes have been reported 
to exist in embryonic tissues 12,15. Fetal monocytes were shown to develop from fetal 
liver resident progenitors in contrast to their adult counterparts that derive from bone 
marrow HSCs 12. Notably, the developmental pathways of DCs in early life remain still 
poorly studied and thus our knowledge regarding their development is solely based on 
studies performed in adults. Therefore, an important aim of the present study was to 
delineate whether DC-poiesis in early life emerges from a distinct hematopoietic 
source compared to their adult counterparts. 
Adult bone marrow contains a fraction of myeloid progenitor cells capable of generat-
ing monocytes and DCs, that has therefore been termed macrophage and DC progen-
itor (MDP) 16. MDPs further give rise to so-called common monocyte progenitors 
(cMoPs) 17 and common DC progenitors (CDPs) 18-22. cMoPs are the immediate up-
stream progenitors of monocytes. It is worth mentioning that monocytes under both 
steady state and inflammatory conditions can egress to peripheral tissues and differ-
entiate to monocyte-derived cells with features resembling that of DCs or macro-
phages 23,24. On the other hand, CDPs were initially thought to exclusively generate 
plasmacytoid DCs (pDCs) and conventional DCs (cDCs). pDCs are critical for defend-
ing against viruses due to their ability to responds to viral antigens and secrete copious 
amounts of type I interferons (IFN) 25,26. They were described to terminate their differ-
entiation in the bone marrow in a manner dependent upon the transcription factor E2-
2 25,26. Interestingly, recent studies have challenged the myeloid origin of pDCs sug-
gesting that they originate primarily from lymphopoiesis 27,28. cDCs excel in the activa-
tion of adaptive immune responses by presenting antigens to T cells. In mice, cDC-
restricted progenitors are distinguished within the CDP fraction by the expression of 
the C-type lectin receptor DNGR-1 (encoded by the Clec9a gene) 21. This cDC-com-
mitted CDP fraction further differentiates to pre-conventional dendritic cells (pre-
cDCs), which continue to express DNGR-1, exit the bone marrow and migrate to lym-
phoid and non-lymphoid tissues to complete their differentiation into cDC subsets, 
namely cDC1 and cDC2. Initially it has been thought that pre-cDC differentiation to 
either cDC subset was solely driven in response to environmental cues 29. However, 
according to recent studies, pre-cDCs were found to be a heterogeneous mosaic of 
subpopulations, some of which are pre-committed to a specific cDC subtype even be-
fore egressing from the bone marrow 30,31. While this debate is not fully resolved it 
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could have very interesting implications in explaining the noted variation in the quali-
tative representation of cDC subsets in different tissues and in the same tissue during 
different developmental timepoints, especially given the distinct functions of each cDC 
subset in immune responses. For the development of both pDCs and cDCs the growth 
factor-receptor axis between fms tyrosine kinase 3 ligand (FLT3L) and its receptor 
FLT3/CD135 has been found to be vital. Mice deficient for FLT3L have markedly re-
duced numbers of cDCs and pDCs in lymphoid organs such as thymus, spleen and 
lymph nodes 32,33. In these mice, the cellularity of the spleen is also decreased due to 
reduced numbers of B and T cells together with NK cell deficiency 32. FLT3 is ex-
pressed on DC progenitors and thus cultures of total murine bone marrow cells with 
recombinant or in house produced FLT3L have been used to generate the in vitro 
equivalents of pDCs and cDCs 34. Additionally, in vivo administration of recombinant 
FLT3L has been used as a means to induce expansion of cDCs and pDCs 35-37. Col-
lectively, while in recent years many studies have contributed in delineating the distinct 
ontogenetic pathways throughout development of the members of the mononuclear 
phagocyte system, the developmental pathways of DCs during embryogenesis and 




Figure 1 Developmental scheme of mononuclear phagocytes. In adults the macrophage and dendritic cell 
progenitor (MDP) gives rise to the common monocyte progenitors (cMoP) and the common dendritic cell progenitor 
(CDP). cMoPs differentiate already in the bone marrow to monocytes that egress in the blood stream and can seed 
peripheral tissues. There either under steady state or inflammatory conditions they can give rise to monocyte-
derived cells resembling macrophages or dendritic cells. CDPs give rise to pre-conventional dendritic cells (pre-
cDC) that seed peripheral tissues and give rise to both conventional dendritic cell subsets. CDPs were also thought 
to generate pDCs, however recent publications suggest that a lymphoid progenitor is the main source of pDCs. All 
mononuclear phagocytes in adults originate from bone marrow hematopoietic stem cells (HSCs) with the exception 
of some tissue resident macrophages that emerge during embryogenesis and are not replaced by HSC-derived 




1.3 Conventional dendritic cells exist as subsets with distinct 
developmental requirements, surface phenotype and unique 
functions in immunity  
 
In the adult state, cDC1 and cDC2 comprise developmentally and functionally distinct 
subsets that exhibit remarkable division of labor when it comes to their role in immune 
responses 2,7,38 (Figure 2). Both cDC subsets are characterized by a high expression 
of CD11c and MHC-II but can be distinguished by their differential dependence on 
transcription factors and expression of other surface markers. Core cDC1 and cDC2 
transcriptional programs have been described 39,40, however, these cells can adapt 
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Figure 2 Transcription factors, phenotypic markers and functional properties typically associated with each con-
ventional dendritic cell subset. 
cDC1 rely on the transcription factors ID2, IRF8 and BATF3 for their development 
40,43,44. Studies have described a severe and systematic depletion of cDC1 when IRF8 
or BATF3 are absent, thus identifying their continuous and high expression as prereq-
uisites for maintaining the developmental and functional program of this subset 43,44. 
cDC1 can be reliably identified across tissues by the expression of XCR-1, DNGR-
1/CLEC9A, CD24 and CD205 7,42. In addition, CD8a is a characteristic molecule for 
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cDC1 in lymphoid tissues while the integrin CD103 is used as a non-lymphoid tissue 
cDC1 marker, despite its expression also on an intestinal cDC2 subset 42. Functionally, 
cDC1 have a dominant role of inducing Th1 polarized responses against intracellular 
pathogens like viruses, bacteria (e.g. Listeria monocytogenes) and others 2,44-46. They 
are remarkable activators of CD8+ T cells due to their ability of cross-presenting extra-
cellular antigens on MHC-I molecules 2,44-46. Additionally, they possess a strong ca-
pacity to produce copious amounts of the cytokine IL-12 that enhances Th1 responses 
both directly, by acting on T cells themselves, and indirectly, by promoting production 
of a Th1-favorable cytokine milieu from other cells 2,44-46. 
Notably, in the spleen c DC1 share many phenotypic markers with a unique DC popu-
lation, termed BATF3-independent non-canonical CD8a+ DCs 47-49. More specifically 
both DC populations stain positive for CD24 and CD8a, however non-canonical CD8a+ 
DCs lack expression of XCR-1 and CD205 while they stain positive for markers typi-
cally associated with cDC2 like CD172a and CX3CR-1 47,49. Developmentally, non-
canonical CD8a+ DCs are similar to pDCs as they depend on E2-2 and exhibit somatic 
rearrangements in the genes of the immunoglobulin heavy chain 49. Their tran-
scriptomic profile resembles more that of cDC2 49 and therefore, these cells were re-
cently suggested as a transitional cell type with pDC and cDC2 characteristics 50. 
Functionally, they have lower ability to produce type I IFNs than pDCs and IL-12 com-
pared cDC1 while seem unable to cross-present cell associated antigens 47,49. While 
the full spectrum of their functional properties has yet to be described, transcriptomic 
analysis has shown that non-canonical CD8a+ DCs possess a unique array of pattern 
recognition and endocytic receptors suggesting a unique place within the DC immu-
nosurveillance network 51. As non-canonical CD8a+ DCs were only recently described, 
their example clearly illustrates the need for using multiple phenotypic markers in order 
to properly dissect the heterogeneity of the DCs in organ like the spleen. 
Regarding the developmental requirements of cDC2, studies have identified a major 
role for the transcription factors IRF4, ZEB2, KLF4 and RELB. Additionally, other sig-
naling pathways involving NOTCH2 and retinoic acid have also been described to 
have an influence in a tissue dependent manner 40,42. Characteristic cDC2 surface 
markers include CD11b, CD172a, CD4 and CLEC4A4 7,42. cDC2 are generally be-
lieved to be more efficient in inducing CD4+ T cell activation and polarization towards 
Tfh, Th2 or Th17 effector responses that are crucial for T cell-dependent antibody 
 
 16 
responses, defense against multicellular pathogens like helminths or extracellular bac-
teria and fungi, respectively 52-56. Another recent study identified a new and unex-
pected functional property of cDC2 in mice. More specifically, Fujita et al. described 
splenic cDC2 as an important source or FLT3L 57. The membrane bound FLT3L of 
splenic cDC2 was cleaved and shed by the A disintegrin and metalloproteinase 
(ADAM) 10 contributing vitally to the systemic levels of this vital DC growth factor. This 
cell autonomous circuit was vital for the development and maintenance of a NOTCH2-
dependent subset of cDC2 as when disrupted the researchers observed an immediate 
depletion of this subset and an accumulation of cDC2-committed pre-cDCs in the 
spleen 57.  
Additionally, cDC2 have been found to exhibit marked diversity and heterogeneity de-
pending on their tissue of residence. In support of the above, while IRF4 is considered 
a hallmark transcription factor for cDC2 its deletion does not lead to a complete halt in 
cDC2 development in all organs 54,55. However, IRF4 deficiency negatively affects the 
ability of cDC2 to migrate from peripheral tissues to their draining lymph nodes 58 and 
also diminishes their ability to induce Th17 responses 54,55. Notably, in some cases 
even within the same organ cDC2 exhibit a remarkable heterogeneity. For example in 
spleen, they can be subdivided to ESAMhigh and ESAMlow subpopulations that diversify 
in terms of functional properties, surface markers and defining transcription factors 59-
61. ESAMhigh cDC2 require NOTCH2 signaling for their development while their tran-
scriptional program is maintained by RUNX3 59,61,62. Functionally, in vivo they have 
been found to excel in induction of Tfh responses and germinal center formation 60. 
ESAMlow cDC2 were described to excel at presenting low dose antigen to T cells in 
vitro 60. Additionally, compared to their ESAMhigh counterparts, they were shown to be 
better producers of pro-inflammatory cytokines after in vitro stimulation with Toll-like 
receptor (TLR) agonists 59. A recent publication suggested a different segregation of 
splenic cDC2, delineated by the expression of the transcription factor T-bet, into T-bet 
expressing cDC2A and T-bet non-expressing cDC2B 63. While cDC2A resembled 
ESAMhigh and cDC2B ESAMlow cells further investigations are warranted to elucidate 
whether ESAM and T-bet expression perfectly correlate and reflect the same subsets 
of cells. Finally, the versatility and heterogeneity of cDC2 was shown to be even 
greater upon an ongoing inflammation. This was supported by Bosteels et al. showing 
that upon infection in the lung a new population of inflammatory cDC2 emerges with 
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functional characteristics that are not typically attributed to cDC2. This population ex-
hibited functional properties of cDC1 like the high production of IL-12 and cross-
presentation of extracellular antigens to CD8+ T cells as well as expressed surface 
markers typical of macrophages, while retaining the proficiency in CD4+ T cell activa-
tion 64. Collectively, cDC2 exhibit marked heterogeneity that is often translated in func-
tional specialization of their subsets as seen in the case of ESAMhigh/low populations in 
the spleen. Additionally, as shown by recent publications, cDC2 have high potency in 
adapting and diversifying their ability to induce effective immune responses under both 
steady state and inflammatory conditions thus, making them a key target in strategies 
aiming to boost protective immunity. 
1.4 Mouse models that enable studying the developmental pathways 
and functional properties of conventional dendritic cells 
 
Deciphering the developmental and functional properties of cDCs in various tissues 
has been accelerated by the emergence of various mouse models that introduce gen-
eralized or more targeted genetic modifications in a constitutive or inducible manner 
2. One approach is the induction of controlled cell death in the cell type of interest 
driven by the expression of the dipheria toxin (DT) A-chain or the simian/human DT 
receptor downstream of a cell specific promoter. The expression of DTA is sufficient 
to induce cell death as it disrupts protein translation while in the case of DTR expres-
sion exogenous administration of DT is required for inducing cell death. Widely used 
examples are the Itgax-DTR 65 which targets all CD11c-expressing and the Zbtb46-
DTR 66 that allowed for a more targeted approach to cDCs, albeit with concomitant 
undesired targeting of endothelial cells as was later described 67. To specifically target 
cDC subsets mouse models like Xcr1-DTRvenus (cDC1) 68 or Clec4a4-DTR (cDC2) 
69 have been used. Another approach is the deletion of cDC lineage defining transcrip-
tion or growths factors. Widely used mouse models are the Irf8-/- and Batf3-/- strains 
aiming at two well-defined cDC1 transcription factors. Batf3 total knockout mice are 
selectively deficient in cDC1 in almost all lymphoid and non-lymphoid tissues 44 as the 
particular transcription factor interacts with IRF8 in order to positively regulate the 
maintenance of cDC1 identity 70. On the same logic, Irf8 total knockout mice exhibit a 
marked impairment in cDC1 development 43 however, also other lineages are affected 
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like B cells and monocytes. Additionally, as mentioned above, Flt3l-/- mice exhibit de-
fects in the development of several lymphoid lineages apart from an almost complete 
absence of DCs 32,71.  
In order to increase the specificity of the genetic interventions and thereby reduce the 
unwanted side effects on other lineages, the Cre-loxP system 72 was adopted for con-
ditional deletion of genes. The principle of this system is that the gene, exon or se-
quence of interest is flanked by two loxP sites and therefore designated as floxed. The 
recombination between the two loxP sites is mediated by a recombinase encoded by 
the Cre gene of the P1 bacteriophage and leads to the deletion of the intervening DNA 
and the subsequent inactivation of the floxed gene. Using this strategy, it was possible, 
for example, to study the depletion of Irf8 specifically in CD11c-expressing cells using 
the Itgax-cre strain 73 but also decipher many aspects of the cDC2 developmental bi-
ology like the NOTCH2 dependence of ESAMhigh splenic cDC2 (Notch2f/f Itgax-cre 
59,62) or the functional defects driven by the deletion of Irf4 and Klf4 in CD11c-express-
ing cells (Irf4f/f Itgax-cre 54,55,58 and Klf4f/f Itgax-cre 56 respectively). However, also other 
lineages can be affected from the aforementioned models as CD11c expression is not 
solely restricted to DCs 74. Taking advantage of the DNGR-1/CLEC9A expression in 
cDC committed progenitors 21, the Clec9a-cre strain was created in which the im-
proved Cre (icre) sequence was used to replace the two first exons if the endogenous 
Clec9a sequence 21. By crossing mice expressing CRE-recombinase under the 
Clec9a promoter to Rosalox-stop-lox-Yellow fluorescent protein (YFP) or Rosalox-stop-lox-
Tomato mice, a fate mapping model enabling for the faithful tracing of the cDC lineage 
has been generated 21,75,76. In these mice, a construct encoding for a fluorescent re-
porter is knocked in the murine Rosa locus, selected due to its constitutive and robust 
transcription. However, the expression of the reporter is halted by the presence of a 
floxed STOP signal. Consequently, in any CLEC9A-expressing cell the Cre-recom-
binase will excise the lox-stop-lox construct thus allowing for the expression of the 
fluorescent reporter and the irreversible marking of the CLEC9A+ cell and its progeny 
with a fluorescent signal. This is important as it instantly describes the power and the 
limitations of this model. On the one hand the Clec9a promoter is not active in other 
myeloid or lymphoid cells, contributing to the specificity of the model, however, it is 
also active in cDC1 and pDCs therefore any labeling in these cells cannot be inter-
preted as sign of their developmental origin 21,75,76. Only in cDC2, in which Clec9a 
expression is lost after the terminal differentiation from their precursors, the presence 
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of fluorescent labeling is a true indication of their ontogeny (Figure 3). Consequently, 
using this model cDC2 can be reliably identified without relying solely in expression of 
surface markers that can overlap with monocytes/macrophages at steady state or that 
are induced in a plastic way under inflammatory conditions 24,42,64. 
 
Figure 3 Shematic illustrating the principle of lineage tracing using Clec9a-cre fate mapping models. The Cre recombinase 
under the control of the Clec9a promoter will excise the STOP sequence lining between the two loxP sites enabling the tran-
scription of a fluorescent reporter (in this case Tomato). Therefore, any cell expressing DNGR-1/CLEC9A and its progeny will 
be labeled irreversibly with the particular reporter. Since cDC2 do not express DNGR-1/CLEC9A in their differentiated state 
any labeling would result from their DNGR-1/CLEC9A-expressing cDC committed progenitors. The same is not true for cDC1 
for their active expression of DNGR-1/CLEC9A prevents interpreting their labeling status as an indication of their ontogeny. 
1.5 The immune system in early life exhibits quantitative and 
qualitative differences compared to adults 
 
The neonatal period in mammals is inherently unique as the newly born organism 
transits from an insulated and sterile embryonic environment to the external world. It 
may not be an overstatement that newborns are exposed to a plethora of antigenic 
stimuli that are encountered for the first time. Mounting an immune response against 
all these new antigens would be detrimental for the survival of the new organism 77 
taking also into consideration that many of these antigens are harmless or part of its 
expanding microflora. Therefore, it is crucial that the organism successfully estab-
lishes tolerance to innocuous environmental antigens and commensal microorgan-
isms 78-80, as failing to do so can result in detrimental and lifelong impacts for the indi-
vidual. On the other hand, such tolerance establishment should be balanced with 
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properly orchestrated host defense to pathogens as the contrary could have immedi-
ate life-threatening implications for the survival of the organism. Thus, it is well-per-
ceived why the neonatal period is characterized as a critical window in the life of an 
organism. 
Many studies have highlighted that several components of the neonatal immune sys-
tem seem to be tailored towards a reduced pro-inflammatory capacity and as such 
they have been thought to be immature compared to their adult counterparts 81-83. This 
implies that they are intrinsically predisposed to induce immune responses of low effi-
ciency and magnitude. However, from another perspective the lower responsiveness 
of the neonatal immunity to any newly encountered antigen, be it pathogenic or not, is 
an actively and tightly regulated procedure with deep roots in promoting the surviva-
bility of the organism 77. Deploying any strategy of host defense involves a cost in both 
the energy allocated to that purpose and the collateral damage caused by the immune 
response. Neonates are able to afford neither the energetic nor the immune cost for 
mounting a full response against any potential pathogenic organism encountered as 
they mainly allocate their energy reserves for growth. Additionally, the resulting im-
munopathology would compromise the development of many organs like the lungs 
and kidneys that is still ongoing after birth 77,84. Therefore, it is an emerging concept 
that a strategy of disease tolerance is selected over disease resistance that may serve 
the energetic demands of the neonatal life and confer protection from the resulting 
immunopathology. Interestingly, this approach functions as a double-edged sword be-
cause on many occasions increases the neonatal susceptibility to certain life-threat-
ening infections 79,85 but also proves beneficial when facing pathogens that cause se-
vere manifestation of immunopathology in adults, like SARS-CoV-2 86. Admittedly, ex-
perimental and clinical data converge on the idea that nearly all the components of the 
neonatal immune system exhibit quantitative and qualitative differences compared to 
adult hosts. These differences will be the subject of the following paragraphs and can 
manifest as an altered repertoire of immune cells and in the form of functional differ-
ences of each individual neonatal population to its adult counterpart.  
Given the fact that neonates are particularly susceptible to pathogens with an intracel-
lular life cycle like viruses and certain bacteria, many studies have focused on neonatal 
CD8+ T cells. Smith et al. showed recently that CD8+ T cells emerging during the ne-
onatal period in mice differ in the type and kinetics of their response to infection com-
pared to their counterparts emerging later during development 87. Interestingly, this 
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study identified that the functional differences between neonatally and adult derived 
CD8+ T cells were majorly impacted by their developmental origin. More specifically, 
neonatally derived CD8+ T cells, deriving from neonatal HSCs, exhibited a memory-
like surface phenotype and were characterized by the authors as early responders to 
infectious challenge reminiscent of innate immune cells. On the other hand, CD8+ T 
cells derived from adult hematopoietic progenitors had slower kinetics in their re-
sponse after the first encounter with the antigen but, differentiated more effectively to 
long lived memory cells that would confer long lasting protection. This study essentially 
showed that the function of neonatal CD8+ T cells was intrinsically pre-programmed 
and reflected in both their transcriptomic and epigenetic landscapes. In humans, con-
tradictory results have been reported. Similar to what was observed in mice, one study 
reported that a distinct epigenetic and transcriptomic profile accounted for the lesser 
cytotoxic effector functions of neonatal CD8+ T cells 88. On the contrary, some others 
have shown that CD8+ T cells from young children can exhibit adult-like effector func-
tions against specific viruses, as measured by perforin and IFN-g production 89. 
Continuing on the T cell field, neonatal murine CD4+ T cells were described to produce 
copious amounts of IL-4 and IL-13 rapidly upon activation in contrast to their adult 
counterparts 90. Chromatin landscape analysis showed that in naïve neonatal CD4+ T 
cells a key regulatory region of the Th2 locus exists in a hypomethylated state render-
ing the entire locus more accessible for transcription and thus sustaining rapid IL-4 
production after activation 90. Thus, neonatal CD4+ T cell immunity has initially been 
thought to be entirely biased towards the Th2 polarization. However, seminar studies 
in mice have shown that upon neonatal antigen exposure in vivo, both Th1 and Th2 
primary responses develop but, re-challenge with any neonatally encountered antigen 
would result solely to Th2 responses 91. Mechanistically, it was discovered that upon 
primary challenge antigen specific Th1 CD4+ T cells upregulate surface expression of 
the IL-13Ra1, forming a heterodimer with IL-4Ra (also called IL-4Ra/IL-13Ra1 het-
eroreceptor (HR)). Upon the secondary challenge, the IL-4 produced by antigen spe-
cific Th2 cells would signal through the HR and induce apoptosis specifically to Th1 
cells. Notably, IL-13Ra1 upregulation could only be prevented if IL-12p70 was found 
in adequate amounts during the primary antigen encounter, however it was shown to 
be insufficiently produced by neonatal DCs, as it will be discussed below 91. In human 
fetuses naïve T cells were described to share many transcriptional similarities with 
regulatory T cells (Tregs) such as expression of the transcription factor Helios and 
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additionally to have an increased propensity for Treg differentiation after antigen en-
counter and activation 92. Moreover, cytokines, such as TGF-b, are found in higher 
levels in fetal secondary lymphoid organs further corroborating the Treg polarization 
of naïve fetal T cells 93. 
Humoral responses in neonates from both humans and mice differ significantly to 
those in adults. More specifically, neonatal T cell dependent humoral responses are 
characterized by a delayed onset, lower magnitude and affinity while additionally the 
conferred protection wanes with time 84. These phenomena could represent a failure 
of T cells to provide sufficient help but also go in hand with age dependent differences 
in the B cell compartment. For example, in the neonatal murine spleen the majority of 
the B cell compartment is comprised by B1 cells that tend to secrete low affinity anti-
bodies primarily of the IgM isotype. Additionally, any B2 cells existing at that develop-
mental timepoint have a rather immature phenotype 84. Notably, mounting of efficient 
antibody responses is a stepwise process that requires the formation of some archi-
tectural structures, namely lymphoid follicles, follicular dendritic cell networks and ger-
minal centers. However, these structures are absent at birth in mice and only fully 
develop after the first week of life together with the overall splenic architecture 84. Ad-
ditionally, efficient humoral responses followed by the establishment of protective 
memory cells are heavily impacted by T cell help provided by follicular helper T cells 
(Tfh). However, a recent study showed that in neonatal mice after immunization with 
standard alum containing regimens, any differentiating Tfh cell seemed to be transcrip-
tionally lodged at a premature stage with lower expression of key signature markers, 
like CXCR5, that could ultimately impact their ability to migrate to B cell areas and 
contribute to the efficient induction of antibody responses 94. Finally, a population of B 
regulatory cells has been described to be expanded in the murine neonatal spleen 
with profound role in dampening inflammatory responses and efficient T cell priming 
through an IL-10 mediated manner 95.  
As far as myeloid immune cells are concerned, early life neutrophils are characterized 
by a reduced transepithelial extravasation. This impacts negatively their ability to lo-
calize in inflamed tissues and is connected to decreased surface expression of the 
CD11b/CD18 complex and of the P-selectin glycoprotein ligand-1 96,97. Added to their 
reduced trafficking, neonatal human neutrophils exhibit impairments in phagocytosis 
and formation of extracellular traps, two vital functions for their immune protective role 
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98. Data suggest that neonatal monocytes exhibit a reduced expression of the adhe-
sion complexes L-selectin and membrane attack complex-1 and thus, similarly to neu-
trophils show a defect in their ability to adhere to inflamed endothelium and be re-
cruited in sites of infection. Additionally, fetal and neonatal monocytes seem to 
hyporespond after stimulation of pattern recognition receptors like TLRs due to re-
duced activation of the intracellular signaling cascade 12,99-101. In murine neonates, 
both neutrophils and monocytes have an increased frequency among splenic leuko-
cytes and exhibit functions reminiscent of myeloid suppressor cells as they were 
shown to directly suppress T cell activation and proliferation in vitro 102. 
Similarly to the other immune system cells mentioned above, early life DCs have been 
documented to differ from their adult counterparts in terms of both their function and 
quantitative distribution 83. As such it has been considered that DCs in early life are 
under-developed and immature, however the underlying reasons of these differences 
have not been investigated in detail. For example, until the point that the present study 
was conducted no data existed on whether neonatal DCs are intrinsically prepro-
grammed to function differently due to an altered developmental pathway in early life, 
as mentioned above for CD8+ T cells, or their function was instructed by different mi-
croenvironvental cues during development. In both human and murine neonates, the 
DC compartment is smaller than that of adults 15,103,104. Indicatively, in the murine 
spleen the numbers of cDCs are much lower than in adults and additionally their fre-
quency among the splenic leukocytes is around ten-fold lower than the respective one 
in the adult spleen 15. While similar scarcity of neonatal cDCs is noted in other lym-
phoid and non-lymphoid tissues in humans and mice 15,103,104 the subset distribution 
differs between these species. In mice, the neonatal cDC compartment is dominated 
by cDC1 and inversely cDC2 are the main cDC subtype in adult tissues 15,103,105. In 
contrast, in most human tissues the relative frequency of cDC1 and cDC2 remains 
stable throughout development 41. Noteworthy, early studies especially in mice, have 
identified the neonatal equivalents of cDC subsets solely based on expression profiles 
of surface markers used for adult cDCs. However, recent studies have started to re-
veal that in fact many hallmark adult cDC markers have an altered expression profile 
in early life. For example, in the first week of life murine cDC1 from the spleen and 
mesenteric lymph node retain expression of the hallmark adult markers CD24, 
CLEC9A, CD205 and XCR-1 but lack CD8a and lung cDC1 have been documented 
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to exhibit reduced expression of the defining marker CD103 in early life 105,106. Simi-
larly, CD4 only reaches adult levels of expression in splenic cDC2 after the second 
week of life 15, while the age dependent distribution of cDC2 subsets based on ESAM 
expression remains yet unexplored. Consequently, due to the use of developmentally 
non conserved phenotypic markers the heterogeneity of early life cDC subsets still 
remains not completely characterized. Additionally, the use of such markers also ham-
pers the complete functional characterization of these cells because their implemen-
tation in experimental designs can lead to isolation of mixed or partial populations, as 
would be the case when using solely CD8a and CD4 to purify early life splenic cDC 
subsets, for example. In continuation, the reasons underlying the age dependent sub-
set distribution and phenotype of cDCs in mice have yet to be identified. On the one 
hand, it is possible that the DC-poiesis during development is biased in generating an 
adapted cDC repertoire that fits the age specific needs, which could go in line, for 
example, with the dominance of cDC1 in early life tissues as this subset is considered 
more capable in inducing Treg formation in the periphery 5. On the other hand, how-
ever, age-specific changes in specific organ microenvironments could alter the skew-
ing of cDC subset development and their phenotype. For example, this seems to be 
the case in lung where the decreased CD103 expression in cDC1 can be attributed to 
reduced levels of GM-CSF the tissue 105. 
Regarding the functional properties of cDCs in early life, the exhibited differences com-
pared to their adult counterparts manifest in a seemingly conserved pattern in both 
humans and mice, although the underlying reasons remain yet undefined. For exam-
ple, in both species neonatal cDCs express lower basal levels of MCH-II and co-stim-
ulatory molecules 41,105,107-110. This could lead to the assumption that they are less 
potent in activating antigen specific T cells and indeed, it was shown that splenic cDC 
subsets from 1-week-old mice were able to stimulate reduced proliferation of alloge-
neic CD4+ T cells in vitro compared to their counterparts isolated from 6-week-old mice 
15. However, it should be noted that cDC subset discrimination in the latter study was 
performed using surface markers with poor expression profile in early life as was later 
shown. CD4+ T cell polarization instructed by neonatal cDCs is thought to be biased 
towards Th2 immune responses and is documented to manifest either during primary 
111 or recall responses 91. Mechanistically, in the lung the abundance of IL-33 in the 
microenvironment has been shown to induce expression of Th2 favorable co-stimula-
tory molecules in cDCs and thus directly instruct Th2 polarization 111 while in spleen 
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the delayed production of IL-12p70 from neonatal cDC1 is the main driver of Th2 bi-
ased recall responses to neonatally encountered antigens 91. Neonatal cDC1 were 
additionally shown to produce lower amounts of IL-12 after stimulation with pathogenic 
stimuli like CpG in vitro or poly I:C in vivo 15,106. The latter observation was very inter-
esting when put into the context of neonatal infection with the bacteria Listeria mono-
cytogenes. More specifically, in the first week of life, CD8a- cDC1 are able to phago-
cytose the bacteria, process and present derived antigens to CD8+ T cells, however, 
compared to their adult counterparts not only they produce less IL-12 but additionally 
secrete the anti-inflammatory cytokine IL-10 106. This ultimately results in dampening 
of the pathogen specific CD8+ T cell effector response with life threatening implications 
for the neonatal mice. In another model of neonatal infection using respiratory syncytial 
virus, neonatal lung cDC1 were shown to preferentially present an altered epitope rep-
ertoire to antigen specific CD8+ T cells, compared to lung cDC1 in adults 105,107. Note-
worthy, this observation hints the existence of age-specific antigen processing differ-
ences, but was also shown to stem from the lower levels of co-stimulatory molecules 
in neonatal lung cDC1 as co-administration of soluble co-stimulatory molecules during 
the infection partially shifted the elicited response to the immunodominant epitope in 
adults 105,107. Lower levels of co-stimulatory molecules in cDC1 could be a result of 
inefficient primary activation by the pathogen or/and to them being refractory to IFN-a 
signaling that is induced during viral infections 112. In contrast to cDC1, only few studies 
have examined in detail cDC2 in early life. Most of our knowledge in mice comes from 
studies in the lung, where cDC2 have been described to express lower levels of MHC-
II and co-stimulatory molecules, promote Th2-mediated allergy and induce moderate 
CD8+ T cell proliferation after infection with respiratory syncytial virus 105,107,111. Addi-
tionally, a recent article studying the cDC compartment in human fetuses described 
that after stimulation with various pathogen associated molecular patterns fetal splenic 
cDC2 were characterized by production of an anti-inflammatory cytokine profile in con-
trast to their adult counterparts 113. The same study highlighted the potential role of 
these cells in maintenance of fetomaternal tolerance, as despite their ability to induce 
allogeneic T cell proliferation fetal cDC2 limited the TNF-a production from activated 
T cells in an arginase-2 dependent manner and promoted differentiation of more 
Foxp3+ regulatory T cells 113. The above data indicate that cDC2 in early life have the 
potential to induce T cell responses and even direct these responses distinctly de-
pending on the tissue of origin. Therefore, from a functional perspective, the present 
 
 26 
thesis focuses mainly on comparing the properties of cDC2 in young mice with those 
of their adult counterparts and uncovering the underlying reasons for the observed 
differences. In accordance with the dynamic role of cDC2 in inducing effector CD4+ T 
cell responses, detailed characterization of the unique early life cDC2 functional prop-
erties could also open possibilities for harnessing their potential and target them to 
boost early life immune responses. 
1.6 Contribution to publication: “Clec9a-Mediated Ablation of 
Conventional Dendritic Cells Suggests a Lymphoid Path to 
Generating Dendritic Cells In Vivo.” 
 
Conventional dendritic cells in adults have been documented to arise from a branch 
of bone marrow derived myeloid progenitors, as described above. Under certain ex-
perimental conditions lymphoid progenitors have been shown to differentiate in cells 
resembling DCs. However, these experiments mostly involved culturing of lymphoid 
progenitors in vitro or adoptively transferring them to irradiated recipients 114-117. It is 
therefore considered that any lymphoid contribution to the pool of cDCs under steady 
state conditions is negligible and even restricted to specific peripheral organs like the 
thymus 114,115.  
The initial aim of this published study was to generate a cDC deficient mouse model 
by using Clec9acreRosaDTA mice. The generated mouse model would take advantage 
of the Clec9a expression profile during cDC development and thus deplete the lineage 
already at the progenitor level. Experimental results showed that cDC progenitors and 
thus also their progeny were reliably and constitutively depleted. However, under 
these experimental conditions, leading to the impairment of myeloid-derived cDCs, 
cells resembling cDC2 were observed in lymphoid and non-lymphoid organs of 
Clec9acreRosaDTA mice. Therefore, this observation suggested that an alternative de-
velopmental pathway could serve as a source for DC-poiesis. Driven by the aforemen-
tioned published results, we hypothesized that lymphoid progenitors could be the al-
ternative source for DC-poiesis when the conventional myeloid pathway is abrogated. 
Additionally, the study aimed to investigate whether a possible differential develop-
mental pathway would pre-program the generated cDC-like cells with distinct func-
tional properties compared to bona fide cDCs. Focusing on the splenic compartment, 
these cDC2-like cells were found to be almost indistinguishable from bona fide cDC2 
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in terms of their surface phenotype and transcriptional profile. These findings were in 
line with previously published results concerning in vitro generated DCs from lymphoid 
progenitors 117, however emphasized the need to use an additional approach to point 
the relatedness of cDC2-like cells in Clec9acreRosaDTA mice to the lymphoid branch of 
hematopoiesis. This was made possible by exhibiting that these cDC2-like cells con-
tained D-J rearrangements at the immunoglobulin heavy chain (IgH) locus. Existence 
of such rearrangements serves as a fingerprint of RAG gene expression history, which 
is a hallmark of lymphoid primed progenitors even in the early stages of their develop-
ment in the bone marrow 118. Thus, this study suggested that when the myeloid branch 
of hematopoiesis is impaired in generating cDCs, lymphopoiesis is capable to fill in 
this gap and contribute to DC-poiesis. 
I established in our lab two published protocols for detecting D-J rearrangements. We 
chose to use both of these protocols because they are complementary and enable 
detection of rearrangements containing different D elements, more specifically of the 
Dfl16 and Dsp2 gene families and of the DHQ52 element. This approach increased 
the sensitivity of detecting the fingerprints of a lymphoid origin as only one D element 
participates in any given rearrangement event and its selection is stochastic. I per-
formed and analyzed the experiments presented in Figures 5E, F and in Supplemen-
tary Figure 5. Results of the aforementioned experiments were essential in supporting 
the lymphoid origin of cDC2-like cells in Clec9acreRosaDTA mice. Additionally, I per-
formed experiments shown in Supplementary Figure 3D. These results suggested that 
the lower expression of CD135 observed in splenic cDC2-like cells from Clec9acreRo-
saDTA mice, a hallmark phenotypic difference when compared to bona fide cDC2, could 
be attributed to receptor downregulation driven by increased systemic levels of its lig-
and, FLT3L, in these mice. 
1.7 Contribution to publication: “Environmental signals rather than 
layered ontogeny imprint the function of type 2 conventional 
dendritic cells in young and adult mice.” 
 
As mentioned in the introductory section, conventional dendritic cells in early life have 
been described to exhibit qualitative and quantitative differences when compared to 
their adult counterparts 83. These observations have led to the impression that early 
life cDCs consist an immature version of adult cDCs with lesser ability to induce and 
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properly polarize immune responses. Aim of this research work was to elucidate the 
reasons shaping these age-dependent functional differences especially with regards 
to cDC2, due to a lack of studies focusing on this subset in early life. Additionally, the 
aforementioned question is approached with an ontogenetic scope, hypothesizing that 
a distinct developmental pathway of neonatal cDCs could pre-program them to func-
tion distinctly in early life than in adulthood. This hypothesis is driven by many publi-
cations describing such layered development in other immune populations like mac-
rophages, T and B cells, mast cells and innate lymphoid cells (ILCs) 9,13,87,92,119. As a 
continuation of our findings using the Clec9acreRosaDTA mice which showed that lym-
phoid progenitors could compensate DC-poiesis when the myeloid branch was im-
paired, we more specifically questioned whether lymphopoiesis could be the source 
of early life cDCs, especially since observing that bona fide myeloid cDC committed 
progenitors in early life hematopoietic organs are present in scarce quantities. This 
study demonstrates for the first time that cDC2 exhibit a layered ontogeny during de-
velopment with lymphoid progenitors having a major contribution to the pool early life 
cDC2. Bona fide myeloid cDC progenitors gradually replace the first wave of DC-poi-
esis and dominate in adulthood. Interestingly, these data suggest that ontogenetic 
origin does not have a major impact in cDC2 function as in early life, cells originating 
from either lymphoid or myeloid progenitors are inseparable in terms of their pheno-
type, transcriptional profile and function. Surprisingly, early life cDC2, irrespective of 
their ontogeny, are fully functional in inducing immune responses with distinct capac-
ities in supporting certain effector polarization states. We also report that cDC2 tran-
scriptional profiles, and in extension functional properties, are imprinted by distinct cy-
tokine environments existing during development. Additionally, this study identified for 
the first time a new subset of cDC2 expressing the transcription factor RORgt, that is 
unique for early life and is currently subject of follow-up studies. 
I performed and analyzed experiments shown in Figure 1, Figure 2 (a,b,d), Figure 3a, 
Figure 4, Figure 5 (a-c, e-i), Figure 6, Supplementary Figure 1 (A-C,E-G), Supplemen-
tary Figure 2, Supplementary Figure 3, Supplementary Figure 4 (A,B), Supplementary 
Figure 5 (A-G), Supplementary Figure 6 (A-G, I-J) and Supplementary Figure 7. I an-
alyzed data generated by our international collaborators presented in Figure 2e and 
Supplementary Figure 5I. Additionally, I contributed to manuscript writing, creation of 
the figures and experimental design under the advice and guidance of my supervisor 
Prof. Dr. Barbara Schraml-Schotta.  
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Conventional dendritic cells (cDCs) are versatile activators of immune responses that 
develop as part of the myeloid lineage downstream of hematopoietic stem cells. We 
have recently shown that in mice precursors of cDCs, but not of other leukocytes, are 
marked by expression of DNGR-1/CLEC9A. To genetically deplete DNGR-1-expressing 
cDC precursors and their progeny, we crossed Clec9a-Cre mice to Rosa-lox-STOP-lox-
diphtheria toxin (DTA) mice. These mice develop signs of age-dependent myeloprolif-
erative disease, as has been observed in other DC-deficient mouse models. However, 
despite efficient depletion of cDC progenitors in these mice, cells with phenotypic char-
acteristics of cDCs populate the spleen. These cells are functionally and transcriptionally 
similar to cDCs in wild type control mice but show somatic rearrangements of Ig-heavy 
chain genes, characteristic of lymphoid origin cells. Our studies reveal a previously unap-
preciated developmental heterogeneity of cDCs and suggest that the lymphoid lineage 
can generate cells with features of cDCs when myeloid cDC progenitors are impaired.
Keywords: dendritic cell, development, CLEC9A/DNGR-1, DC depletion, myelopoiesis, lymphopoiesis, fate 
mapping
INTRODUCTION
Conventional dendritic cells (cDCs) are remarkable activators of adaptive immune responses with a 
superior capacity to capture, process, and present antigens to T cells (1–4). Through the production 
of cytokines, cDCs further direct effector responses and play essential roles in immune homeostasis 
and innate immunity (5–10). This versatility of cDCs in immune responses is regulated in part 
through the functional specialization of cDC subpopulations. cDCs exist as two main developmen-
tally distinct subsets that are found across lymphoid and non-lymphoid organs. cDC1 requires the 
transcription factors Batf3, IRF8, and ID2 for their development and are marked by expression of 
XCR1 and DNGR-1 (a.k.a. CLEC9A) across tissues and species (1, 11, 12). They are exceptional acti-
vators of CD8 T cells owing to their superior capacity to take up dead cells and cross-present antigens 
(1–4). Through the production of IL-12, cDC1 promotes type-I immune responses hallmarked by 
expression of Th1 cytokines (1, 5). In contrast, the differentiation and function of the cDC2 subset 
is controlled by the transcription factors IRF4, KLF4, RelB, and ZEB2 (1, 11–14), although ZEB2 
may predominantly control cDC2 differentiation in inflammatory conditions (15). Phenotypically 
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cDC2 can be distinguished from cDC1 by expression of CD11b, 
CD172a, and CLEC4A4 (DCIR2), as well as expression of IRF4 
and concomitant lack of IRF8 (1, 11, 12, 16). cDC2 appears to 
play a more prominent role in CD4 T-cell activation and the 
promotion of Th2 and Th17 responses, particularly at mucosal 
surfaces (17, 18).
Although the existence of cDCs as independent cell type 
has been a matter of intense debate, lineage tracing and other 
studies in mice have established that cDCs develop as distinct 
hematopoietic cell lineage (12, 19, 20). Single-cell analyses have 
recently suggested that myeloid lineage decisions take place early 
in hematopoiesis but the production of lymphoid and myeloid 
lineages is thought to branch after the lymphoid-primed multi-
potent progenitor (LMPP) stage (20–24). Downstream of LMPP, 
in a stepwise differentiation process, common myeloid progeni-
tors give rise to a lineage (lin) negative CD115+CD117hiCD135+ 
fraction of bone marrow that generates monocytes, plasma-
cytoid DCs (pDCs), and cDCs and has therefore been termed 
macrophage and DC progenitor (MDP) (25, 26). Whether MDPs 
are a true bi-potent developmental intermediate for cDCs/pDCs 
and monocytes is controversial (27). MDPs further give rise 
to common monocyte progenitors that exclusively generate 
monocytes (28) and a lin−CD115+CD117lowCD135+ fraction of 
cells termed common DC progenitors (CDP) that lose monocyte 
potential but generate cDCs and pDCs (29, 30). Within CDPs the 
expression of the C-type lectin receptor DNGR-1 (encoded by 
the Clec9a gene) distinguishes cells with exclusive cDC potential 
(19). CDPs further differentiate into pre-cDCs, which also express 
DNGR-1 (19) and travel via blood to peripheral organs, where 
their terminal differentiation into cDC1 and cDC2 takes place in 
response to environmental cues (31–33). Some pre-cDCs exist 
as pre-committed subsets that can be already distinguished in 
bone marrow based on the expression of specific surface markers 
and transcription factors (32, 34, 35). The developmental steps of 
cDC differentiation appear conserved, as equivalent progenitors 
and transcriptional requirements for cDC differentiation have 
been identified in humans (12, 36–40).
By crossing mice expressing Cre recombinase (Cre) under 
the control of the endogenous Clec9a promoter to Rosa26-
lox-STOP-lox-yellow fluorescent protein (YFP) reporter mice, 
we were able to demonstrate that Clec9a expression history 
faithfully traces the cDC lineage, including the main cDC1 and 
cDC2 subsets, but no other myeloid and lymphoid lineages in 
steady state as well as during inflammation (19). In this model, 
any cell-expressing Cre becomes irreversibly labeled with YFP, 
thereby allowing us to trace DNGR-1-expressing CDP and pre-
cDC irrespective of continuous DNGR-1 expression (19). One 
exception to faithful tracing of the cDC lineage is pDCs, which do 
not arise from DNGR-1-expressing cDC progenitors but express 
low levels of DNGR-1 in their differentiated form (19). In pDCs 
Clec9a expression history, therefore, is not necessarily a measure 
of cell origin (19). The same applies to cDC1, which express high 
levels of DNGR-1 and could become labeled with YFP because 
they express Cre in their differentiated form (19). However, cDC1 
are CDP-derived (1, 11) and arise from DNGR-1-expressing cDC 
progenitors upon adoptive transfer, confirming their classifica-
tion as cDCs (19). Despite these limitations, Clec9a-Cre mice 
offer a powerful means to identify cDCs as descendants from 
Clec9a-expressing cDC progenitors and to trace the cDC line-
age, particularly the cDC2 subtype, which lacks DNGR-1 in its 
differentiated form.
Although we have reached a consensus that cDCs arise as part 
of the myeloid lineage, several studies have suggested a lymphoid 
path to cDC development. Purified lymphoid progenitors can 
differentiate into cells resembling cDC1 and cDC2 after adoptive 
transfer and in vitro (41–47). This process appears to be driven 
by the same lineage promoting transcription factors that control 
cDC development from myeloid progenitors, such as IRF8 (46, 
48). Additionally, B-cell receptor gene rearrangements at the IgH 
locus, indicative of a lymphoid past, can be found in popula-
tions of thymic cDCs, some splenic cDC1, and pDCs (49–52). 
Nevertheless, fate-mapping studies in steady-state mice have 
excluded a prominent contribution of lymphoid progenitors to 
the steady-state cDC pool (53, 54) and have confirmed a binary 
branching of lymphoid and myeloid lineages downstream of 
hematopoietic stem cells (21). However, whether lymphoid 
progenitors can serve as an alternative path to DC poiesis in 
conditions of inflammation or when myeloid cDC progenitors 
are absent has not been investigated. Because cDCs generated 
in vitro from purified human lymphoid or myeloid progenitors are 
indistinguishable by gene expression analysis (42), addressing this 
question requires faithful ontogeny-based fate-mapping models.
Here, we investigated cDC development in mice in conditions 
in which cDC progenitors are impaired. We crossed Clec9a-Cre 
mice to Rosa26-lox-STOP-lox-diphtheria toxin (DTA) reporter 
mice (55) (Clec9aCreRosaDTA) to constitutively deplete Clec9a-
expressing cDC progenitors and their progeny. We found that 
Clec9aCreRosaDTA mice lack cDC progenitors and cDC1 but not 
cDC2. We show that in the absence of cDC progenitors, cells 
with features of cDC2 arise via an alternative developmental 
path. These cells show similarities to bona fide cDC2 in terms 
of transcriptional profile and inflammatory cytokine production 
but exhibit evidence of Ig receptor rearrangements, indicating a 
lymphoid origin. Thus, our data suggest a previously unrecog-
nized role for lymphoid progenitors as an alternative source of 




Clec9a-Cre (19), Rosa26-lox-STOP-lox-EYFP (56), Rosa26-lox-
STOP-lox-DTA (55), Rosa26-lox-STOP-lox-DTR (57), C57BL/6J, 
and B6.SJL mice were bred at Cancer Research UK, at ENVIGO 
or the Biomedical Center in specific pathogen-free conditions. All 
animal experiments were performed in accordance with national 
and institutional guidelines for animal care and approved by the 
Francis Crick Institute Animal Ethics Committee, the UK Home 
Office, or the Regierung of Oberbayern.
Cell Isolation
Spleen and lymph nodes were cut into small pieces and digested 
with Collagenase IV (200  U/mL; Worthington) and DNase I 
(0.2  mg/mL Roche) in RPMI for 30  min at 37°C. Cells were 
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strained through 70-µm cell strainers (BD Biosciences), washed 
with FACS buffer [PBS, 1% fetal calf serum (FCS), 2.5-mM EDTA, 
0.02% sodium azide] and incubated for 2 min in red blood cell lysis 
buffer (Sigma). Cells were then washed and resuspended in FACS 
buffer. Bone marrow was isolated by flushing one femur with 
FACS buffer onto a cell strainer. Erythrocytes were lysed as above. 
Colonic single-cell suspensions were prepared as published (19).
Cell Culture
CD11c+ cells from spleen were enriched by positive selection 
using magnetic beads and LS-columns (Miltenyi), cultured 
in complete RPMI (10% FCS, penicillin/streptomycin, non-
essential amino acids, sodium pyruvate, L-glutamine, 0.025-mM 
β-mercaptoethanol), and stimulated with LPS (100  ng/mL) or 
CpG (0.5 µg/mL) for 2 h before addition of brefeldin A (5 µg/
mL) for an additional 4 h.
ELISA
FLT3L and G-CSF were measured with DuoSet mFLT3L (DY427) 
and Quantikine® ELISA kits (both R&D Systems) according to 
the manufacturer’s recommendations. Other cytokines were 
measured by Legendplex (BioLegend).
Flow Cytometry
Data were collected on a LSR Fortessa (BD Biosciences) and 
analyzed with FlowJo software (Tree Star, Inc.). Cell sorting was 
performed on an Aria III Fusion (BD Biosciences). Antibodies 
used in this study can be found in Table S2 in Supplementary 
Material. For intracellular cytokine staining cells were fixed with 
2% paraformaldehyde (15 min, room temperature), then washed 
in FACS buffer with 0.05% saponin and stained in 0.5% saponin. 
IRF8 and IRF4 were stained in Foxp3 transcription factor staining 
set (eBioscience-00-5523-00) and Zbtb46 in transcription factor 
buffer from BDBioscience-562574. Dead cells were identified 
with Dapi or live/dead fixable violet (Invitrogen) or zombie UV 
dye (Biolegend).
Microarray Analysis
CD11c+ cells were enriched using magnetic beads and LS 
columns (Miltenyi Biotec). Cells were then sorted as CD11c+ 
MHCII+CD11b+CD24−CD64−Gr-1− cells from Clec9acre/cre 
RosaDTA mice or as YFP+CD11c+MHCII+CD11b+CD24−CD64− 
Gr-1− cells from Clec9acre/creRosaYFP mice. Total RNA was isolated 
using Qiagen RNeasy Micro Kit and prepared for hybridization 
on Affymetrix Mouse Gene 1.0 ST Arrays. We processed microar-
ray data with R/bioconductor (R version 3.4.2) using the annota-
tion package “mogene10sttranscriptcluster.db” version 8.7.0. The 
Robust Multichip Average (RMA) algorithm was used to extract 
raw expression values (library “oligo,” version 1.42.0 and “pd.
mogene.1.0.st.v1” version 3.14.1). We subsequently removed 
probe sets with zero variance and kept the ones with a median 
log2 expression level higher than 4.5 in at least one condition. 
Many-to-one probe-sets-to-gene relationships were resolved 
by retaining per gene only the probe set with the highest inter-
quartile range of expression levels across the samples. External 
data were merged and batch corrected using ComBat (library 
“sva,” version 3.26.0). Principle component analysis (PCA) was 
performed on 50% of the genes defined by highest variance across 
all samples. Heatmaps were generated using function pheatmap 
(library pheatmap, version 1.0.8) including gene-based scaling 
and clustering.
DJ-Rearrangement Polymerase Chain 
Reaction (PCR)
Genomic DNA was extracted by phenol chloroform extraction 
and 20-ng DNA were used per reaction. PCR for the IgH locus 
(Dfl16 and Dsp2 D gene families) (58) was split in two reactions 





IgH DJ-rearrangements for the DHQ52 element were assessed 
by sequential PCRs with the following primers:
PCR-1: DHQ52-1-CACAGAGAATTCTCCATAGTTGATAGC 
T C A G ; D H Q 5 2 - 2 G C C T C A G A AT T C C T G T G G T C 
TCTGACTGGT; PCR-2: JH4-1-AGGCTCTGAGATCCCTAG 
ACAG; JH4-2- GGGTCTAGACTCTCAGCCGGCTCCCTC 
AGGG as previously described (51).
Diphtheria Toxin (DT)-Mediated Cell 
Ablation
Mice were injected intraperitoneally with 25 ng per gram body 
weight DT (SIGMA). Spleens were analyzed 24 h later.
Statistical Analysis
Statistical testing was performed using two-sided, unpaired 
Welch t-tests in GraphPad Prism 6 software (GraphPad, La Jolla, 
CA, USA). A p < 0.05 was considered significant.
RESULTS
Clec9aCre/CreRosaDTA Mice Develop 
Myeloproliferative Disease
To generate mice lacking progeny derived from cDC-restricted 
progenitors, we crossed Clec9a-Cre mice to Rosa26-lox-STOP-
lox-DTA reporter mice to induce apoptotic cell death in Cre-
expressing cells and their progeny (55). We have previously 
shown that the penetrance of Cre-mediated recombination is 
increased in homozygous Clec9a-Cre mice without affecting 
specificity (19). For most experiments, we therefore generated 
mice homozygous for the Clec9a-Cre locus that were either 
heterozygous or homozygous for the Rosa26-lox-STOP-lox-
DTA allele (henceforth referred to as Clec9aCre/CreRosaDTA 
mice). Clec9aCre/CreRosaDTA mice were born at Mendelian ratio 
and developed normally (not shown). With age, spleens from 
Clec9aCre/CreRosaDTA mice appeared larger (not shown) and 
exhibited significantly increased cellularity compared to spleens 
from littermate controls (Clec9a+/+RosaDTA or Clec9aCreRosa+/+ 
mice, henceforth referred to as controls, Figure 1A). Despite 
prominent splenomegaly in mice 10 weeks or older, no differ-
ence in bone-marrow cellularity was observed (Figure  1A). 
FIGURE 1 | Clec9acre/creRosaDTA mice showing signs of age-dependent myeloproliferation. (A) The total number of leukocytes per spleen and femur from control and 
Clec9acre/creRosaDTA mice of the indicated ages is shown. (B,C) Ly-6C+CD11b+ cells were identified by flow cytometry in spleen from control and Clec9acre/creRosaDTA 
mice. (B) Representative gating strategy of Ly-6C+CD11b+ cells in 10-week-old mice. Plots are gated on DAPI− live cells. (C) Frequency and total counts of 
Ly-6C+CD11b+ cells in mice of the indicated ages and genotypes. (D) Serum was collected from control and Clec9acre/creRosaDTA mice at 6 and 14–17 weeks of age 
and the concentrations of FLT3L were determined by ELISA. Each symbol represents one mouse. ns, not significant; * p < 0.05, ** p < 0.001, and *** p < 0.0001.
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DC deficiency is associated with myeloproliferation leading 
to systemic neutrophilia and monocytosis (59–62). In 5-week-
old mice, we observed no differences in the frequency and 
number of Ly-6C+CD11b+ myeloid cells but in mice 10 weeks 
or older Ly-6C+CD11b+ cells were significantly increased 
(Figures 1B,C). This age-dependent increase in Ly-6C+CD11b+ 
cells encompassed both neutrophils and monocytes, whereas 
red pulp macrophages were not affected (Figures S1A–C in 
Supplementary Material). Myeloproliferation in DC-deficient 
mice is thought to be secondary to dysregulation of growth 
factors, such as FLT3L, G-CSF, or GM-CSF (59, 61). Clec9aCre/Cre 
RosaDTA mice displayed increased serum levels of FLT3L, with 
a slight increase evident even before the onset of overt spleno-
megaly in 6-week-old mice (Figure 1D). Systemic levels of other 
cytokines implicated in neutrophil and monocyte homeostasis 
were unaffected (Figure S1D in Supplementary Material). Of note, 
we could not detect GM-CSF in serum of control or Clec9aCre/Cre 
RosaDTA mice (unpublished observation). Therefore, Clec9aCre/Cre 
RosaDTA mice develop splenomegaly and exhibit increased 
levels of FLT3L, reminiscent of the myeloproliferative disease 
reported in other cDC-deficient animal models (59, 61–63).
Loss of cDC1 but Not cDC2 in Clec9aCre/Cre 
RosaDTA Mice
To analyze the efficiency of cDC depletion in Clec9aCre/CreRosaDTA 
mice, we focused on steady-state spleen, where cDCs can reliably 
be identified as CD11c+MHCII+ cells and the two main cDC1 and 
cDC2 subsets can be distinguished as CD24+ and CD11b+ cells, 
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respectively (Figure 2A) (12). At 10 weeks of age Clec9aCre/CreRosaDTA 
mice showed a twofold reduction in the frequency of splenic cDCs 
compared to controls. Due to the increased organ cellularity, 
however, there was no effect on the absolute number of splenic 
CD11c+MHCII+ cells (Figures  2A,B). The same was observed 
in older Clec9aCre/CreRosaDTA mice (14–17  weeks; Figure  2B). In 
5-week-old mice that do not exhibit increased spleen cellularity, 
a reduction of splenic CD11c+MHCII+ cells was apparent in cell 
counts (Figure 2B), yet cell depletion was surprisingly inefficient 
(about 3.5-fold). When we further separated CD11c+MHCII+ 
cells into cDC1 and cDC2 using the surface markers CD24 and 
CD11b (Figure 2A), we found that cDC1 were completely depleted 
in spleens from Clec9aCre/CreRosaDTA mice at all ages examined 
(Figure 2C and unpublished observations). In contrast, CD11b+ 
cDC2 showed a significant but small reduction (Figure  2C) 
only in 5-week-old Clec9aCre/CreRosaDTA mice and their frequency 
and absolute number was not reduced in mice 10 weeks or older 
(Figure 2C). This could be seen in other lymphoid organs, as well 
as in mice heterozygous for Cre expression, as the lymph nodes of 
Clec9a+/CreRosaDTA mice also lacked cDC1 but not resident cDC2 
or migratory CD103+CD11b+ and CD103- CD11b+ cDC2 (Figure 
S2F in Supplementary Material). Finally, these findings could be 
extended to non-lymphoid organs as cDC1 but not CD103+CD11b+ 
or CD103− CD11b+ cDC2 were absent from colon of Clec9aCre/Cre 
RosaDTA mice (Figure S2G in Supplementary Material).
The lack of cDC2 depletion was surprising, as this population 
shows near complete fluorescent reporter labeling in Clec9aCre/Cre 
RosaYFP mice (19) and can be depleted with DT in Clec9a-Cre 
mice crossed to Rosa26-lox-STOP-lox-diphtheria toxin receptor 
mice (DTR; Clec9aCre/CreRosaDTR) (64). We confirmed that a single 
injection of DT was sufficient to efficiently deplete pre-cDCs, 
cDC1, and cDC2 in Clec9aCre/CreRosaDTR mice (Figures  2D,E; 
Figures S2A,B in Supplementary Material). Of note, 24 h after 
DT injection no increase in splenic neutrophils or monocytes was 
observed (Figure S2C in Supplementary Material), suggesting 
that Clec9aCre/CreRosaDTR mice do not develop acute monocytosis 
and neutrophilia (62). Therefore, Clec9a-Cre mice serve as an 
efficient model to transiently deplete cDC1 and cDC2 when 
crossed to RosaDTR mice (64) but depletion of cDC2 is not seen 
when crossed to RosaDTA mice.
Fully differentiated pDCs express low levels of DNGR-1 
although they do not arise from DNGR-1-expressing CDPs (19). 
Splenic pDC numbers were not altered in Clec9aCre/CreRosaDTA mice 
(Figure S2D in Supplementary Material). However, pDCs that 
developed in Clec9a+/CreRosaDTA mice almost completely lacked 
DNGR-1 (Figure S2E in Supplementary Material). These data 
suggest that DNGR-1-expressing pDCs are depleted and replaced 
with DNGR-1 negative pDCs. We conclude that constitutive 
depletion of DNGR-1-expressing cells in Clec9aCre/CreRosaDTA adult 
mice leads to a complete loss of cDC1 but not cDC2 or pDCs.
Efficient Depletion of Pre-cDCs in Bone 
Marrow and Spleen of Clec9aCre/CreRosaDTA 
Mice
We next investigated whether cDC progenitors were 
depleted in Clec9aCre/CreRosaDTA mice. As expected, Clec9aCre/Cre 
RosaDTA mice showed no reduction in MDPs lin− 
CD11c−CD115+CD135+CD117hi compared to control mice 
(Figures  3A,B). In contrast, CDPs (lin−CD11c−CD115+CD135+
CD117low/−) were significantly reduced in Clec9aCre/CreRosaDTA mice 
(Figures 3A,B). High serum levels of FLT3L in Clec9aCre/CreRosaDTA 
mice could have led to downregulation of CD135 in MDPs or 
CDPs, causing them to be missed in our gating. This was not 
the case because bone marrow lin−CD11c−CD115+CD117hi and 
lin−CD11c−CD115+CD117low/− cells from control and Clec9aCre/Cre 
RosaDTA mice expressed similar levels of CD135 (Figure  3C). 
Pre-cDCs, identified as lin−CD11c+CD135+CD172alow cells, 
were also nearly absent in bone marrow of Clec9aCre/CreRosaDTA 
mice when compared to controls (Figures  3A,B) and this was 
true when pre-cDC were also identified irrespective of the 
CD135 marker as the lin−CD11c+ fraction of bone marrow 
(Figure S3A in Supplementary Material). Similarly, in spleen, 
lin−CD11c+CD43+CD135+CD172alow pre-cDCs were virtu-
ally absent in Clec9aCre/CreRosaDTA mice, as well as heterozygous 
Clec9a+/CreRosaDTA mice (Figures  3D,E; Figure S3C in 
Supplementary Material). Although CD43+CD135− cells were 
found in the splenic pre-cDC gate, those cells expressed reduced 
levels of CD11c, indicating that they were contaminants rather 
than bona fide pre-cDCs (Figures  3D–F; Figures S3B,C in 
Supplementary Material). A more efficient depletion of pre-cDCs 
compared with CDPs is to be expected because Cre-mediated DNA 
rearrangement in pre-cDCs is higher than in CDPs, reflecting the 
developmental hierarchy of DNGR-1 expression in rapidly cycling 
progenitors (19). Thus, our data indicate efficient depletion of cDC 
progenitors in bone marrow and spleen of Clec9aCre/CreRosaDTA mice 
and suggest that cells resembling cDC2 in Clec9aCre/CreRosaDTA mice 
arise independently of the classical CDP and pre-cDC differentia-
tion pathway.
cDC2 From Clec9aCre/CreRosaDTA Mice 
Phenotypically and Functionally Resemble 
cDCs
Phenotypic analysis revealed that cDC2 from Clec9aCre/CreRosaDTA 
mice showed no alterations in surface expression of the cDC 
markers CD172a, MHCII, CLEC4A4, and ESAM, although the 
expression of CD4 was slightly lower on cDC2 from Clec9aCre/Cre 
RosaDTA mice compared to controls (Figure  4A). cDC2 from 
Clec9aCre/CreRosaDTA mice further showed normal expres-
sion of lineage defining transcription factors ZBTB46, IRF4 
and IRF8 (Figure  4A). cDC2 from control and Clec9aCre/Cre 
RosaDTA mice responded similarly to stimulation with the TLR 
ligands lipopolysaccharide (LPS) and CpG oligonucleotides 
(Figure 4B). Interestingly, upon LPS treatment fewer cDC2 from 
Clec9aCre/CreRosaDTA mice than from control mice produced TNF, 
whereas this was not the case for IL-12 (Figure  4B). Reduced 
TNF production after LPS stimulation was already present in 
cDC2 from young Clec9aCre/CreRosaDTA mice that did not yet 
display myeloproliferation (Figure 4C) indicating that it was not 
merely a functional adaptation to the myeloproliferative environ-
ment. We conclude that cDC2 from Clec9aCre/CreRosaDTA mice are 
broadly similar to cDC2 from control mice, other than a slight 
impairment in the production of TNF after LPS stimulation.
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FIGURE 2 | Continued
FIGURE 2 | Loss of cDC1 but not cDC2 in spleen from Clec9acre/creRosaDTA mice. (A–C) CD11c+MHCII+ conventional dendritic cells (cDCs) were identified by flow 
cytometry in spleen from Clec9acre/creRosaDTA and control mice and further analyzed for CD24 and CD11b expression, to identify cDC1 and cDC2, respectively. (A) 
Representative gating strategy to identify CD11c+MHCII+ cDCs, CD24+ cDC1, and CD11b+ cDC2. (B) Frequency and total counts of CD11c+MHCII+ cells in spleen 
from control and Clec9acre/creRosaDTA mice of the indicated ages. (C) Frequency and total counts of CD24+ cDC1 and CD11b+ cDC2 in mice of the indicated ages. 
(D,E) Clec9acre/creRosaDTR and control mice were injected i.p. with DT and 24 h later spleens were analyzed by flow cytometry to identify CD11c+MHCII+ cells, as well 
CD24+ cDC1 and CD11b+ cDC2 (D). (E) The frequency and counts of total cDCs and cDC subsets identified as in (D). Each symbol represents one mouse. ns, not 
significant; * p < 0.05, ** p < 0.001, and *** p < 0.0001.
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cDC2 From Clec9aCre/CreRosaDTA Mice Are 
Transcriptionally Similar to Bona Fide 
cDC2 but Exhibit Somatic 
Rearrangements of Lymphoid Receptor 
Genes
We next performed whole transcriptome profiling by microarray 
of cDC2 from Clec9aCre/CreRosaDTA mice. To this end, we sorted 
splenic CD11c+MHCII+CD11b+ cDC2 from Clec9aCre/CreRosaDTA 
mice (CD11b+ DTA) and compared their mRNA profile to that 
of cDC2 sorted as YFP+CD11c+MHCII+CD11b+ cells from 
Clec9aCre/CreRosaYFP mice (YFP+; Figure 5; Figure S3 and Table S1 
in Supplementary Material). We chose this experimental strategy 
to ensure comparison to bona fide cDC2 arising from Clec9a-
expressing myeloid cDC progenitors. Our analysis revealed 
surprisingly few differences in gene expression, indicating that 
cDC2 from Clec9aCre/CreRosaDTA mice are very similar to YFP+ 
cDC2. Interestingly, among the 50 most significantly differentially 
expressed genes, only 11 showed more than a twofold difference 
and we found CD135 as a top hit (Table S1 in Supplementary 
Material). The expression of CD135 was about twofold lower in 
cDC2 from Clec9aCre/CreRosaDTA mice than in YFP+ cDC2 (Table 
S1 in Supplementary Material), raising the possibility that expres-
sion of the lineage defining marker CD135 may be dysregulated at 
the mRNA level. Consistent with that notion, staining for CD135 
was reduced on cDC2 from Clec9aCre/CreRosaDTA mice (Figure 4A). 
However, incubation of cDCs with FLT3L inhibited CD135 stain-
ing intensity, even in conditions in which endocytosis should be 
blocked (Figure S3D in Supplementary Material), suggesting that, 
when occupied by FLT3L, CD135 may no longer be freely avail-
able for antibody binding. Therefore, decreased CD135 staining 
on cDC2 from Clec9aCre/CreRosaDTA mice may reflect the fact that 
the receptor is engaged by FLT3L, as well as a possible reduction 
in gene expression. We next used cDC and macrophage core 
gene signatures (65) and performed unsupervised hierarchical 
clustering of cDC2 from Clec9aCre/CreRosaDTA mice and YFP+ cDC2 
in the context of published datasets for cDC and macrophage 
populations from the Immgen database. When compared in this 
manner cDC2 from Clec9aCre/CreRosaDTA mice and YFP+ cDC2 
showed greater similarity to splenic cDC2 than to cDC1 or red 
pulp macrophages (Figures  5A,B; Figure S3 in Supplementary 
Material). cDC2 from Clec9aCre/CreRosaDTA mice did not display a 
migratory cDC signature (Figure S4 in Supplementary Material), 
suggesting that they are not cDC2 that have aberrantly migrated 
from the periphery.
We next performed principal component analysis (PCA) in 
the context of published datasets for splenic cDCs, thymic cDCs, 
migratory cDCs, splenic pDCs, macrophages, and monocytes. 
Notably, cDC2 from Clec9aCre/CreRosaDTA mice were most closely 
related to YFP+ cDC2 and splenic cDC2 and clustered far 
away from monocytes/macrophages, thymic cDCs, or pDCs 
(Figure 5C). In humans, a subset of cDC2 has been identified that 
appears to be related to pDCs (66). These cells can be distinguished 
from cDC2 and pDCs by expression of signature genes, including 
Axl, Pp1rb, Dab2, CD22, and IL3Ra (66). However, we found no 
enrichment of the Axl gene signature in cDC2 from Clec9aCre/Cre 
RosaDTA mice compared with YFP+ cDC2 (Figure  5D). Taken 
together, these data demonstrate that cDC2 from Clec9aCre/Cre 
RosaDTA mice do not show a comprehensive loss of cDC identity 
and resemble cDC2 from wild type mice.
CLPs can give rise to cDCs in vivo and in vitro under certain 
conditions (41–48) and pDCs in normal mice can originate 
from myeloid or lymphoid progenitors that appear phenotypi-
cally indistinguishable except for a history of RAG expression in 
those originating from the latter (50, 67–69). We therefore sorted 
CD11b+CD11c+MHCII+ cells from control and Clec9aCre/Cre 
RosaDTA mice (Figures  5E,F; Figures S5A–C in Supplementary 
Material) and performed PCR analysis for Ig gene rearrangements 
indicative of historical RAG activity. Sorted pDCs from control 
mice exhibited prominent Ig gene rearrangements (Figures 5E,F; 
Figure S5C in Supplementary Material), as reported (49, 50), 
serving as a positive control. Strikingly, cDC2 from Clec9aCre/Cre 
RosaDTA mice also showed clear evidence of Ig gene rearrange-
ments, which were completely absent in cDC2 from control 
mice (Figures 5E,F; Figure S5C in Supplementary Material). In 
summary, cDC2 that arise in the absence of Clec9a-expressing 
cDC progenitors are transcriptionally similar to bona fide cDC2 
but they exhibit RAG gene expression history in the form of D–J 
somatic rearrangements, indicating a putative lymphoid origin.
DISCUSSION
Although the existence of a lymphoid path to cDC development in 
mice has been suggested (43, 47, 49, 50, 70), in steady-state cDCs 
arise primarily from myeloid progenitors (53). Here, we report 
the generation of Clec9aCre/CreRosaDTA mice as a model to consti-
tutively deplete Clec9a-expressing cDC progenitors and their 
progeny. We show that in the absence of these myeloid-derived 
cDC progenitors, cells that are phenotypically and transcription-
ally similar to bona fide cDC2 develop in spleen. These cells show 
RAG gene expression history in the form of D-J rearrangements 
at the IgH locus indicating a relation to the lymphoid branch of 
hematopoiesis. Therefore, our study suggests that lymphopoiesis 
can contribute to the generation of cDC-like cells in a situation in 
which myeloid cDC progenitors are impaired. This observation 
opens an interesting conundrum, namely, whether such cells 
FIGURE 3 | Efficient depletion of conventional dendritic cell (cDC) progenitors in bone marrow and spleen. (A,B) cDC progenitors were identified by flow cytometry 
in the bone marrow of 10-week-old control and Clec9acre/creRosaDTA mice. (A) Live lineage negative (lin−; CD3, CD4, CD8, CD11b, MHCII, Ter119, NK1.1, and B220) 
cells were gated and further analyzed for CD11c, CD117, CD115, CD172a, and CD135 expression. Macrophage and DC progenitor (MDPs) were identified as 
CD11c−CD115+CD135+CD117hi cells, common DC progenitors (CDPs) as CD11c−CD115+CD135+CD117int/− cells, and pre-cDCs as CD11c+CD172aintCD135+ 
cells. (B) The number of MDP, CDP, and pre-cDC per femur is shown. (C) Lin−CD115+ CD117hi and lin−CD115+CD117int/− bone-marrow cells from control and 
Clec9acre/creRosaDTA mice were gated and further analyzed for CD135 expression. Mean fluorescence intensity (MFI) (n = 4) of the CD135+ cell fraction, as gated in 
the histogram overlays, is shown. It was normalized to MFI on the same population from control mice, which is set as 1. (D–F) Pre-cDCs in spleen from control and 
Clec9acre/creRosaDTA mice 10 weeks of age were identified as lin−CD11c+CD43+CD172aintCD135+ cells by flow cytometry (D). (E) The frequency and number of 
pre-cDCs per spleen is shown. (F) CD11c MFI on splenic lin−MCHII−CD11c+CD43+ cells from Clec9acre/creRosaDTA mice is shown. It was normalized to MFI on the 
same population from control mice, which is set as 1 (n = 4). Each symbol represents one mouse. ns, not significant; * p < 0.05, ** p < 0.001, and *** p < 0.0001.
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FIGURE 4 | Continued
should be considered part of the cDC lineage. We and others have 
proposed that mononuclear phagocytes should predominantly 
be defined on the basis of their ontogeny (12, 71, 72). However, 
environmental imprinting appears to be a major identity deter-
mining criterion for mononuclear phagocytes (73–77). Therefore, 
an ontogenetic view to cell definition may be less tenable if cell 
FIGURE 4 | cDC2 from Clec9aCre/CreRosaDTA mice phenotypically and functionally resemble cDCs. (A) Splenic CD11c+MHCII+CD11b+ cells from control (red) and 
Clec9acre/creRosaDTA (blue) mice were analyzed for the expression of indicated surface markers or transcription factors (lower line) by flow cytometry. Gray traces represent 
staining with isotype matched control antibody. (B,C) CD11c+ cells from control and Clec9acre/creRosaDTA mice of the indicated ages were enriched using magnetic 
beads, stimulated with lipopolysaccharide (LPS) (100 ng/mL) or CpG (0.5 µg/mL) for 6 h followed by intracellular cytokine staining. CD11c+MHCII+CD11b+ cDC2 were 
identified by flow cytometry and TNF and IL-12 production was analyzed. (B) The frequency of cytokine positive cDC2 is shown. (C) Frequency of TNF producing cDC2 
from mice of the indicated ages stimulated with LPS. Each data point represents one mouse. Data are compiled from two independent experiments. * p < 0.05.
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populations with different origins turn out to be identical by all 
measures examined. Because cDC2 in Clec9aCre/CreRosaDTA mice 
are not CDP-derived but show lymphoid gene expression history, 
we suggest to refer to these cells as lymphoid DC2 for the time 
being (12). Although we find strong similarities between cDC2 
and lymphoid DC2, additional studies are necessary to further 
define the transcriptional and growth factor requirements, as well 
as functional properties of lymphoid DC2 to firmly establish their 
lineage affiliation and determine whether these cells should be 
considered a new type of mononuclear phagocyte (12).
As cDC differentiation from precursors is thought to be 
homeostatically regulated by the size of the mature cDC pool 
(78, 79), we cannot formally exclude at this point that some 
CDPs escape deletion in Clec9aCre/CreRosaDTA mice to preferen-
tially expand and contribute to the cDC2 population. However, 
our data demonstrate that at least part of the cDC2 pool in 
Clec9aCre/CreRosaDTA mice derives from a cell type that has under-
gone Ig gene rearrangement and that pool is therefore qualitatively 
distinct from CDP-derived cDC2. Whether these ontogenetically 
distinct cDC2s arise from early lymphoid-committed progeni-
tors, such as CLPs, is an attractive possibility that will need to be 
explored. However, it is worth mentioning that some myeloid 
progenitors reportedly express RAG1 and can generate pDCs 
with D-J rearrangements in  vitro (50). Such RAG1-expressing 
myeloid progenitors, which would presumably lack DNGR-1, 
could contribute to cDC2 generation in Clec9aCre/CreRosaDTA mice, 
in which case our designation of these cells as “lymphoid cDC2” 
would be incorrect. Finally, it is possible that pDCs, some of 
which have a lymphoid past (49, 50), could convert to lymphoid 
cDC2 in the FLT3L-rich environment of Clec9aCre/CreRosaDTA mice, 
although this is difficult to reconcile with the fact that we failed 
to find any pDC-specific transcripts in lymphoid DC2 (Figure 5 
and unpublished observations). Another intriguing observation 
is that lymphoid DC2 display decreased surface staining for 
CD135. Gene expression analysis suggests that CD135 may be 
dysregulated at the RNA level (Figure 5). However, it is equally 
possible that CD135 could be downregulated upon continuous 
receptor engagement by FLT3L (80) or may no longer be available 
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FIGURE 5 | Continued
FIGURE 5 | cDC2 from Clec9aCre/CreRosaDTA mice are transcriptionally similar to bona fide cDC2 but exhibit somatic rearrangements of lymphoid receptor genes. 
Splenic CD11c+MHCII+CD11b+ cDC2 from Clec9acre/creRosaDTA mice (CD11b+ DTA) and CD11c+MHCII+CD11b+YFP+ cDC2 (YFP+) from Clec9acre/creRosaYFP mice 
were sorted and subjected to microarray analysis. (A,B) Population clustering and heat map display of the relative expression values for core conventional dendritic 
cells (cDC) signature genes (A) and core CD8neg cDC signature genes (B) comparing cDC2 from Clec9acre/creRosaDTA mice and YFP+ cDC2 to the indicated murine 
cDC and macrophage populations from the Immgen database. (C) Principle component analysis (PCA) was performed on 50% of the genes defined by highest 
variance across all samples. Each dot of the same color represents a replicate sample. For each cluster, normal confidence ellipses are indicated. (D) Box plots of 
the log2 expression values of the indicated genes in cDC2 from Clec9acre/creRosaDTA mice and YFP+ cDC2. (E,F) CD11c+MHCII+CD11b+ cDC2 from control and 
Clec9acre/creRosaDTA mice were sorted and genomic DNA was isolated. (E) Polymerase chain reaction (PCR) was performed using primers for the germline (GL) locus 
and primer mixtures homologous for regions of the Dfl16 and Dsp2 D gene families for detecting D–J rearrangements of the IgH chain. DJ rearrangements in pDCs 
(SiglecH+B220+) and neutrophils (Ly-6G+) are shown as control. * indicates an unspecific band. (F) Genomic PCR was performed using primers for the GL locus and 
primer sets for the DHQ52 element for detecting D–J rearrangements of the IgH chain. DJ rearrangements in pDCs (SiglecH+B220+), CD205+ cDC1, and neutrophils 
(Ly-6G+) are shown as control. Each lane in E and F represents independent replicates from different mice.
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Salvermoser et al. A Lymphoid Path to cDCs
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 699
REFERENCES
1. Merad M, Sathe P, Helft J, Miller J, Mortha A. The dendritic cell lineage: 
ontogeny and function of dendritic cells and their subsets in the steady state 
and the inflamed setting. Annu Rev Immunol (2013) 31:563–604. doi:10.1146/
annurev-immunol-020711-074950 
2. Steinman RM, Idoyaga J. Features of the dendritic cell lineage. Immunol Rev 
(2010) 234:5–17. doi:10.1111/j.0105-2896.2009.00888.x 
3. Schlitzer A, Ginhoux F. Organization of the mouse and human DC network. 
Curr Opin Immunol (2014) 26:90–9. doi:10.1016/j.coi.2013.11.002 
4. Durai V, Murphy KM. Functions of murine dendritic cells. Immunity (2016) 
45:719–36. doi:10.1016/j.immuni.2016.10.010 
for antibody binding (Figure S3D in Supplementary Material). 
As FLT3L-deficient mice lack all cDCs (33, 81), it is unlikely that 
lymphoid DC2 arise independently of FLT3L. It will be important 
to determine whether different growth factors may preferentially 
promote the differentiation of lymphoid and myeloid progenitors 
into cDCs.
The fact that lymphoid DC2 are strikingly similar to bona 
fide cDC2 of myeloid origin in terms of transcriptional profile 
is in agreement with data demonstrating that in vitro generated 
human myeloid-derived cDC1 are indistinguishable from ones 
derived from human lymphoid-committed progenitors (42). 
These data suggest a primary role for the environment in the 
functional imprinting of cDCs, similar to observations made 
for macrophages and monocytes (73–76). Despite functional 
similarities between lymphoid DC2 and cDC2 in  vitro, these 
cells respond somewhat differently to the TLR ligand LPS. 
These data raise the possibility that lymphoid DC2 are not fully 
functionally equivalent to cDC2, which needs to be addressed 
experimentally in more detail. In this context, it is noteworthy 
that Clec9aCre/CreRosaDTA mice develop signs of systemic myelo-
proliferation, which is typical of mice lacking both cDC1 and 
cDC2 but has not been reported in mice lacking only the cDC1 
subset (82, 83).
It will be important to determine whether additional 
situations exist where a lymphoid path may contribute to gen-
erating or replacing bona fide cDC2, either to ensure functional 
redundancy or to mediate specific immune functions. Notably, 
RAG-expressing immune-restricted progenitors contribute to 
embryonic myelopoiesis in the fetal liver and, although this occurs 
before the onset of definitive hematopoiesis (84), it indicates that 
lymphoid and myeloid lineage decisions are not always binary. 
During emergency hematopoiesis distinct monocyte progenitors 
have been suggested to respond to inflammatory stimuli on a per 
need basis, yielding a situation-adapted repertoire of inflamma-
tory monocytes (85). It is intriguing to speculate that, in a similar 
manner, lymphoid and myeloid progenitors may be differentially 
triggered in certain conditions of inflammation to generate lym-
phoid DC2 and cDC2, respectively.
ETHICS STATEMENT
All animal experiments were performed in accordance with 
national and institutional guidelines for animal care and approved 
by the Francis Crick Institute Animal Ethics Committee, the UK 
Home Office, or the Regierung of Oberbayern.
AUTHOR CONTRIBUTIONS
JS and BS planned and performed experiments. JB, NP, SR, 
MP, DP, NR, and SJK performed experiments. TS performed 
Microarray analysis. JS, BS, and CRS wrote the manuscript. BS 
and CRS designed the study.
ACKNOWLEDGMENTS
We thank members of the Schraml lab for helpful discussions 
and critical reading of the manuscript. We also thank members 
of the Brocker and Krug laboratories for technical help. This 
work was supported by the German Research Foundation Emmy 
Noether Grant: Schr 1444/1-1 (to BS) and SFB914- project A11 
(to BS), by The Francis Crick Institute (to CRS), which receives 
core funding from Cancer Research UK (FC001136), the UK 
Medical Research Council (FC001136), and the Wellcome Trust 
(FC001136), by an ERC Starting Grant awarded to BS (ERC-
2016-STG-715182), and an ERC Advanced Investigator grant 
awarded to CRS (2010-AdG-268670).
SUPPLEMENTARY MATERIAL




Salvermoser et al. A Lymphoid Path to cDCs
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 699
5. Briseño CG, Murphy TL, Murphy KM. Complementary diversification of 
dendritic cells and innate lymphoid cells. Curr Opin Immunol (2014) 29:69–78. 
doi:10.1016/j.coi.2014.04.006 
6. Satpathy AT, Briseño CG, Briseño GC, Lee JS, Ng D, Manieri NA, et  al. 
Notch2-dependent classical dendritic cells orchestrate intestinal immunity to 
attaching-and-effacing bacterial pathogens. Nat Immunol (2013) 14:937–48. 
doi:10.1038/ni.2679 
7. Kinnebrew MA, Buffie CG, Diehl GE, Zenewicz LA, Leiner I, Hohl TM, et al. 
Interleukin 23 production by intestinal CD103(+)CD11b(+) dendritic cells 
in response to bacterial flagellin enhances mucosal innate immune defense. 
Immunity (2012) 36:276–87. doi:10.1016/j.immuni.2011.12.011 
8. Arora P, Baena A, Yu KO, Saini NK, Kharkwal SS, Goldberg MF, et  al. A 
single subset of dendritic cells controls the cytokine bias of natural killer 
T cell responses to diverse glycolipid antigens. Immunity (2014) 40:105–16. 
doi:10.1016/j.immuni.2013.12.004 
9. Loschko J, Schreiber HA, Rieke GJ, Esterházy D, Meredith MM, Pedicord VA, 
et al. Absence of MHC class II on cDCs results in microbial-dependent intes-
tinal inflammation. J Exp Med (2016) 213:517–34. doi:10.1084/jem.20160062 
10. Naik S, Bouladoux N, Linehan JL, Han S-J, Harrison OJ, Wilhelm C, et al. 
Commensal-dendritic-cell interaction specifies a unique protective skin 
immune signature. Nature (2015) 520:104–8. doi:10.1038/nature14052 
11. Murphy TL, Grajales-Reyes GE, Wu X, Tussiwand R, Briseño CG, Iwata A, 
et al. Transcriptional control of dendritic cell development. Annu Rev Immunol 
(2015) 34:93–119. doi:10.1146/annurev-immunol-032713-120204 
12. Guilliams M, Ginhoux F, Jakubzick C, Naik SH, Onai N, Schraml BU, et al. 
Dendritic cells, monocytes and macrophages: a unified nomenclature based 
on ontogeny. Nat Rev Immunol (2014) 14:571–8. doi:10.1038/nri3712 
13. Tussiwand R, Everts B, Grajales-Reyes GE, Kretzer NM, Iwata A, Bagaitkar J, 
et al. Klf4 expression in conventional dendritic cells is required for T helper 2 
cell responses. Immunity (2015) 42:916–28. doi:10.1016/j.immuni.2015.04.017 
14. Scott CL, Soen B, Martens L, Skrypek N, Saelens W, Taminau J, et  al. The 
transcription factor Zeb2 regulates development of conventional and plasma-
cytoid DCs by repressing Id2. J Exp Med (2016) 213(6):897–911. doi:10.1084/
jem.20151715 
15. Wu X, Briseño CG, Grajales-Reyes GE, Haldar M, Iwata A, Kretzer NM, et al. 
Transcription factor Zeb2 regulates commitment to plasmacytoid dendritic 
cell and monocyte fate. Proc Natl Acad Sci U S A (2016) 113:14775–80. 
doi:10.1073/pnas.1611408114 
16. Guilliams M, Dutertre C-A, Scott CL, McGovern N, Sichien D, Chakarov S, et al. 
Unsupervised high-dimensional analysis aligns dendritic cells across tissues 
and species. Immunity (2016) 45:669–84. doi:10.1016/j.immuni.2016.08.015 
17. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, et al. IRF4 
transcription factor-dependent CD11b+ dendritic cells in human and mouse 
control mucosal IL-17 cytokine responses. Immunity (2013) 38:970–83. 
doi:10.1016/j.immuni.2013.04.011 
18. Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hägerbrand K, 
Marsal J, et  al. IRF4 transcription-factor-dependent CD103(+)CD11b(+) 
dendritic cells drive mucosal T helper 17 cell differentiation. Immunity (2013) 
38:958–69. doi:10.1016/j.immuni.2013.03.009 
19. Schraml BU, van Blijswijk J, Zelenay S, Whitney PG, Filby A, Acton SE, et al. 
Genetic tracing via DNGR-1 expression history defines dendritic cells as a 
hematopoietic lineage. Cell (2013) 154:843–58. doi:10.1016/j.cell.2013.07.014 
20. Naik SH, Perié L, Swart E, Gerlach C, van Rooij N, de Boer RJ, et al. Diverse 
and heritable lineage imprinting of early haematopoietic progenitors. Nature 
(2013) 496:229–32. doi:10.1038/nature12013 
21. Pei W, Feyerabend TB, Rössler J, Wang X, Postrach D, Busch K, et al. Polylox 
barcoding reveals haematopoietic stem cell fates realized in  vivo. Nature 
(2017) 548:456–60. doi:10.1038/nature23653 
22. Paul F, Arkin Y, Giladi A, Jaitin DA, Kenigsberg E, Keren-Shaul H, et  al. 
Transcriptional heterogeneity and lineage commitment in myeloid progeni-
tors. Cell (2015) 163:1663–77. doi:10.1016/j.cell.2015.11.013 
23. Perié L, Duffy KR, Kok L, de Boer RJ, Schumacher TN. The branching point 
in erythro-myeloid differentiation. Cell (2015) 163:1655–62. doi:10.1016/j.
cell.2015.11.059 
24. Schultze JL, Beyer M. Myelopoiesis reloaded: single-cell transcriptomics leads 
the way. Immunity (2016) 44:18–20. doi:10.1016/j.immuni.2015.12.019 
25. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, Littman DR, et  al. A 
clonogenic bone marrow progenitor specific for macrophages and dendritic 
cells. Science (2006) 311:83–7. doi:10.1126/science.1117729 
26. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, Saederup N, 
et  al. CX3CR1+ CD115+ CD135+ common macrophage/DC precursors 
and the role of CX3CR1 in their response to inflammation. J Exp Med (2009) 
206:595–606. doi:10.1084/jem.20081385 
27. Sathe P, Metcalf D, Vremec D, Naik SH, Langdon WY, Huntington ND, et al. 
Lymphoid tissue and plasmacytoid dendritic cells and macrophages do not 
share a common macrophage-dendritic cell-restricted progenitor. Immunity 
(2014) 41:104–15. doi:10.1016/j.immuni.2014.05.020 
28. Hettinger J, Richards DM, Hansson J, Barra MM, Joschko A-C, Krijgsveld J, 
et al. Origin of monocytes and macrophages in a committed progenitor. Nat 
Immunol (2013) 14:821–30. doi:10.1038/ni.2638 
29. Onai N, Obata-Onai A, Schmid MA, Ohteki T, Jarrossay D, Manz MG. 
Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and 
conventional dendritic cell progenitors in mouse bone marrow. Nat Immunol 
(2007) 8:1207–16. doi:10.1038/ni1518 
30. Naik SH, Sathe P, Park H-Y, Metcalf D, Proietto AI, Dakic A, et al. Development 
of plasmacytoid and conventional dendritic cell subtypes from single 
precursor cells derived in vitro and in vivo. Nat Immunol (2007) 8:1217–26. 
doi:10.1038/ni1522 
31. Liu K, Victora GD, Schwickert TA, Guermonprez P, Meredith MM, Yao K, 
et al. In vivo analysis of dendritic cell development and homeostasis. Science 
(2009) 324:392–7. doi:10.1126/science.1170540 
32. Naik SH, Metcalf D, Van Nieuwenhuijze A, Wicks I, Wu L, O’Keeffe M, 
et al. Intrasplenic steady-state dendritic cell precursors that are distinct from 
monocytes. Nat Immunol (2006) 7:663–71. doi:10.1038/ni1340 
33. Ginhoux F, Liu K, Helft J, Bogunovic M, Greter M, Hashimoto D, et al. The 
origin and development of nonlymphoid tissue CD103+ DCs. J Exp Med 
(2009) 206:3115–30. doi:10.1084/jem.20091756 
34. Grajales-Reyes GE, Iwata A, Albring J, Wu X, Tussiwand R, Kc W, et al. Batf3 
maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional 
DC clonogenic progenitor. Nat Immunol (2015) 16:708–17. doi:10.1038/
ni.3197 
35. Schlitzer A, Sivakamasundari V, Chen J, Sumatoh HRB, Schreuder J, Lum J, 
et al. Identification of cDC1- and cDC2-committed DC progenitors reveals 
early lineage priming at the common DC progenitor stage in the bone marrow. 
Nat Immunol (2015) 16:718–28. doi:10.1038/ni.3200 
36. Breton G, Lee J, Zhou YJ, Schreiber JJ, Keler T, Puhr S, et  al. Circulating 
precursors of human CD1c+ and CD141+ dendritic cells. J Exp Med (2015) 
212:401–13. doi:10.1084/jem.20141441 
37. Breton G, Zheng S, Valieris R, Tojal da Silva I, Satija R, Nussenzweig MC. 
Human dendritic cells (DCs) are derived from distinct circulating precursors 
that are precommitted to become CD1c +or CD141 +DCs. J Exp Med (2016) 
213:2861–70. doi:10.1084/jem.20161135 
38. Lee J, Breton G, Oliveira TYK, Zhou YJ, Aljoufi A, Puhr S, et al. Restricted 
dendritic cell and monocyte progenitors in human cord blood and bone 
marrow. J Exp Med (2015) 212:385–99. doi:10.1084/jem.20141442 
39. Poulin LF, Reyal Y, Uronen-Hansson H, Schraml BU, Sancho D, Murphy KM, 
et al. DNGR-1 is a specific and universal marker of mouse and human Batf3-
dependent dendritic cells in lymphoid and nonlymphoid tissues. Blood (2012) 
119:6052–62. doi:10.1182/blood-2012-01-406967 
40. Collin M, Bigley V, Haniffa M, Hambleton S. Human dendritic cell deficiency: 
the missing ID? Nat Rev Immunol (2011) 11:575–83. doi:10.1038/nri3046 
41. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. Dendritic 
cell potentials of early lymphoid and myeloid progenitors. Blood (2001) 
97:3333–41. doi:10.1182/blood.V97.11.3333 
42. Helft J, Anjos-Afonso F, Van der Veen AG, Chakravarty P, Bonnet D, Reis 
e Sousa C. Dendritic cell lineage potential in human early hematopoietic 
progenitors. Cell Rep (2017) 20:529–37. doi:10.1016/j.celrep.2017.06.075 
43. Izon D, Rudd K, DeMuth W, Pear WS, Clendenin C, Lindsley RC, et al. A 
common pathway for dendritic cell and early B cell development. J Immunol 
(2001) 167:1387–92. doi:10.4049/jimmunol.167.3.1387 
44. Ardavin C, Wu L, Li CL, Shortman K. Thymic dendritic cells and T  cells 
develop simultaneously in the thymus from a common precursor population. 
Nature (1993) 362:761–3. doi:10.1038/362761a0 
45. Welner RS, Esplin BL, Garrett KP, Pelayo R, Luche H, Fehling HJ, et  al. 
Asynchronous RAG-1 expression during B lymphopoiesis. J Immunol (2009) 
183:7768–77. doi:10.4049/jimmunol.0902333 
46. Becker AM, Michael DG, Satpathy AT, Sciammas R, Singh H, Bhattacharya D. 
IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage 
14
Salvermoser et al. A Lymphoid Path to cDCs
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 699
commitment in both myeloid and lymphoid mouse progenitors. Blood (2012) 
119:2003–12. doi:10.1182/blood-2011-06-364976 
47. Wu L, D’Amico A, Hochrein H, O’Keeffe M, Shortman K, Lucas K. Development 
of thymic and splenic dendritic cell populations from different hemopoietic 
precursors. Blood (2001) 98:3376–82. doi:10.1182/blood.V98.12.3376 
48. Lee J, Zhou YJ, Ma W, Zhang W, Aljoufi A, Luh T, et al. Lineage specification 
of human dendritic cells is marked by IRF8 expression in hematopoietic 
stem cells and multipotent progenitors. Nat Immunol (2017) 18:877–88. 
doi:10.1038/ni.3789 
49. Corcoran L, Ferrero I, Vremec D, Lucas K, Waithman J, O’Keeffe M, et  al. 
The lymphoid past of mouse plasmacytoid cells and thymic dendritic cells. 
J Immunol (2003) 170:4926–32. doi:10.4049/jimmunol.170.10.4926 
50. Sathe P, Vremec D, Wu L, Corcoran L, Shortman K. Convergent differentia-
tion: myeloid and lymphoid pathways to murine plasmacytoid dendritic cells. 
Blood (2013) 121:11–9. doi:10.1182/blood-2012-02-413336 
51. Bar-On L, Birnberg T, Lewis KL, Edelson BT, Bruder D, Hildner K, et  al. 
CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to 
plasmacytoid dendritic cells. Proc Natl Acad Sci U S A (2010) 107:14745–50. 
doi:10.1073/pnas.1001562107 
52. Shigematsu H, Reizis B, Iwasaki H, Mizuno S-I, Hu D, Traver D, et  al. 
Plasmacytoid dendritic cells activate lymphoid-specific genetic programs 
irrespective of their cellular origin. Immunity (2004) 21:43–53. doi:10.1016/j.
immuni.2004.06.011 
53. Schlenner SM, Madan V, Busch K, Tietz A, Läufle C, Costa C, et  al. Fate 
mapping reveals separate origins of T cells and myeloid lineages in the thymus. 
Immunity (2010) 32:426–36. doi:10.1016/j.immuni.2010.03.005 
54. Luche H, Ardouin L, Teo P, See P, Henri S, Merad M, et  al. The earliest 
intrathymic precursors of CD8α(+) thymic dendritic cells correspond to 
myeloid-type double-negative 1c cells. Eur J Immunol (2011) 41:2165–75. 
doi:10.1002/eji.201141728 
55. Ivanova A, Signore M, Caro N, Greene NDE, Copp AJ, Martinez-Barbera JP. In 
vivo genetic ablation by Cre-mediated expression of diphtheria toxin fragment 
A. Genesis (2005) 43:129–35. doi:10.1002/gene.20162 
56. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM, et  al. 
Cre reporter strains produced by targeted insertion of EYFP and ECFP 
into the ROSA26 locus. BMC Dev Biol (2001) 1:4. doi:10.1186/1471- 
213X-1-4 
57. Buch T, Heppner FL, Tertilt C, Heinen TJAJ, Kremer M, Wunderlich FT, 
et  al. A Cre-inducible diphtheria toxin receptor mediates cell lineage abla-
tion after toxin administration. Nat Methods (2005) 2:419–26. doi:10.1038/ 
nmeth762 
58. Schlissel MS, Corcoran LM, Baltimore D. Virus-transformed pre-B  cells 
show ordered activation but not inactivation of immunoglobulin gene 
rearrangement and transcription. J Exp Med (1991) 173:711–20. doi:10.1084/
jem.173.3.711 
59. Birnberg T, Bar-On L, Sapoznikov A, Caton ML, Cervantes-Barragán L, Makia D, 
et al. Lack of conventional dendritic cells is compatible with normal devel-
opment and T cell homeostasis, but causes myeloid proliferative syndrome. 
Immunity (2008) 29:986–97. doi:10.1016/j.immuni.2008.10.012 
60. Sichien D, Scott CL, Martens L, Vanderkerken M, Van Gassen S, Plantinga M, 
et al. IRF8 transcription factor controls survival and function of terminally 
differentiated conventional and plasmacytoid dendritic cells, respectively. 
Immunity (2016) 45:626–40. doi:10.1016/j.immuni.2016.08.013 
61. Jiao J, Dragomir A-C, Kocabayoglu P, Rahman AH, Chow A, Hashimoto D, 
et  al. Central role of conventional dendritic cells in regulation of bone 
marrow release and survival of neutrophils. J Immunol (2014) 192:3374–82. 
doi:10.4049/jimmunol.1300237 
62. Tittel AP, Heuser C, Ohliger C, Llanto C, Yona S, Hämmerling GJ, et  al. 
Functionally relevant neutrophilia in CD11c diphtheria toxin receptor trans-
genic mice. Nat Methods (2012) 9:385–90. doi:10.1038/nmeth.1905 
63. Holtschke T, Löhler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, et  al. 
Immunodeficiency and chronic myelogenous leukemia-like syndrome in 
mice with a targeted mutation of the ICSBP gene. Cell (1996) 87:307–17. 
doi:10.1016/S0092-8674(00)81348-3 
64. van Blijswijk J, Schraml BU, Rogers NC, Whitney PG, Zelenay S, Acton SE, 
et  al. Altered lymph node composition in diphtheria toxin receptor-based 
mouse models to ablate dendritic cells. J Immunol (2015) 194:307–15. 
doi:10.4049/jimmunol.1401999 
65. Miller JC, Brown BD, Shay T, Gautier EL, Jojic V, Cohain A, et al. Deciphering 
the transcriptional network of the dendritic cell lineage. Nat Immunol (2012) 
13:888–99. doi:10.1038/ni.2370 
66. Villani A-C, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. 
Single-cell RNA-seq reveals new types of human blood dendritic cells, mono-
cytes, and progenitors. Science (2017) 356:eaah4573. doi:10.1126/science.
aah4573 
67. Shortman K, Sathe P, Vremec D, Naik S, O’Keeffe M. Plasmacytoid den-
dritic cell development. Adv Immunol (2013) 120:105–26. doi:10.1016/
B978-0-12-417028-5.00004-1 
68. Reizis B. Regulation of plasmacytoid dendritic cell development. Curr Opin 
Immunol (2010) 22:206–11. doi:10.1016/j.coi.2010.01.005 
69. Pelayo R, Hirose J, Huang J, Garrett KP, Delogu A, Busslinger M, et  al. 
Derivation of 2 categories of plasmacytoid dendritic cells in murine bone 
marrow. Blood (2005) 105:4407–15. doi:10.1182/blood-2004-07-2529 
70. Vremec D, Shortman K. What’s in a name? Some early and current issues 
in dendritic cell nomenclature. Front Immunol (2015) 6:267. doi:10.3389/
fimmu.2015.00267 
71. Schraml BU, Reis e Sousa C. Defining dendritic cells. Curr Opin Immunol 
(2015) 32:13–20. doi:10.1016/j.coi.2014.11.001 
72. Ginhoux F, Guilliams M, Naik S. Dendritic cell and macrophage nomenclature 
and classification. Front Immunol (2016). doi:10.3389/978-2-88919-918-1 
73. Lavin Y, Winter D, Blecher-Gonen R, David E, Keren-Shaul H, Merad M, 
et al. Tissue-resident macrophage enhancer landscapes are shaped by the local 
microenvironment. Cell (2014) 159:1312–26. doi:10.1016/j.cell.2014.11.018 
74. Gosselin D, Link VM, Romanoski CE, Fonseca GJ, Eichenfield DZ, Spann NJ, 
et  al. Environment drives selection and function of enhancers controlling 
tissue-specific macrophage identities. Cell (2014) 159:1327–40. doi:10.1016/j.
cell.2014.11.023 
75. Gosselin D, Skola D, Coufal NG, Holtman IR, Schlachetzki JCM, Sajti E, 
et  al. An environment-dependent transcriptional network specifies human 
microglia identity. Science (2017) 1617:eaal3222. doi:10.1126/science.aal3222 
76. van de Laar L, Saelens W, De Prijck S, Martens L, Scott CL, Van Isterdael G, 
et  al. Yolk sac macrophages, fetal liver, and adult monocytes can colonize 
an empty niche and develop into functional tissue-resident macrophages. 
Immunity (2016) 44:1–27. doi:10.1016/j.immuni.2016.02.017 
77. Gibbings SL, Goyal R, Desch AN, Leach SM, Prabagar M, Atif SM, et  al. 
Transcriptome analysis highlights the conserved difference between embry-
onic and postnatal-derived alveolar macrophages. Blood (2015) 126:1357–66. 
doi:10.1182/blood-2015-01-624809 
78. Hochweller K, Miloud T, Striegler J, Naik S, Hämmerling GJ, Garbi N. 
Homeostasis of dendritic cells in lymphoid organs is controlled by regulation 
of their precursors via a feedback loop. Blood (2009) 114:4411–21. doi:10.1182/
blood-2008-11-188045 
79. Kabashima K, Banks TA, Ansel KM, Lu TT, Ware CF, Cyster JG. Intrinsic 
lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue 
dendritic cells. Immunity (2005) 22:439–50. doi:10.1016/j.immuni.2005. 
02.007 
80. Tussiwand R, Onai N, Mazzucchelli L, Manz MG. Inhibition of natural type I 
IFN-producing and dendritic cell development by a small molecule receptor 
tyrosine kinase inhibitor with Flt3 affinity. J Immunol (2005) 175:3674–80. 
doi:10.4049/jimmunol.175.6.3674 
81. McKenna HJ, Stocking KL, Miller RE, Brasel K, De Smedt T, Maraskovsky E, 
et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hemato-
poietic progenitor cells, dendritic cells, and natural killer cells. Blood (2000) 
95:3489–97. 
82. Hildner K, Edelson BT, Purtha WE, Diamond M, Matsushita H, Kohyama M, 
et  al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells 
in cytotoxic T  cell immunity. Science (2008) 322:1097–100. doi:10.1126/
science.1164206 
83. Ohta T, Sugiyama M, Hemmi H, Yamazaki C, Okura S, Sasaki I, et al. Crucial 
roles of XCR1-expressing dendritic cells and the XCR1- XCL1 chemokine 
axis in intestinal immune homeostasis. Sci Rep (2016) 6:1–11. doi:10.1038/
srep23505 
84. Böiers C, Carrelha J, Lutteropp M, Luc S, Green JCA, Azzoni E, et  al. 
Lymphomyeloid contribution of an immune-restricted progenitor emerging 
prior to definitive hematopoietic stem cells. Cell Stem Cell (2013) 13:535–48. 
doi:10.1016/j.stem.2013.08.012 
15
Salvermoser et al. A Lymphoid Path to cDCs
Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 699
85. Yáñez A, Coetzee SG, Olsson A, Muench DE, Berman BP, Hazelett DJ, et al. 
Granulocyte-monocyte progenitors and monocyte- dendritic cell progenitors 
independently produce functionally distinct monocytes. Immunity (2017) 
47:890–902.e4. doi:10.1016/j.immuni.2017.10.021 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2018 Salvermoser, van Blijswijk, Papaioannou, Rambichler, Pasztoi, 
Pakalniškytė, Rogers, Keppler, Straub, Reis e Sousa and Schraml. This is an 
open-access article distributed under the terms of the Creative Commons Attribution 
License (CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) and the copyright owner are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 




Clec9a-mediated ablation of conventional dendritic cells suggests a 
lymphoid path to generating dendritic cells in vivo 
 
Johanna Salvermoser1,2, Janneke van Blijswijk3, Nikos E. Papaioannou2, Stephan 
Rambichler1,2, Maria Pasztoi2, Dalia Pakalniškytė1,2, Neil C. Rogers3, Selina J. Keppler4, Tobias 
Straub2,5, Caetano Reis e Sousa3*, Barbara U. Schraml1,2* 
 
1Walter-Brendel-Centre for Experimental Medicine, University Hospital, LMU Munich, 
Großhaderner Str. 9, 82152 Planegg Martinsried, Germany 
2Biomedical Center, LMU Munich, Großhaderner Str. 9, 82152 Planegg Martinsried, Germany 
3Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, 
United Kingdom 
4 Technische Universität München, Klinikum Rechts der Isar, Institut für Klinische Chemie und 
Pathobiochemie, Ismaningerstr. 22, 81675 Munich, Germany 
5 Core Facility Bioinformatics, Biomedical Center (BMC), LMU Munich, Großhaderner Str. 9 
82152 Planegg Martinsried 
*These authors contributed equally 
 
correspondence: barbara.schraml@med.uni-muenchen.de , caetano@crick.ac.uk  
  
















































































































































































Supplementary Figure 1: Clec9acre/creRosaDTA mice develop signs of age-dependent 
myeloproliferation  
A, B. Neutrophils and monocytes were identified by flow cytometry in spleen from control and 
Clec9acre/creRosaDTA mice. A. Representative gating strategy in 14-week-old mice. Neutrophils 
were identified as live CD11b+Ly-6G+ cells. Monocytes were identified as live Ly-6G-Ly-
6C+CD11b+ cells. B. The frequency and total counts of splenic Ly-6G+ neutrophils and Ly-6C+ 
monocytes are plotted. C. Frequency and counts of red pulp macrophages (RPM) identified as 
autofluorescent CD64+F4/80hi cells or as autofluorescent CD64+ cells in spleen from 
Clec9acre/creRosaDTA and control mice. Representative gating strategies to identify red pulp 
macrophages are shown. D. Serum was collected from control and Clec9acre/creRosaDTA mice 
older than 10 weeks and the concentrations of G-CSF, CXCL9, CCL5, CCL17, and CCL22 
were determined by ELISA or cytometric bead array as described in the materials and methods. 
Data are compiled from at least two independent experiments. Each symbol represents one 
mouse. * p<0.05, ** p<0.001. 
  
  


















































































































































































































































cDC1 cDC2 cDC1 DP cDC2 SP cDC2







































































































Supplementary Figure 2: Analysis of pDCs in spleen from Clec9acre/creRosaDTA mice and 
loss of pre-cDCs in Clec9acre/creRosaDTR mice 
A, B, C. Clec9acre/creRosaDTR and control mice were injected i.p. with 25 ng/g of diphtheria 
toxin (DT). 24 hours later spleens were analysed by flow cytometry. A. Representative gating 
strategy of splenic lin- (CD3, CD4, CD8, Ter119, NK1.1, B220, CD11b, MHCII) 
CD11c+CD43+CD135+CD172alow pre-cDCs. B. Frequency and total counts of pre-cDCs were 
identified as in (A). C. The frequency and total counts of neutrophils (Ly-6G+CD11b+) and Ly-
6C+ monocytes (Ly-6G-Ly-6C+CD11b+) are shown. D. Splenic pDCs were identified as 
SiglecH+B220+ cells by flow cytometry in Clec9acre/creRosaDTA and control mice. The frequency 
and counts of splenic pDCs in Clec9acre/creRosaDTA and control mice of the indicated ages are 
shown. E. Analysis of DNGR-1 protein expression on pDCs from Clec9a+/creRosaDTA mice. 
DNGR-1 protein levels were analysed by flow cytometry on splenic B220+SiglecH+ pDCs from 
Clec9a+/creRosa+/+ control mice and compared to levels on pDCs from Clec9a+/creRosaDTA mice. 
Homozygous Clec9acre/creRosa+/+ mice serve as a negative control for DNGR-1 protein staining. 
F, G. mesenteric LN from Clec9a+/creRosaDTA and control mice (F) and colon from 
Clec9acre/creRosaDTA and control mice (G) were analysed for total organ cellularity, as well as 
for the presence of the indicated DC subsets. F. Resident and migratory cDCs were 
distinguished as CD11c+MHCII+ and CD11cintMHCIIhi cells respectively. cDC1 were 
identified as XCR-1+CD11b- cells and cDC2 were identified as XCR-1-CD11b+ or 
CD103+CD11b+ (DP) and CD103-CD11b+ (SP) cDC2. F. Colonic cDCs were identified as 
CD11c+MHCII+CD64- cells and distinguished as XCR-1+CD172a- cDC1, as well as 
CD103+CD11b+CD172a+ (DP) and CD103-CD11b+CD172a+ (SP) cDC2. Each symbol 
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Supplementary Figure 3. Loss of cDC progenitors in Clec9acre/creRosaDTA and 
Clec9a+/creRosaDTA mice. 
A, B. cDC progenitors were identified by flow cytometry in the bone marrow and spleen of 10-
week-old control and Clec9acre/creRosaDTA mice. A. Live lineage negative (lin-; CD3, CD4, 
CD8, CD11b, MHCII, Ter119, NK1.1, B220) CD11c+ cells from bone marrow of 
Clec9acre/creRosaDTA and control mice were gated and quantified. The frequency and total counts 
per femur are shown. B. Lin-CD11c+CD43+ splenocytes, containing pre-cDCs, were identified 
in control and Clec9acre/creRosaDTA mice 10 weeks of age. Frequency and total counts per spleen 
are shown. C. Lin-CD11c+CD43+CD135+CD172alow pre-cDCs were quantified in spleen from 
Clec9a+/creRosaDTA mice 9-12 weeks of age. D. CD11c+ splenocytes were cultured with or 
without 15ng/ml FLT3L for 2 hours at 37°C or 4°C in the presence or absence of 0,02% sodium 
azide to interfere with endocytosis. Cells were then washed and analysed for CD135 expression. 












































































































































































































































































































































































































































































































































































































Supplementary Figure 4: Transcriptional profiling of cDC2 from Clec9acre/creRosaDTA 
mice reveals no major loss in cDC identity. 
Splenic CD11c+MHCII+CD11b+ cDC2 Clec9acre/creRosaDTA mice (CD11b+ DTA) and cDC2 
(identified as CD11c+MHCII+CD11b+YFP+ cells from Clec9acre/creRosaYFP mice; YFP+) were 
sorted and subjected to microarray analysis. Population clustering and heat map display of the 
relative expression values for migratory cDC signature genes (A), resident cDC signature genes 
(B), and core macrophage signature genes (C) in CD11b+ DTA and YFP+ cDC2 samples 
compared to the indicated murine cDC and macrophage populations from the Immgen database. 
  

Supplementary Figure 5: cDC2 from Clec9acre/creRosaDTA mice exhibit somatic 
rearrangements of lymphoid receptor genes.  
A, B. Gating strategy and purity check for DJ- rearrangement PCR. A. CD11c+MHCII+CD11b+ 
cDC2 from control and Clec9acre/creRosaDTA mice were sorted according to the indicated gating 
strategy. B. The purity of the sorted cDC2 populations from control and Clec9acre/creRosaDTA 
mice is shown. C. CD11c+MHCII+CD11b+ cDC2 from control and Clec9acre/creRosaDTA mice 
were sorted and genomic DNA was isolated. Genomic PCR was performed using primers for 
the germline (GL) locus and primer mixtures homologous for regions of the Dfl16 and Dsp2 D 
gene families for detecting D–J rearrangements of the IgH chain. DJ rearrangements in pDCs 
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Conventional dendritic cells (cDC) are key activators of naive T cells, and can be targeted in
adults to induce adaptive immunity, but in early life are considered under-developed or
functionally immature. Here we show that, in early life, when the immune system develops,
cDC2 exhibit a dual hematopoietic origin and, like other myeloid and lymphoid cells, develop
in waves. Developmentally distinct cDC2 in early life, despite being distinguishable by fate
mapping, are transcriptionally and functionally similar. cDC2 in early and adult life, however,
are exposed to distinct cytokine environments that shape their transcriptional profile and
alter their ability to sense pathogens, secrete cytokines and polarize T cells. We further show
that cDC2 in early life, despite being distinct from cDC2 in adult life, are functionally com-
petent and can induce T cell responses. Our results thus highlight the potential of harnessing
cDC2 for boosting immunity in early life.
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Vaccination is a reliable means of inducing protectiveimmunity but it can have limited efficacy in infants1. Thenewborn immune system exhibits quantitative and qua-
litative differences compared to adult hosts that ultimately result
in dampened immune responses in early life, which are necessary
to tolerate the sudden encounter with commensal microbes and
environmental antigens2,3. The unique features of the early life
immune system also leave infants at increased risk of infection3.
Antigen presentation and priming of T cells are pre-requisites for
adaptive immune responses and the establishment of protective
immunity. Improving T-cell priming by tailoring the design of
vaccines towards the age-specific immune parameters of neonates
and infants has therefore been suggested as a possibility to boost
vaccination efficacy and immunity in early life3,4.
Classical or conventional dendritic cells (cDCs) are potent
activators of naive T cells that have successfully been targeted to
induce adaptive immune responses in adults5–8. In early life,
however, these cells are considered under-developed or func-
tionally immature. In murine and human neonates, the cDC
compartment is smaller than that of adults9–11 and cDCs from
both human and murine neonates express lower basal levels of
major histocompatibility complex II (MHCII) and costimulatory
molecules rendering them less potent at stimulating T cells12–15.
The early life murine cDC compartment further exhibits an
intrinsic bias to generate T-helper type 2 (Th2) immune
responses due to delayed production of IL-12p7016,17. Such Th2
bias is also evident in cord blood cDCs, which exhibit reduced IL-
12p70 production and upregulation of costimulatory molecules
following pathogenic stimulation compared to cDCs from per-
ipheral blood of adults13,14,18. However, expansion of cDCs in
early life by administration of the DC growth factor fms tyrosine
kinase 3 ligand (FLT3L) can improve innate and adaptive
immune defense in mice19,20, indicating a potential of early life
cDCs to initiate functional immune responses.
The cDC compartment is composed of developmentally dis-
tinct subsets with unique functions in immunity5,6,21. cDC1 are
potent cross-presenters and activators of CD8+ T cells and pro-
mote Th1 differentiation through the production of interleukin-
12 (IL-12) and interferon-γ (IFN-γ)22–24. In contrast, cDC2 are
considered more potent activators of CD4+ T cells and inducers
of Th2, Th17, and T-follicular helper cell differentiation25–29. The
neonatal cDC compartment in mice is dominated by cDC1,
whereas cDC2 constitute the main cDC subtype in most adult
organs9,10,30,31. Considering the predominant role of cDC1 in
producing IL-12 and IFN-γ in adults23,24, it is unlikely that subset
distribution can account for the observed Th2 bias of the cDC
compartment in early life and in most human tissues the relative
frequency of cDC1 and cDC2 remains stable throughout life15.
These data suggest that an additional layer of age-dependent
regulation influences cDC function. This is highlighted by the fact
that neonatal cDC1 are refractory to IFN-α signaling, produce
less IL-12 but more IL-10 than their adult counterparts and have
a reduced capacity to activate CD4+ T cells and select epitopes for
presentation to CD8+ T cells during viral infection9,16,17,32,33.
Few studies have investigated cDC2 in early life. In neonatal
mouse spleen, CD8− cDCs show lower production of IFN-γ and
reduced activation of alloreactive T cells than their adult coun-
terparts9. Although CD8 expression does not reliably distinguish
cDC1 and cDC2 in neonatal spleen17,34, these data suggest a
reduced ability of neonatal cDC2 to activate T cells. Similarly,
cDC2 in neonatal lung express lower costimulatory molecules
than adult cDC232,35–37, although they can promote Th2-
mediated allergy and induce some CD8+ T-cell proliferation
when infected with respiratory syncytial virus30,32,38. These data
indicate that in early life, cDC2 have the potential to activate
T cells in some circumstances, raising the question whether this
capacity could be harnessed in a broader sense, for instance to
initiate T-cell responses in the spleen, which is a major site for
antibody production39.
The first blood and immune cells arise from extra-embryonic
yolk sac progenitors and for some cell types, such as macrophages
or mast cells, yolk sac-derived cells can persist in tissues for
extended periods of time after birth40–42. cDCs first arise during
embryogenesis in mice and humans, when they are thought to
critically contribute to fetomaternal tolerance9,10,40,43. However,
the origins of cDCs in early life have not been investigated. In
adults, cDCs develop downstream of hematopoietic stem cells
(HSCs) from a fraction of myeloid bone marrow progenitors
capable of generating plasmacytoid DCs (pDCs) and cDCs that
has been termed common DC progenitor (CDP)44–47. Within
CDPs in mice, expression of the C-type lectin receptor DNGR-1
(encoded by the Clec9a gene) distinguishes cDC-restricted pro-
genitors48. CDPs further differentiate into pre-cDCs, which
continue to express DNGR-148, exit the bone marrow and
terminally differentiate into cDC subtypes in peripheral organs
and in response to environmental cues49. The Clec9a promoter is
also active in cDC1 and to a lower extent on pDCs but it is not
active in cDC2 and other lymphoid or myeloid cells48,50–52. By
crossing mice expressing CRE-recombinase under the Clec9a
promoter to Rosalox-stop-lox-yellow fluorescent protein (YFP) or
Rosalox-stop-lox-TOMATO mice, we have generated mice that
faithfully track cells belonging to the cDC lineage in steady state
and under inflammatory conditions48,53,54. Using these mice, we
have found that cDC2 in adult spleen are predominantly derived
from CDP/pre-cDC48,53,54, which is consistent with other
studies55,56.
Here we set out to investigate the differences between cDC2 in
early and adult life and clarify the reasons underlying age-
dependent functional regulation of cDC2. We reveal that cDC2,
analogous to other lymphoid and myeloid cell types, develop in
waves. cDC2 arising from distinct hematopoietic sources in early
life are phenotypically and transcriptionally similar, and func-
tionally capable to induce T-cell responses. cDC2 in early and
adult life, however, have a distinct ability to sense pathogens,
produce cytokines and induce T-cell differentiation that is tran-
scriptionally imprinted by distinct cytokine signaling in early and
adult life. Exploiting the unique aspects of cDC2 in early life may
thus provide an efficient means to boost vaccination efficacy and
protective immunity.
Results
Early-life cDC2 exhibit ontogenetic diversity. To investigate
phenotype and origin of cDCs in early life, we first profiled these
cells in Clec9acre/+RosaTOM mice. In this context, we defined the
neonatal period as the first 10 days after birth57. In the steady-
state mouse spleen, cDCs, identified as CD11c+MHCII+ cells5,
could be found as early as embryonic day 16 (E16, Fig. 1a, b and
Supplementary Fig. 1). The frequency of CD11c+MHCII+ cells
increased steadily with age and reached adult levels at around
4 weeks of age (Fig. 1a, b and Supplementary Fig. 1), confirming
results of previous studies9,10. CD11c+MCHII+ cells could fur-
ther be divided into CD24+ and CD11b+ cells5. CD24+ cDCs
include XCR-1+ BATF3-dependent cDC1, as well a subset of
non-canonical BATF3-independent CD8+ cDCs that expresses
CD172a and CX3CR1 but lacks XCR-1 (Fig. 1a)58–60. As expec-
ted, CD24+ cDCs dominated the splenic cDC compartment in
early life but became less frequent with age, whereas the pro-
portion of CD11b+ cDC2 increased with age9 (Fig. 1c). Notably,
XCR-1+ cDC1 were the more frequent cell type within CD24+
cells at most ages examined, although in 2-day-old and adult mice
non-canonical CD8+ cDC and cDC1 were present at equal
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proportions (Fig. 1d). In the spleen, CD11b+ cDC2 can be divi-
ded into NOTCH2- and RUNX3-dependent ESAMhigh cDC2 and
ESAMlow cDC2, which develop independent of these transcrip-
tion factors61–63 (Fig. 1a and Supplementary Fig. 1A, B). Notably,
ESAMhigh cells were less frequent within the cDC2 compartment
of neonatal compared to adult mice; however, the proportion of
ESAMhigh cells within the cDC2 compartment reached adult
levels between 2 and 3 weeks of age (Fig. 1e and Supplementary
Fig. 1A, B), which coincides with the organization of the splenic
architecture.
We next assessed Clec9a-expression history with age by
profiling TOMATO expression in splenic leukocytes from
Clec9acre/+RosaTOM mice. cDC2 lack DNGR-1 expression and
therefore TOMATO labeling in this population is a true indicator
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of cell origin48. Consistent with our previous observations and
their CDP origin5,48,54–56, cDC2 from adult spleen showed near-
complete labeling with TOMATO in Clec9acre/+RosaTOM mice
(93 ± 1.28%). Notably, in neonatal mice TOMATO labeling in
cDC2 was strongly reduced (20.6 ± 4.48%), indicating ontogenetic
heterogeneity. The frequency of TOMATO+ cells within cDC2
increased with age until adult labeling was reached at around
4 weeks of age (86 ± 1.4%; Fig. 1f, g).
We have previously shown that increased CRE levels (in
homozygous Clec9acre mice) leads to markedly increased labeling
of DC precursors and differentiated cDCs, because a fraction of
precursors ‘escapes’’ labeling in a stochastic fashion48. In
addition, the choice of fate reporter can influence labeling
efficiency due to differences in the distance between the loxP
sites64. To exclude that reduced labeling of neonatal cDC2 was an
artifact of the specific fate reporter used or due to “progenitor
escape” in mice heterozygous for cre, we analyzed homozygous
Clec9acre/creRosaTOM mice and Clec9acre/creRosaYFP mice. In both
models, a relative lack of Clec9acre-mediated fate labeling in
neonatal cDC2 was observed (Supplementary Fig. 1C, D).
Importantly, TOMATO labeling did not correlate with either of
the two cDC2 subsets, as ESAMhigh or ESAMlow cells showed
similar labeling frequency at all ages examined (Supplementary
Fig. 1E). Comparable to observations in adult mice48,54, Clec9acre-
mediated TOMATO labeling in young mice remained restricted
to CD11c+MHCII+ cDCs and cells resembling pDCs or pre-
cDCs based on low CD11c and MHCII expression (Supplemen-
tary Fig. 1F, G).
As most of our work on DC ontogeny stems from studies in
adult mice, we next confirmed that DNGR-1-expressing cDC
progenitors were present in early life bone marrow and spleen. Cells




could be found in bone marrow from neonatal mice (Supplemen-
tary Fig. 2A, B). Notably, putative MDPs were more frequent,
whereas CDP and pre-cDC-like cells were less frequent in neonatal
compared to adult bone marrow (Supplementary Fig. 2B).
Importantly, pre-cDC-like cells in bone marrow from 2-day- and
1-week-old mice uniformly expressed DNGR-1 (Fig. 1h and
Supplementary Fig. 2C). Accordingly, TOMATO was detected in
CDPs and pre-cDCs, but not MDPs or common lymphoid
progenitors (CLPs) of 1- and 2-week-old Clec9acre/creRosaTOM
mice, as defined phenotypically (Supplementary Fig. 2E). These
data confirm that Clec9a-driven CRE was active in DC precursors
in early life. Importantly, pre-cDCs from 1- and 2-week-old
mice labeled with TOMATO to a similar extent as their counter-
parts from adult mice, although labeling at 1 week of age
had not completely reached adult levels (Supplementary Fig. 2E;
81.15 ± 2.77% PND7, 94.67 ± 1.72% 2 weeks, 93.61 ± 2.93% adult).
Pre-cDC-like cells with unimodal DNGR-1 expression were also
found in spleen from 2-day- and 1-week-old mice (Fig. 1i and
Supplementary Fig. 2D), and labeled with TOMATO at similar
levels as their bone marrow counterparts (Supplementary Fig. 2E,
F), indicating that CRE-mediated labeling of pre-cDCs completes in
bone marrow. Actively cycling progenitor cells can escape labeling
because of a time lag between CRE protein synthesis and DNA
recombination45,48,49. If cDC2 in neonates escaped labeling because
of such rapid transition through their precursor stage, we would
expect higher labeling in differentiated cDC2 than in their
immediate progenitors. However, splenic pre-cDC labeled with
TOMATO to a larger extent than differentiated cDC2 from the
same mice at one and 2 weeks of age (Supplementary Fig. 2F).
This is in contrast to adult mice, where labeling of splenic cDC2
and pre-cDCs was similar (Supplementary Fig. 2f). To further
exclude the possibility that cDC2 in early life lack detectable
TOMATO, because they have had insufficient time to
accumulate enough fluorescent protein, we sorted TOMATO+
and TOMATO− CD11c+MHCII+CD11b+ cells from 1-week-old
Clec9acre/creRosaTOM mice and cultured them in the presence of the
DC survival factors FLT3L and Granulocyte-macrophage colony-
stimulating factor (GM-CSF). After 24 h, TOMATO− cells had
remained TOMATO−, supporting the notion that these cells arise
independently of Clec9a-expressing progenitors (Supplementary
Fig. 2G). Thus, cells resembling bona fide Clec9a-expressing cDC
progenitors exist in early life and Clec9acre mice can be used to trace
cDCs in early life.
Fate mapping reveals a lymphoid contribution to cDC2 in
early life. To address the origin of cDC2 in early life, we first
crossed Clec9acre/creRosaYFP mice to mice lacking the growth
factor FLT3L, which is required for the development of all DCs65.
In 2-week-old Clec9acre/creRosaYFPFlt3l−/− mice, both cDC1 and
cDC2 were strongly reduced (Fig. 2a). Thus, early-life cDC2
require FLT3L for their development, independent of whether
they arise from Clec9a-expressing progenitors or not. Hemato-
poiesis begins before birth and, in mice, yolk sac progenitors
contribute to the generation of lymphoid and myeloid immune
cells41,42,66,67. To assess the contribution of yolk sac ery-
thromyeloid progenitors to the cDC2 compartment in early life,
we treated pregnant Csf1rMer-iCre-MerRosaYFP dams at E8.5 with
4OH-tamoxifen41,67 and analyzed spleens from offspring mice at
E18.5, as well as 2 and 4 weeks after birth. Importantly, neither
CD24+ nor CD11b+ cDCs labeled with YFP at any ages exam-
ined, when compared to liver Kupffer cells and splenic macro-
phages, which served as positive controls (Fig. 2b and
Supplementary Fig. 3A). The transcription factor c-Myb is dis-
pensable for yolk sac hematopoiesis but essential for the
Fig. 1 Developmental heterogeneity of early life cDC2. a–e Spleens from Clec9acre/+RosaTOM and Clec9acre/creRosaTOM mice of the indicated ages were
analyzed by flow cytometry. a Single live autofluorescence-negative cells were gated and cDCs identified as CD11c+MHCII+CD64− cells. cDCs were
further divided into CD24+ and CD11b+ cells, and analyzed for XCR-1 and ESAM expression, respectively. b Frequency of CD11c+MHCII+ cDCs in total
splenocytes (n= 13, PND2; n= 25, PND7–8; n= 20, PND14–15; n= 14, PND19–22; n= 12, 4 weeks; n= 5, adult). c Ratio of CD11b+ to CD24+ cells within
CD11c+MHCII+ cDCs (n= 13, PND2; n= 21, PND7–8; n= 20, PND14–15; n= 14, PND19–22; n= 12, 4 weeks; n= 5, adult). d The percentage of XCR-1+
and XCR-1− cells within CD24+ cDC1 is shown (n= 12, PND2; n= 21, PND7–8; n= 20, PND14–15; n= 14, PND19–22; n= 12, 4 weeks; n= 5, adult). e The
percentage of ESAMhigh and ESAMlow cells within CD11b+ cDC2 is shown (n= 6, PND2; n= 11, PND7–8; n= 18, PND14–15; n= 14, PND19–22; n= 11,
4 weeks; n= 4, adult). f Representative flow cytometry gating for TOMATO expression in splenic cDC2 from 1-week-old and adult Clec9acre/+RosaTOM
mice. g The frequency of TOMATO+ cells within splenic CD11b+ cDC2 of Clec9acre/+RosaTOM mice with age (n= 4, PND2; n= 11, PND7–8; n= 6,
PND14–15; n= 10, PND19–22; n= 5, 4 weeks; n= 3, adult). Each dot represents one mouse, horizontal bars represent mean, error bars represent SD, gray
rectangles indicate weaning. ns: not significant. Statistical analysis was performed using two-tailed t-test. h, i Bone marrow (h) and spleen (i) from 2-day-
old wild-type mice were analyzed by flow cytometry. Lin−(CD3, B220, NK1.1, CD4, CD8α, TER119) cells were gated, pre-cDCs were identified as indicated
and stained with anti-DNGR-1 (red) or isotype-matched control antibodies (gray). Source data are provided as a Source Data file.
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development of definitive HSCs68. Myb-deficient mice are
embryonically lethal but survive until E16.5. At this time CD24+
and CD11b+ cDCs, but not splenic macrophages, were reduced in
spleens from Myb−/− compared to littermate control embryos
(Fig. 2c). Thus, CD11c+MHCII+ cells arise independent of yolk
sac-derived erythromyeloid progenitors and in late embryogen-
esis require c-Myb for their development, suggesting that they
arise from definitive hematopoiesis.
CLPs can generate cDC-like cells in adoptive transfer69–73 and
we have shown that lymphopoiesis contributes to cDC generation
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when myeloid cDC progenitors are impaired74. When cultured
in vitro with FLT3L CLPs from Clec9acre/+RosaTOM mice gave
rise to CD11c+MHCII+ cDC-like cells that predominantly
resembled cDC1. However, few cDC2-like cells were also
generated. These remained TOMATO negative, suggesting that
CLP can generate TOM− cDC2 (Supplementary Fig. 3B).
Expression of recombination-activating gene-1 is first detected
in CLPs and required for the development of B and T cells by
promoting somatic rearrangements of antigen receptor genes75.
Therefore, we profiled YFP labeling of splenic leukocytes in
neonatal Rag1creRosaYFP mice at 2–3 and 7–9 days after birth, as
well as in adulthood. As lineage decisions are stochastic, fate
mapping with constitutive Cre is not absolute and should be
considered at the population level and in the context of positive
and negative control populations. Although B cells exhibited
near-complete labeling with YFP at all ages examined (Fig. 2d),
labeling in neutrophils (11 ± 2.86% PND2–3, 6.63 ± 2.32%
PND7–9, 2.27 ± 0.82% adults, Fig. 2d) and bone marrow
erythroid cells (5.32 ± 1.88% PND2–3, 1.87 ± 0.8% PND7–9)
(Supplementary Fig. 3C), which served as negative controls, was
low as expected66. Notably, in 2- to 3-day- and 7- to 9-day-old
Rag1creRosaYFP mice cDC2 labeled with YFP at 29 ± 5.30% and
13.43 ± 3.16%, respectively (Fig. 2d and Supplementary Fig. 3C),
whereas in cDC2 from adult spleen Rag1cre-mediated YFP
labeling did not exceed labeling of negative control populations
(Fig. 2d and Supplementary Fig. 3C). Importantly, YFP labeling
was comparable between ESAMhigh (16.15 ± 1.01%) and ESAM-
low (15.21 ± 1.07%) cDC2 in 7- to 9-day-old mice (Supplementary
Fig. 3D), again supporting similar early life heterogeneity in both
subsets. Of note, CD24+ cDC1 showed greater evidence of
Rag1cre expression history compared to cDC2 in neonatal and
adult mice (Fig. 2d). IL-7 receptor (Il7r)-cre mice have been used
to demonstrate that lymphoid progenitors do not contribute to
cDCs in adult mice76. We therefore used these mice as
independent model to map the fate of lymphoid-restricted
progenitors. Importantly, cDC2 from 2-day- and 1-week-old
Il7rcreRosaRFP mice labeled strongly with RFP, although labeling
was lower in cDC2 from 1 week compared to 2-day-old mice
(Fig. 2e).
Cxcr4creER mice label consecutive stages of definitive hemato-
poiesis in embryonic and adult mice, while not labeling yolk sac
progenitors77. We therefore pulsed Cxcr4creERRosamTmG mice
with tamoxifen at E12.5, reasoning that fetal liver HSCs would be
labeled, allowing us to assess their contribution to splenic DCs. At
E18.5, microglia, which served as negative control, exhibited no
green fluorescent protein (GFP) labeling, as expected77. In
contrast, we observed labeling of monocytes and macrophages
in E18.5 spleen, consistent with their descendance from fetal liver
HSCs (Supplementary Fig. 3E). Importantly, cDCs labeled with
GFP to a similar extent, supporting the notion that fetal liver-
resident progenitors contribute to cDC2 in early life (Supple-
mentary Fig. 3E).
Thus, fate mapping indicates a lymphoid contribution to the
steady-state cDC2 pool in early life, but not adulthood. Coupled
to the observation that cDC2 acquire Clec9acre expression history
with age, these data suggest that cDC2 development is
regulated in waves, with fetal liver-resident lymphoid progenitors
contributing early but being gradually replaced with age by
bona fide cDCs arising from Clec9a-expressing progenitors.
Henceforth, we will refer to CD11c+MHCII+CD11b+ cells
from Clec9acreRosaTOM mice that lack TOMATO expression as
TOM− DC2 (Fig. 1f).
TOM+ cDC2 and TOM− DC2 in early life are phenotypically
similar. Phenotypic analysis revealed no obvious differences in
the expression of the prototypical cDC2 markers CLEC4A4,
CD172a, CD26, ESAM, or CD4 on TOM+ cDC2 and TOM−
DC2 from 1-week-old Clec9acre/creRosaTOM mice (Fig. 3a).
Expression of MHCII and the costimulatory molecule CD80 were
also similar between TOM+ and TOM− cells (Fig. 3a). Using
cytospin analyses we found cells with the typical dendritic mor-
phology of cDCs, as well as cells with round morphology and
little cytoplasm within TOM+ cDC2 and TOM− DC2 (Supple-
mentary Fig. 3F). TOM+ cDC2 and TOM− DC2 in spleens from
1-week-old mice were located in the developing white pulp and in
close proximity to CD3+ T cells (Fig. 3b). Thus, Clec9a-negative
progenitors generate cDC2-like cells with similar phenotype and
tissue localization to bona fide cDC2 arising from Clec9a-
expressing progenitors.
TOM+ cDC2 and TOM− DC2 in early life are transcriptionally
identical. Although environment strongly impacts cell identity,
myeloid and lymphoid cell types arising from distinct hemato-
poietic sources at specified times during development can differ
transcriptionally and functionally42,78–82. To address if ontogeny
transcriptionally imprints cDC2, we compared the gene expres-
sion profile of TOM+ cDC2 and TOM− DC2 from 1-week-old
Clec9acre/creRosaTOM mice to that of TOM+ cDC2 from adult
mice. We used homozygous Clec9acre/creRosaTOM mice to ensure
highest penetrance Clec9acre and the 1-week time point, because
ontogenetic heterogeneity was prominent enough to sort suffi-
cient cells of both populations (Supplementary Fig. 1C), although
ESAMhigh to ESAMlow subset distribution at this age was still
slightly lower than in adult mice (Fig. 1e). In principal compo-
nent analysis (PCA) TOM+ cDC2 and TOM− DC2 from 1-week-
old mice segregated away from adult TOM+ cDC2, identifying
age as a major contributor to variation (Fig. 4a). Principle com-
ponent 2 allowed some segregation between TOM+ cDC2 from
TOM− DC2 from young mice, indicating differences in gene
expression correlating with differential ontogeny (Fig. 4a). Using
unsupervised hierarchical k-means clustering of differentially
expressed genes we defined 14 clusters with distinct expression
characteristics (Supplementary Fig. 4A). Of these, most clusters
identified differences between cells from young and adult mice
independent of Clec9acre expression history (Supplementary
Fig. 4A), again highlighting that the biggest differences in gene
expression are related to age. Clusters 8 and 14 identified genes
Fig. 2 Fate mapping reveals a lymphoid contribution to cDC2 in early life. a Spleens from 2-week-old Flt3l−/−Clec9acre/creRosaYFP (n= 7) and
Flt3l+/+Clec9acre/creRosaYFP (n= 4) mice were analyzed by flow cytometry. Shown are the frequency and number of CD11c+MHCII+ cells (left) and of
cDC2 (middle). b Csf1rMer-iCre-Mer dams were mated with male RosaYFP mice and injected with 4OH-tamoxifen on E8.5. Spleen and liver from offspring mice
were analyzed by flow cytometry on E18.5. The percentage of YFP+ cells in the indicated populations is plotted (n= 8). c Spleens from Myb−/− and
Myb+/− littermate control mice were analyzed on E16.5. The frequency of the indicated populations was calculated and plotted (n= 9). d The percentage
of YFP+ cells within the respective populations in spleen from Rag1creRosaYFP mice at the indicated ages (n= 5, PND2–3; n= 11 PND7–9; n= 8 adult; n= 3
and 4 for pDCs in PND2–3 and adult mice). e The percentage of RFP+ cells within the indicated populations in spleen from Il7rcreRosaRFP mice at the
indicated ages (n= 9, PND2–3; n= 5, PND7–9). Each dot represents one mouse, horizontal bars represent mean, error bars represent SD. ***p < 0.001,
****p < 0.0001. Statistical analysis in a, c–e was performed using two-tailed t-test. Source data are provided as a Source Data file.
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Fig. 3 TOM− DC2 phenotypically resemble TOM+ cDC2. a TOM+ cDC2 and TOM− DC2 from 1-week-old Clec9acre/creRosaTOM mice were analyzed for
expression of the indicated surface markers. Data are representative of at least two independent experiments with four to seven mice. b Spleens from
PND8 Clec9acre/creRosaTOM mice were analyzed for expression of CD31 (cyan), CD3 (blue), MHCII (green), TOMATO (red), and CD11b (magenta) by
microscopy. Numbered inset squares were magnified on the bottom panels TOM+ cDC2 (red arrows) or TOM− DC2 (white arrows) were identified. Data
are representative of two independent experiments with three biological replicates.
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with distinct expression characteristics in TOM− DC2 compared
to TOM+ cDC2 from young and adult mice (Supplementary
Fig. 4A), identifying putative variation caused by ontogeny.
Pairwise comparison of TOM+ cDC2 and TOM− DC2 from
young mice identified 167 differentially expressed genes (log2 fold
change (log2FC) > 1, adjusted p-value (padj) < 0.05) (Fig. 4b and
Supplementary Data 1). In this comparison, TOM+ cDC2 showed
an enrichment of cell cycle genes (Fig. 4c), possibly reflecting the
fact that these cells expand in number and gradually replace
TOM− DC2 with age. Most notable, several genes implicated in
the biology of innate lymphoid cells (ILCs), such as Rorc, Tcf7,
Il18r1, Ccr6, Lingo4, and Lta, showed higher expression in TOM−
DC2 than TOM+ cDC2 (Fig. 4b). Using flow cytometry, we
detected a fraction of RORγt-expressing cells in TOM− DC2 but
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20659-2
8 NATURE COMMUNICATIONS |           (2021) 12:464  | https://doi.org/10.1038/s41467-020-20659-2 | www.nature.com/naturecommunications
not in TOM+ cDC2 from 1-week-old Clec9acre/creRosaTOM mice
(Fig. 4d, E). These cells lacked the canonical ILC markers CD127
and CD9083–85 and expressed typical cDC2 markers, including
CD11c, MHCII, CD172a, CLEC4A4, ESAM and CD26, unlike
ILCs (lin−CD11b−CD90+CD127+), which are CD11c negative
(Supplementary Fig. 4B, C). Notably, the frequency of RORγt+
cells within the TOM− DC2 population decreased with age and
RORγt+ cells were not found in the adult cDC2 pool (Fig. 4e),
raising the possibility that these RORγt+ cells may constitute a
unique population of DC2 that is transiently present in early life
and disappears with age.
To address this, we next performed droplet-based single-cell
RNA-sequencing (scRNA-seq). We sort-purified splenic MHCII+
cells from 9-day-old Clec9acre/creRosaTOM mice, after excluding
CD19+ B cells and F4/80high macrophages (Supplementary
Fig. 5A). Using this approach, we expected to identify all main
DC subsets, including cDC1, non-canonical CD8+ cDCs, TOM+
cDC2, and TOM− DC2 and CD11clowMHCIIlow pDCs, as well as
a fraction of RORγt-expressing type 3 ILCs that expresses MHCII
but lacks CD11c (Supplementary Figs. 4B and 5a). Unsupervised
graph-based clustering identified 15 clusters as visualized by
dimensionality reduction using Uniform Manifold Approxima-
tion and Projection (UMAP) (Fig. 4f)86,87. We identified some
proliferating cells (being in G2M and S phase) in all clusters, but
excluded clusters 4, 7, 9, and 14 from comparative analyses, as
they consisted predominately of proliferating cells (Fig. 4f). The
identity of each cluster was determined using the top differen-
tially expressed genes in combination with a priori knowledge
about signature genes of cDCs and other immune cells
(Supplementary Fig. 5B–E). Cluster 5 identified a contamination
with Cd19-expressing B cells (Supplementary Fig. 5B), indicating
a possible sort impurity or a discord between RNA and protein
expression88. cDC1 were partitioned across 5 clusters (1, 2, 4, 9,
and 13) based on expression of Xcr1, Cd24a, Irf8, and Tlr3
(Supplementary Fig. 5B, C). We further added the sequence of cre
as inserted in the Clec9a locus48,89 into the reference transcrip-
tome and found cre expression exclusively in clusters 1, 2, 4, 9,
and 13, consistent with Clec9a expression in early life cDC117.
Cluster 8 constituted Siglech and Ccr9 expressing pDCs and
clusters 6 and 14 showed high expression of Rorc, Rora, Il7r,
Il18r1, and Tox, identifying them as ILC3s83,84. Cluster 12
resembled E2-2-dependent non-canonical CD8+ cDCs based on
Cx3cr1, Cd24a, Sirpa (CD172a), and Tcf4 (encoding for E2-2)
expression58,60 (Supplementary Fig. 5B, C). cDC2 were spread
across clusters 0, 3, and 7 based on expression of Sirpa, Itgam,
Irf4, and published signature genes90 (Supplementary Fig. 5B, D).
Notably, cluster 3 more closely resembled ESAMlow,
whereas cluster 0 resembled ESAMhigh cDC259 (Supplementary
Fig. 5F). In addition, we identified cluster 10 as cells
resembling migratory cDCs90 (Supplementary Fig. 5E). We were
not able to assign a clear identity to cluster 11, although this
cluster showed expression of core cDC2 and ESAMhigh
cDC2 signature genes (Supplementary Fig. 5D, F). Notably, Rorc
was found among the genes characteristic for cluster 11 and this
population showed an enrichment of genes with higher expres-
sion in TOM− DC2 in the pairwise comparison of TOM+ cDC2
and TOM− DC2 in bulk RNA-seq (Fig. 4g and Supplementary
Fig. 5B).
We next identified TOM+ cDC2 and TOM− DC2 by adding
the sequence of Tomato and the predicted transcript of the
unrecombined Rosa locus into the reference transcriptome91.
Forming the ratio of normalized Tomato reads per cell to
normalized reads per cell of the predicted transcript of the
unrecombined Rosa locus (ratio Tom/unrec. Rosa) clearly
separated B cells (cluster 5) and cDC1 (clusters 1, 2, 4, 9, and
13), which served as negative and positive controls for Tomato
expression, respectively (Fig. 4h). Accordingly, we set a threshold
and identified Tom− (ratio Tom/unrec. Rosa <−0.5) and Tom+
cells (ratio Tom/unrec. Rosa > 0.5, Fig. 4h). Tom+ and Tom− cells
distributed evenly within the UMAP of cDC2 clusters 0, 3, and 7
(Fig. 4i), and pairwise comparison of Tom+ and Tom− cells
within clusters 0 and 3 revealed few differences in gene
expression, indicating that these cells are transcriptionally similar
(Supplementary Data 2). Notably, cells within cluster 11 were
predominantly Tom−, again indicating that this cluster corre-
sponds to RORγt-expressing TOM− DC2 (Fig. 4i).
In adults, cDC2 can be divided into T-bet expressing cDC2A
and T-bet-negative cDC2B, putatively controlled by RORγt and
C/EBPα92. This division appeared to hold up in early life as
cluster 0 showed an enrichment of T-bet+ cDC2A signature
genes (Supplementary Fig. 5G), whereas cluster 3 more closely
resembled T-bet− cDC2B (Supplementary Fig. 5G). Interestingly,
cells in cluster 11 did not correspond to T-bet− cDC2B but more
closely resembled T-bet+ cDC2A (Supplementary Fig. 5G),
consistent with the high expression of ESAM on RORγt+ DC2
(Supplementary Fig. 4C). To gain insights into a putative
developmental hierarchy between Rorc-expressing cluster 11,
cDC2 (clusters 0, 3, and 7), and ILC3 (clusters 6 and 14), we
applied Palantir algorithm93. Setting the starting point within
cluster 11 identified two terminal states, one in ILC cluster 14 and
one in cDC2 cluster 0 (Supplementary Fig. 5H). However,
differentiation potential diminished quickly upon exit from
cluster 11 and the branch probability that cells from cluster 11
reach the terminal states was low (Supplementary Fig. 5H).
Accordingly, fate mapping in RorccreRosaRFP mice94 identified
only few RFP+ cDC2 in 2-week-old mice that included a fraction
that also stained positive for RORγt (Supplementary Fig. 5I). As
RFP+ cells were only a minor fraction of the total splenic DC2
compartment in young mice, RORγt+ cells are unlikely to act as
progenitors for TOM− DC2 in early life.
Fig. 4 TOM+ cDC2 and TOM−DC2 in early life are transcriptionally identical. a–c TOM− DC2 and TOM+ cDC2 from 8-day-old and TOM+ cDC2 from
adult Clec9acre/creRosaTOM mice were sorted and analyzed by mRNA sequencing. a Principal component analysis (PCA) of the top 500 most variable genes
across all samples. Dots represent biological replicates. b Pairwise comparison of TOM+ cDC2 and TOM− DC2 from 8-day-old mice. c Normalized
enrichment score (NES) of gene sets enriched in TOM+ cDC2 (red) and TOM− DC2 (blue) from 8-day-old mice. d TOM− DC2 and TOM+ cDC2 from 8-
day-old Clec9acre/creRosaTOM mice were analyzed by flow cytometry for RORγt, CD90.2, and CD127 expression. Data are representative of three biological
replicates. e The percentage of RORγt+ cells within TOM+ cDC2 and TOM- DC2 in Clec9acre/creRosaTOM mice at the indicated ages is shown (n= 3, PND8;
n= 6, PND13; n= 4, adult). Each dot represents one mouse, horizontal bars represent mean, error bars represent SD. f, g CD19−MHCII+ cells from spleen
of 9-day-old Clec9acre/creRosaTOM mice were sorted after gating out F4/80high macrophages and subjected to scRNA-Seq. f UMAP display of 1788 cells
analyzed by unsupervised graph-based clustering with Seurat algorithm to indicate cluster identity (left) and cell cycle status (right) within clusters.
g Heatmap displaying expression of genes enriched in TOM−DC2 compared to TOM+ cDC2 in bulk mRNA sequencing (Fig. 4b) among scRNA-Seq
clusters. h, i The ratio of normalized Tomato reads per cell to normalized reads per cell of the predicted transcript of the unrecombined ROSA locus was
calculated (h) and cells with a ratio > 0.5 were identified as Tom+, whereas cells with a ratio <−0.5 were identified as Tom−. i Tom+ and Tom− cells
visualized on the UMAP display. Source data are provided as a Source Data file.
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Thus, in concordance with fluorescence-activated cell sorting
(FACS) analyses, scRNA-seq revealed that cDC2 in 1-week-old
mice contain the two main cDC2 subtypes also found in adults,
and that, despite their distinct origin, TOM+ cDC2 and TOM−
DC2 distribute evenly across cDC2 clusters, indicating they
constitute transcriptionally identical cells. Differences in gene
expression between TOM+ cDC2 and TOM− DC2 from 1-week-
old mice in bulk RNA-seq correlated to a unique Rorc-expressing
cluster of cDC2 that transcriptionally closely resembles but is
distinct from ESAMhigh cDC2 and present exclusively in
early life.
Age defines the strongest differences in gene expression. Hav-
ing established ontogeny as a minor contributor to transcriptional
variation, we next focused on differences in gene expression
caused by age. Pairwise comparison of TOM+ cDC2 from 1-
week-old and adult mice identified 1490 differentially expressed
genes (log2FC > 1, padj < 0.05) (Fig. 5a and Supplementary
Data 3). TOM+ cDC2 from 1-week-old mice showed an
enrichment of genes involved in cell cycle (Fig. 5b), possibly
reflecting increased homeostatic proliferation within the
expanding DC pool. TOM+ cDC2 from adults were enriched for
genes implicated in the inflammatory response, which could
indicate an increased level of activation or functional maturation
of adult cDC215. Most notable was the identification of genes
involved in signaling downstream of IFN-γ, tumor necrosis
factor-α (TNF-α), IL-2, and IFN-α (Fig. 5b) enriched in cDC2
from adult mice. As expression of receptors for these cytokines
was comparable in 1-week-old and adult mice (Supplementary
Data 3), these data suggested a distinct cytokine environment
acting on cDC2 in spleen from neonatal and adult mice. We
confirmed higher expression of PD-L1 (encoded by the Cd274
gene) and CD38 (Cd38), which are regulated by type I and II IFN
signaling95,96, on TOM+ cDC2 from adult compared to 2-week-
old mice (Fig. 5c). Importantly, expression of these markers was
reduced on cDC2 from adult Ifnar−/− compared to wild-type
control mice (Fig. 5d), supporting the notion that distinct cyto-
kine environments act on splenic cDC2 in early and adult life and
indicating that age-dependent differences in gene expression are
at least in part caused by IFN-α.
Among genes differentially expressed with age, we identified
several pattern recognition receptors (PRRs) with higher expres-
sion in TOM+ cDC2 from adults, including Clec7a (encoding for
Dectin-1), Tlr7, and Tlr5 (Supplementary Fig. 6A). In contrast,
expression of Clec4n (encoding for Dectin-2), Tlr4, and Tlr2 was
higher in early life (Supplementary Fig. 6A), whereas expression
of other PRRs, such as Tlr6, Tlr9, and Nod1 was comparable in
cDC2 from 1-week-old and adult mice (Supplementary Fig. 6A).
In line with previous observations in the lung32,35–37, cDC2 from
adult mice showed higher expression of several costimulatory
molecules, including Cd80 , Cd40 , Cd274 (encoding for PD-L1)
and Tnfsf4 (encoding for OX40L) (Fig. 5a). Lower expression of
costimulatory molecules could indicate a reduced ability of early-
life cDC2 to activate T cells but costimulatory signals also balance
effector T-cell responses. Tnfsf4 and Cd274 for instance can
suppress IL-17A production in T cells97,98. Interestingly, adult
cDC2 further showed higher expression of bone morphogenic
protein 2 (Bmp2), which also suppresses IL-17A production from
T cells99 (Supplementary Fig. 6B). On the contrary, TOM+ cDC2
from 1-week-old mice showed higher levels of factors that
promote Th17 and Treg differentiation, such as Lgals3, Il6ra,
Lgals1, and Sema4a100–106 (Supplementary Fig. 6B). In line with
age being the foremost contributor to transcriptional variation,
expression of the aforementioned genes was similar between
TOM+ cDC2 and TOM− DC2 from 1-week-old mice. Taken
together, these data suggest that distinct cytokine environments
in early and adult life act on cDC2 to shape their transcriptional
profile and ability to induce immune responses.
Early-life cDC2 induce distinct T-cell responses in vitro com-
pared to adult-life cDC2. The above data suggested that cDC2 in
early and adult life may differ in their ability to induce effector T-
cell differentiation. To address this possibility in vitro, we sort-
purified TOM+ cDC2 and TOM− DC2 from young and TOM+
cDC2 from adult mice, and pulsed them with Ovalbumin (OVA)
peptide 323–339 (OVA323–339). cDC2 populations were sorted
from two to 2.5-week-old mice, because at this age ESAMhigh to
ESAMlow subset distribution had reached adult levels and
ESAMhigh cells dominated the cDC2 compartment (Fig. 1e).
Although DNGR-1 has no known function in DC development
and is not expressed in cDC2, we used mice heterozygous for cre
in functional assays, because Clec9acre/cre mice lack functional
DNGR-148. Peptide pulsed DC2 populations were subsequently
cultured with naive OT-II transgenic T cells from adult mice in
the absence or presence of T-cell polarizing cytokines. Adult
T cells were chosen as responders, because neonatal T cells
exhibit an intrinsic Th2 bias2. Notably, TOM+ cDC2 and TOM−
DC2 from young mice and TOM+ cDC2 from adult mice sti-
mulated similar proliferation of naive T cells in all conditions
tested (Fig. 5e, f and Supplementary Fig. 6C, D), indicating that
adult cDC2 do not exhibit an increased level of activation in
terms of their ability to stimulate T cells. Compared to adult
cDC2, TOM+ cDC2, and TOM− DC2 from young mice also
induced similar effector differentiation of OT-II cells under non-
polarizing (Th0) and Th1 conditions, as assessed by IFN-γ pro-
duction (Fig. 5g and Supplementary Fig. 6D). We did not observe
IL-4 production from T cells stimulated under Th0 conditions by
intracellular staining but Th2 cytokine levels in culture super-
natants from T cells stimulated with cDC2 from young and adult
mice were similar (Supplementary Fig. 6F). Thus, early life splenic
cDC2 do not exhibit an intrinsic Th2 bias, which is in contrast to
neonatal cDC2 from lung30. In line with higher expression of
positive regulators of Th17 differentiation, TOM+ cDC2 and
TOM− DC2 from young mice induced twofold higher IL-17A
production from T cells under Th17 conditions than cDC2 from
adult mice (Fig. 5f, g). Similarly, under Treg conditions more OT-
II T cells were positive for Foxp3 when stimulated with DC
populations from young mice (Fig. 5f, g). Thus, despite exhibiting
increased expression of proliferation related genes (Fig. 5b), cDC2
from young mice induce similar proliferation of T cells as their
adult counterparts, whereas inducing higher Th17 and Treg dif-
ferentiation, indicating qualitative, rather than quantitative dif-
ferences in the ability to polarize T cells.
As ESAMhigh and ESAMlow cDC2 have different transcrip-
tional programs and may stimulate different types of T-cell
responses62, we next addressed whether both subsets have
different functions with age. We therefore sorted ESAMhigh and
ESAMlow TOM+ cDC2 from 2-week-old and adult mice and
assessed their ability to stimulate Th17 and Treg differentiation
as above. ESAMhigh and ESAMlow cDC2 from young mice
induced higher Th17 differentiation than their counterparts from
adult mice (Fig. 5h). Similarly, ESAMhigh cDC2 from young mice
induced higher Treg differentiation than their adult counter-
parts, whereas ESAMlow cDC2 from young and adult mice
induced similar Treg differentiation (Fig. 5h). Thus, functional
differences between early and adult life exist for ESAMhigh and
ESAMlow cDC2, although there appears to be some level of
subset specific functional regulation. As ESAMhighTOM− DC2
contain a unique fraction RORγt-expressing cells of unknown
function (1.15 ± 0.38%, Fig. 4e), we next crossed Rorc-eGFP mice
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to Clec9acre/+RosaTOM mice. We then sorted ESAMhighTOM+
cDC2 and ESAMhighTOM−DC2 from 2-week-old RorceGFPCle-
c9acre/+RosaTOM mice, whereas excluding GFP+ cells and
compared their ability to promote Th17 and Treg differentiation.
Importantly, despite excluding RORγt+ cells ESAMhighTOM+
cDC2 and ESAMhighTOM−DC2 had similar ability to induce
Th17 and Treg differentiation (Supplementary Fig. 6G),
confirming that the presence RORγt+ cells does not influence
the ability of TOM− cDC2 to induce T-cell differentiation.
To determine whether early-life cDC2 are also capable of
antigen uptake and processing, we first cultured TOM+ cDC2
and TOM− DC2 from 2-week-old and TOM+ cDC2 from adult
Clec9acre/+RosaTom mice with fluorescently labeled latex beads
in vitro for 2 h in the presence or absence of cytochalasin D. All
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20659-2 ARTICLE
NATURE COMMUNICATIONS |          (2021) 12:464  | https://doi.org/10.1038/s41467-020-20659-2 | www.nature.com/naturecommunications 11
populations took up fluorescently labeled beads with similar
efficiency (Supplementary Fig. 6H). Bead uptake was mediated by
phagocytosis, as it was inhibited by cytochalasin D (Supplemen-
tary Fig. 6H). Thus, TOM+ cDC2 and TOM− DC2 do not differ
in their phagocytic ability. We next cultured TOM+ cDC2 and
TOM− DC2 from young mice and adult TOM+ cDC2 with
CellTrace Violet (CTV)-labeled OT-II T cells in the presence
of OVA under Th17 conditions (Fig. 5i). As observed before,
TOM+ cDC2 and TOM− DC2 from young mice induced a
higher frequency of IL-17A-producing T cells than adult cDC2
(Fig. 5i). Thus, TOM+ cDC2 and TOM− DC2 from young mice
are comparable to their adult counterparts in their ability to
process antigen and induce naive T-cell proliferation in an
antigen-specific manner. TOM+ cDC2 and TOM− DC2 from
young mice promoted similar Th17 and Treg differentiation;
however, compared to adult cDC2, Th17 and Treg differentiation
was increased, supporting the notion that distinct environmental
cues in young and adult mice shape the ability of DCs to induce
T-cell differentiation. Although such cytokines could be regulated
in response to the microbiota, cDC2 from adult mice housed in
germ-free (GF) and specific pathogen-free (SPF) conditions
induced similar OT-II cell differentiation under Th0, Th17, and
Treg conditions, and did not recapitulate the phenotype of young
cDC2 in terms of PDL-1 and CD38 expression (Supplementary
Fig. 6I, J). These data suggest that functional differences of cDC2
in early life are not simply due to a lower microbial load at this
age.
Early-life cDC2 induce distinct T-cell responses upon targeted
antigen delivery compared to adult-life cDC2. Having estab-
lished that cDC2 from young mice can activate T cells in vitro, we
next asked whether cDC2 from young mice have this capacity
upon direct delivery of antigens in vivo. We relied on an estab-
lished method to target the model antigen OVA to cDC2 by
coupling it to an antibody directed against the C-type lectin
receptor CLEC4A4/DCIR225,107. As TOM+ cDC2 and TOM−
DC2 were phenotypically identical, we were unable to target
either cell population individually but CLEC4A4 was expressed
by both TOM+ cDC2 and TOM− DC2 (Fig. 3a). We injected 2-
week-old Clec9acre/+RosaTOM mice with anti-DCIR2-OVA or
isotype-matched control antibody of irrelevant specificity. Twelve
hours later, we sort-purified splenic TOM+ cDC2 and TOM−
DC2, and co-cultured them with CTV-labeled OT-II T cells from
adult mice (Fig. 6a) to overcome any T-cell intrinsic differentia-
tion bias in early life2. In this experimental set up, TOM+ cDC2
and TOM− DC2 induced OT-II proliferation upon targeting with
anti-DCIR2-OVA but not isotype-matched control antibody
(Fig. 6a). Thus, TOM+ cDC2 and TOM− DC2 from 2-week-old
mice could be targeted with anti-DCIR2 and process
antibody–antigen complexes for presentation to CD4+ T cells,
although OT-II proliferation in the absence of adjuvant was low,
as expected107.
Immune responses in early life are Th2 biased but such
predisposition can be overcome through the use of Th1
adjuvants, such as CpG-B108,109. CpG-B signals through TLR9,
which was similarly expressed between the profiled cDC2
populations in bulk mRNA sequencing (Supplementary Fig. 6A).
Nonetheless, TOM+ cDC2 and TOM− DC2 from 2-week-old and
TOM+ cDC2 from adult mice showed a distinct cytokine profile
after CpG-B stimulation. In response to CpG-B TOM− DC2 from
young mice were the most efficient cytokine producers and
secreted higher amounts of IL-6, IL-12p40, and TNF-α than
cDC2 from adults (Fig. 6b). Interestingly, IL-6 and TNF-α
production were significantly higher in TOM− DC2 compared to
TOM+ cDC2 from young mice, raising the possibility that these
cells have distinct inflammatory potential. Independent of origin
cDC2 from young mice produced higher IL-10 and IL-27 than
their adult counterparts (Fig. 6b and Supplementary Fig. 7A).
Although IL-27 production was low and not detectable in all
samples, it is noteworthy, because DCs from peripheral blood of
children show increased IL-27 production compared to DCs from
adults110. Thus, despite exhibiting similar Tlr9 expression cDC2
from young mice have different cytokine response to CpG-B than
cDC2 from adults, indicating distinct signaling downstream of
TLR9 and supporting the hypothesis that age imprints cDC2 with
distinct immune reactivity.
We next tested whether the distinct response to CpG-B
stimulation would influence the ability of cDC2 to activate T cells
and induce their differentiation. We injected 2.5-week-old or
adult mice with anti-DCIR2-OVA in the presence of CpG-B as
adjuvant. Twelve hours later, we sorted TOM+ cDC2 and TOM−
DC2 from young mice, as well as TOM+ cDC2 from adult mice
and co-cultured them with CTV-labeled OT-II T cells isolated
from adult mice (Fig. 6c, d). After 3.5 days, T-cell proliferation,
cytokine production, and Foxp3 expression were analyzed. In this
Fig. 5 Age causes strongest differences in gene expression and cell function. a, b Bulk mRNA sequencing performed as in Fig. 4A–C. a Pairwise
comparison of TOM+ cDC2 from 8-day-old and adult mice indicating genes with a log2FC > 1 and padj < 0.05 in red. b NES of gene sets enriched in TOM+
cDC2 from 8-day-old (red) or in cDC2 from adult mice (blue). c TOM+ cDC2 from 2-week-old and adult Clec9acre/+RosaTOM mice were analyzed for
expression of PD-L1 (n= 5, 2-week-old; n= 4, adult) and CD38 (n= 7, 2-week-old; n= 6, adult) (MFI=mean fluorescence intensity). d Splenic cDC2
from adult wild-type and Ifnar−/− mice were profiled for expression of PD-L1 and CD38 (n= 5). Expression levels are depicted as MFI. Each dot represents
one mouse, horizontal bars represent mean, error bars represent SD. e–g TOM− DC2 and TOM+ cDC2 from 2-week-old and TOM+ cDC2 from adult
Clec9acre/+RosaTOM mice were sorted, pulsed with OVA323–339, and co-cultured with CTV-labeled OT-II cells under Th0 or polarizing conditions for
3.5 days. e Left: CTV dilution of OT-II cells co-cultured with the indicated populations or CD11c-enriched splenocytes without OVA323–339 (gray). Right:
division and proliferation indexes of OT-II cells after co-culture with the indicated DC2 populations (n= 5/6, 2-week-old TOM+ and TOM− cDC2, n= 4,
adult TOM+ cDC2). f T cells were analyzed for expression of Foxp3 and IL-17A. For Th17 conditions (right) numbers in each quadrant represent the mean
± SD (n≥ 7). g The percentage of cytokine or Foxp3-positive cells within proliferated OT-II cells is shown. APC : T-cell ratio 1 : 2 for Th0, Th1, Th17 and 1 : 10
for Treg (n= 6, Th0/Th1; n= 3, Treg; n= 8, Th17; for 2-week-old TOM+ cDC2; n= 5, Th0; n= 4, Treg/Th1; n= 8, Th17 for TOM− DC2; n= 4, Th0/Th1/
Treg ; n= 7, Th17 for adult TOM+ cDC2). h TOM+ cDC2 from 2-week-old (n= 5) and adult mice (n= 6, Treg; n= 7, Th17) were sorted as ESAMhigh and
ESAMlow cells, pulsed with OVA323–339 and cultured with CTV-labeled OT-II cells under Treg and Th17 polarizing conditions as above. The percentage of
cytokine or Foxp3-positive cells within proliferated OT-II cells is shown. i TOM− DC2 and TOM+ cDC2 from 2-week-old and TOM+ cDC2 from adult
Clec9acre/+RosaTOM mice were co-cultured with OT-II cells in the presence of OVA under Th17 conditions for 4 days. The division index (left) and
percentage of IL-17A producing OT-II cells (right, APC : T-cell ratio 1 : 2) are shown (n= 4). Each dot represents one biological replicate from four
independent experiments, horizontal bars represent mean, error bars represent SD. ***p < 0.001, ****p < 0.0001. Statistical analysis was performed using
two-tailed paired t-test (comparing TOM−DC2 and TOM+ cDC2 groups), one-way ANOVA (comparing 2-week-old and adult groups) or two-tailed t-test
in (c, d, h). Only statistically significant comparisons are indicated. Source data are provided as a Source Data file.
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assay, TOM+ cDC2 and TOM− DC2 from young mice and cDC2
from adult mice induced similar OT-II T-cell proliferation
(Fig. 6c). Targeting was cell-type specific as cDC1 did not
promote T-cell proliferation (Fig. 6c). Importantly, T cells
stimulated with TOM+ cDC2 and TOM− DC2 from young
mice produced more TNF-α than T cells stimulated with cDC2
from adult mice (Fig. 6d). Notably, this is in contrast to splenic
human cDC2 from fetal tissue, which suppress T-cell-derived
TNF-α through ARGINASE 243. T cells stimulated with TOM−
DC2 from young mice also produced more IFN-γ than T cells
stimulated with cDC2 from adult mice (Fig. 6d and Supplemen-
tary Fig. 7B). Increased IFN-γ production was also observed for
T cells stimulated with TOM+ cDC2 from young mice compared
to cDC2 from adults (Fig. 6d and Supplementary Fig. 7B),
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although differences did not reach statistical significance. Thus,
TOM+ cDC2 and TOM− DC2 from young mice induced more
TNF-α production from T cells and greater Th1 differentiation
than adult cDC2. Increased Th1 differentiation could be related
to the slight increase in IL-12p40 production in cDC2 from young
compared to adult mice upon CpG-B stimulation (Fig. 6b);
however, it is likely that other factors, such as costimulatory
molecules (Fig. 5a), also contribute. Notably, production of Th2
cytokines and Foxp3 expression was similar between T cells
stimulated with cDC2 from young and adult mice (Fig. 6d and
Supplementary Fig. 7B) and Th17 cytokine production was not
observed. Taken together, early-life TOM+ cDC2 and TOM−
DC2 are fully capable of inducing T-cell proliferation upon
targeted antigen delivery in vivo but in the context of CpG-B
stimulation early-life cDC2 induce an increased Th1 response
compared to adult-life cDC2.
Discussion
The cDC compartment in early, compared to adult life, exhibits
quantitative and qualitative differences in its ability to induce
immunity, leading some to suggest that cDCs in early life may be
functionally immature. Here we set out to define the reasons
underlying age-dependent functional differences of cDCs. We
demonstrate that early-life cDC2 exhibit a distinct hematopoietic
origin and, similar to other myeloid and lymphoid cells, develop
sequentially at specified times during development. In contrast to
other cell types that develop in waves42,80–82, cell origin appeared
negligible for cell function, as ontogenetically distinct cDC2 in
early life were transcriptionally and functionally similar and
within 2 weeks after birth could prime naive T cells at levels
comparable to cDC2 from adult mice. Instead our data suggest
that cytokine environments in early and adult life imprint cDC2
with a distinct gene expression profile that alters their ability to
respond to pathogenic stimuli, secrete cytokines, and induce T-
cell differentiation. Thus, cDC2 in early life are functionally
capable but transcriptionally pre-disposed to respond differently
to pathogens and induce distinct T-cell responses than their adult
counterparts.
In early life, the majority of cDC2 originated from Clec9a-
negative progenitors denoted here as TOM− DC2. These cells
were replaced within the first few weeks after birth by cells arising
from bona fide Clec9a-expressing myeloid cDC progenitors,
denoted as TOM+ cDC2. Coinciding with the increase in
Clec9a-cre expression history, we found evidence of a lymphoid
contribution to the early-life cDC2 compartment using Rag1cre
and Il7rcre mice that declined with age. Rag1cre also labels the
progeny of yolk sac-derived lymphomyeloid primed progeni-
tors66 and Il7rcre expression history is found in macrophages of
yolk sac origin111. As we exclude a yolk sac origin but demon-
strate cDCs to be Myb-dependent, our data indicate an HSC-
derived lymphoid contribution to early-life cDCs. Such lymphoid
progenitors likely arise from fetal liver-resident progenitors, as we
find splenic cDC2 as early as E16.5 (Fig. 2c and Supplementary
Fig. 1D), at which stage hematopoiesis has yet to colonize bone
marrow112,113. This notion is further supported by in utero
Cxcr4creER fate mapping77. A lymphoid path to generating cDCs
has been suggested69,71–74 but does not contribute to the steady-
state cDC pool in adult mice48,74,76. Our data suggest that lym-
phopoiesis contributes to the cDC compartment of mice in early
life. Such layered ontogeny is reminiscent of other immune cells
that develop in waves during development, including macro-
phages, mast cells, ILCs, B, and T cells42,80,81,114,115. Although
layered immune development can generate progressively adapted
immune populations80–82, TOM+ cDC2 and TOM− DC2 exhibit
apparently identical phenotype, transcriptional profile, and
similar cell function, which is consistent with other studies
comparing human and murine cDCs generated from lymphoid or
myeloid progenitors74,116. It is possible that functional differences
exist between TOM+ cDC2 and TOM− DC2 in situations that we
have not yet explored; however, lymphopoiesis may compensate
DC poiesis when bona fide cDC progenitors are not present in
sufficient quantities to generate a full repertoire of cDCs74. This
hypothesis is consistent with the low frequency of CDPs and pre-
cDCs in bone marrow from neonatal compared to adult mice.
Whether cDC-like cells in early life arise from lymphoid-
committed progenitors, such as CLPs, or from conversion of
already differentiated lymphoid cells, such as pDCs or ILCs117–
119 needs to be investigated. We and others have proposed that
cDCs and other mononuclear phagocytes should predominantly
be defined on the basis of their ontogeny5,114,120; however, our
data imply that an ontogenetic view to cell definition may not be
plausible if populations with different origins turn out to be
identical by all measures examined74,79,121–123.
In continuation of earlier studies9,10,17, we profiled the cDC
compartment by flow cytometry with age using large marker
panels. We demonstrate that the major subsets of splenic cDCs,
including cDC1, non-canonical CD8+ cDCs, as well as ESAMhigh
and ESAMlow cDC2, are present in murine spleen as early as
1 week after birth. These findings were further substantiated using
unbiased dissection of the cDC compartment of 1-week-old mice
using scRNA-seq. In this analysis, cDC1 segregated across several
clusters, possibly reflecting functional heterogeneity within this
compartment17,124. Non-canonical CD8+ cDCs were positioned
more closely to cDC2 than pDCs or cDC1, which is consistent
with bulk transcriptome profiling in adult mice59,60. Although
non-canonical CD8+ cDCs were recently suggested to constitute
a transitional cell type with pDC and cDC2 characteristics in
adult mice125, our data indicate non-canonical CD8+ cDCs as a
unique DC subset with close resemblance to cDC2 in early life. In
scRNA-seq, early-life cDC2 spread across two main clusters
resembling ESAMhigh and ESAMlow subsets found in adult
Fig. 6 Early-life cDC2 induce distinct T-cell responses upon targeted antigen delivery compared to adult-life cDC2. a 2-Week-old Clec9acre/+RosaTOM
mice were injected i.p. with aDCIR2-OVA or isotype-OVA control antibody. After 12 h, TOM+ cDC2 and TOM− DC2 were sorted and co-cultured with
OT-II cells for 3.5 days. CTV dilution (left) and division index of OT-II cells after co-culture with the indicated DC2 populations (right) are shown (n= 6, 1:1
ratio; n= 5, 1:10 ratio; n= 3, isotype-OVA). b TOM+ cDC2 and TOM− DC2 from 2-week-old and TOM+ cDC2 from adult Clec9acre/+RosaTOM mice were
sorted and stimulated with CpG-B. Cytokine production was analyzed 18−20 h later. Each dot represents a biological replicate from 4 (IL-6, TNF-α, and IL-
10) or two (IL-12p40) independent experiments. c, d 2-Week-old and adult Clec9acre/+RosaTOM mice were injected i.p with anti-DCIR2-OVA antibody plus
CpG-B. After 12 h DC populations were sorted and co-cultured with OT-II T cells as in a. c CTV dilution (left) and division index (right) of OT-II cells after
co-culture with the indicated DC populations (n= 10, 2-week-old; n= 8, adult and cDC1 from 2-week-old mice). d Percentage of TNF-α, IFN-γ, and Foxp3-
positive cells within proliferated OT-II cells (n= 10, 2-week-old; n= 8, adult). Each dot represents one biological replicate from at least three independent
experiments, horizontal bars represent mean, error bars represent SD. ***p < 0.001. Statistical analysis was performed using two-tailed paired t-test
(comparing TOM−DC2 and TOM+ cDC2 groups) or one-way ANOVA (comparing 2-week-old and adult groups). Only statistically significant comparisons
are indicated. Source data are provided as a Source Data file.
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spleen62, which, despite being profiled at a different age, also
resembled the T-bet-positive and T-bet-negative cDC2, respec-
tively92. We also identified a cluster of cells resembling migratory
cDCs, which has recently been observed in adult spleen92.
Importantly, scRNA-seq revealed TOM− DC2 and TOM+ cDC2
as transcriptionally identical. Although bulk RNA-seq identified
differences in gene expression between TOM− DC2 from TOM+
cDC2, we could correlate these genes to a unique cluster of Rorc-
expressing cells that transcriptionally resembles cDC2 but lacks
Clec9acre expression history. Accordingly, RORγt+ cells could be
identified by flow cytometry within TOM− DC2 in early life but
RORγt+ cDC2 were not found in adult spleen. Rorccre-mediated
fate mapping and trajectory analyses indicate that these cells are
unlikely to serve as progenitors for cDC2 or other cDC subsets.
The fact that Rorc-expressing cluster 11 segregated away from the
putative RORγt-regulated cDC2B92 (cluster 3) further supports
that RORγt+ TOM− DC2 constitute a unique cDC subtype
present transiently during early life.
Although in adult spleen ESAMhigh cells constituted the
dominant cDC2 population, this subset was a minority of cDC2
in mice under 1 week of age. ESAMhigh and ESAMlow cDC2 can
activate CD4+ T cells but they may differ in their ability to
promote effector differentiation62,92,126. We mostly characterized
bulk cDC2 in 2- to 2.5-week-old mice when ESAMhigh and
ESAMlow subset distribution had reached adult levels, because
sufficient TOM+ cDC2 and TOM− DC2 could be isolated to
probe cell function. At this time, splenic TOM+ cDC2 and
TOM− DC2 were fully capable of initiating T-cell activation but
they induced greater Th17 and Treg differentiation under in vitro
polarizing conditions than adult cDC2. These observations could
be correlated to the unique gene expression profile of cDC2 in
early and adult life. Early-life cDC2 expressed higher levels of
factors known to promote Tregs, such as Lgals1, Aldh2, and
Sema4a100–103,106, suggesting increased tolerogenic potential of
cDC2 in early life, which is also consistent with their greater IL-10
production in response to CpG-B stimulation. Higher levels of
Il6ra on cDC2 from young mice could increase IL-6 transpre-
sentation104 and promote Th17 differentiation in conjunction
with reduced expression of Tnfsf4 (OX40L) and Cd274 (PD-L1)
in early life, which can suppress Th17 differentiation97,98,127,128.
Some of these age-dependent transcriptional changes could be
related to small differences in the composition of cDC2 in 1-
week-old and adult mice. We nonetheless consider age to be the
most prominent contributor to variation, because we demon-
strated that both ESAMhigh and ESAMlow cDC2 function differ-
ently in early and adult life.
The notion that cDC2 are equipped with an age-dependent
gene expression profile that alters their ability to induce T-cell
differentiation was further supported using targeted antigen
delivery to cDC2 in early and adult life followed by ex vivo
antigen presentation25,107. This approach allowed us to (a)
compare cell function in vivo across age, while excluding age-
dependent functional regulation of other immune components as
confounding factor and (b) to demonstrate the potential to target
cDC2 to induce T-cell responses. CpG-B was chosen as adjuvant,
because despite similar Tlr9 expression across age, TOM+ cDC2,
and TOM− DC2 from 2-week-old mice showed distinct cytokine
production after CpG-B stimulation in vitro, including higher
levels of IL-12p40, IL-6, IL-10, and IL-27, supporting a distinct
immune reactivity of cDC2 with age. IL-27 is a pleiotropic
cytokine with pro- and anti-inflammatory properties in multiple
cell types129, but after vaccination in mice its expression corre-
lates with protective CD8+ T-cell responses130. DCs from per-
ipheral blood of children show higher IL-27 production than DCs
from adults110 but whether cDC2-derived IL-27 plays a role in
early-life immunity needs to be investigated. Despite producing
increased amounts of IL-10, which dampens CD4+ T-cell
responses131, early-life TOM+ cDC2 and TOM− DC2 induced
similar OT-II T-cell proliferation compared to cDC2 from adults
upon DCIR2-mediated antigen targeting in the context of CpG
stimulation. However, early-life cDC2 induced greater Th1 dif-
ferentiation and TNF-α production from T cells. Human fetal
DC2 suppress TNF-α production from T cells43, suggesting that
cDC2 function changes dynamically after birth. Transcriptional
profiling of fetal and neonatal cDC2, possibly at the single-cell
level, may provide further insights into the processes involved in
shaping early-life cDC2 function. Differences in cytokine pro-
duction and T-cell stimulatory capacity between cDC2 from
young and adult mice were not simply regulated at the level of
PRR expression but most probably involve downstream signaling
events, costimulatory molecules, or epigenetic modification.
Therefore, it is likely that age-dependent differences in cDC2
function will be magnified when cells are stimulated through
PRRs with differential gene expression across age and additional
adjuvants must be tested for their ability to promote cDC2-
mediated T-cell priming and differentiation with age.
Our studies indicate that splenic cDC2 do not exhibit a Th2
bias, which is in contrast to cDC2 in the developing lung. In this
organ, IL-33 induces OX40L expression on cDC2, which pro-
motes Th2 skewing30. Therefore, site-specific cytokine environ-
ments appear to play a major role in imprinting cDC function in
different organs and with age. This is consistent with previous
studies38,92 and our observation that cDC2 from adult compared
to young mice showed an enrichment of genes involved in sig-
naling downstream of IL-2, IFN-γ, TNF-α, and IFN-α. In our
hands, cDC2 from GF mice did not recapitulate the phenotypic
and functional features of neonatal cDC2. Although GF mice
have a complete absence of commensals, in an SPF environment
cDC2 are expected to encounter a variety of microbial signals
within the first days of birth. We therefore believe that these
observations do not exclude the possibility that microbially
derived signals or signals induced in response to commensals play
a role in imprinting cDC2 function with age. During weaning, the
intestinal microbiota induces a cytokine response termed the
“weaning reaction,” which is required for normal immune
development132. As cDC2 function in our hands has been
assessed before this period, it is intriguing to speculate that
cytokines or other factors that change in response to alterations in
commensals or diet during weaning are involved in shaping cDC
function with age. Such effects could even be mediated by lasting
alterations on progenitor populations similar to the concept of
trained immunity.
Neonates are highly susceptible to infections with Candida
albicans, Bordetella pertussis, and Streptococcus pneumoniae,
which can cause life-threatening complications in early
life1,133,134. Defense against these pathogens requires Th17
responses135,136. Our demonstration that early-life cDC2 are fully
capable of activating naive CD4+ T cells, and supporting Th1 and
Th17 differentiation highlights the potential of harnessing these
cells for boosting protective immunity in early life. This could for
instance be achieved by delivering antigens specifically to cDC2 in
the context of adjuvants that target age-specific parameters of
cDC2 function.
Methods
Mice. Clec9atm2.1(icre)Crs (Clec9a-cre)48 (Jackson Laboratory Stock No: 025523), Gt
(ROSA)26Sortm1(EYFP)Cos (Rosa26lox-STOP-lox-EYFP)137 (Jackson Laboratory Stock No:
006148), Gt(ROSA)26Sortm9(CAG-tdTomato)Hze (Rosa26lox-STOP-lox-tdtomato)91 (Jackson
Laboratory Stock No: 007909), Tg(Csf1r-cre/Esr1*)1Jwp (Csf1rMer-iCre-Mer)138 (Jack-
son Laboratory Stock No: 019098), Flt3ltm1Imx (Flt3l−/−)65 (MMRRC Stock No:
37395-JAX), Mybtm1Ssp (Myb+/−)68 (Jackson Laboratory Stock No: 004757),
Rag1tm1(cre)Thr (Rag1cre)139, Tg(TcraTcrb)425Cbn (OT-II)140 (Jackson Laboratory
Stock No: 004194) crossed to a Thy1.1 (CD90.1) background, Tg(Rorc-EGFP)1Ebe
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(RorceGFP)141, Cxcr4creER77, Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/
J (RosamTmG)142 (Jackson Laboratory Stock No: 007576), Ly5.1 (CD45.1) B6.SJL
(Jackson Laboratory Stock No: 002014), and C57BL/6J mice were bred at the Bio-
medical Center or Walter-Brendel-Centre for Experimental Medicine. Tg(Rorc-cre)
1Litt (Rorc-cre)94 (Jackson Laboratory Stock No: 022791), Il7rtm1.1(icre)Hrr (Il7rcre)76,
and Gt(ROSA)26Sortm1Hjf (Rosa26lox-STOP-lox-RFP)143 (EMMA strain ID EM:02112)
mice were bred at the University of Birmingham, UK. Ifnar1tm1Agt (Ifnar−/−)144
(MMRRC Stock No: 32045-JAX) mice were bred at the University Hospital Erlangen,
Germany. Mice were maintained in SPF conditions with a 12 h dark/light cycle, in
individually vented cages (type II long, measuring 18 × 30 × 13 cm with stocking
density according to EU guideline 2010/63) supplied with autoclaved bedding, play
tunnels, nestles, and mouse houses. Irradiated food and sterile filtered and ultraviolet-
light exposed water were provided ad libitum. Cage manipulations took place in
laminar flow hoods. Air temperature was 22 ± 2 °C and humidity 55 ± 10% with daily
control and record. GF mice were provided by Dirk Haller. For timed matings, mice
of desired genotypes were mated overnight. Embryonic development was estimated
considering the day of vaginal plug formation as E0.5. Mice over the age of 8 weeks
were considered adults. The neonatal period was defined as the first 10 days of life.
Mice younger than 3 weeks of age were killed by decapitation. Adult mice were killed
by cervical dislocation. Mice were sex-matched but male and female mice were used
for all experiments. In most experiments, littermates were used. When littermates
could not be used, e.g., in experiments involving mice of different age, mice were kept
under the same barrier conditions and in the same racks. All animal procedures were
performed in accordance with national and institutional guidelines for animal welfare
and approved by the Regierung of Oberbayern.
Cell isolation for flow cytometry. Spleens were minced into small pieces and
digested in 1 mL of RPMI (Thermo Fisher Scientific) with 200 U/mL collagenase IV
(Worthington) and 0.2 mg/mL DNAse I (Roche) for 30 min at 37 °C while shaking.
After digestion, cells were passed through a 70 µm strainer and washed once with
FACS buffer (phosphate-buffered saline (PBS), 1% fetal calf serum (FCS), 2.5 mM
EDTA, 0.02% sodium azide). Erythrocytes were lysed with Red Blood Cell Lysing
Buffer Hybri-Max (Sigma-Aldrich) for 2 min at room temperature (RT), washed
once, and resuspended in FACS buffer for further analysis. Bone marrow from
adult mice was isolated from femurs and tibiae by flushing, and bone marrow from
mice under 2 weeks of age was isolated by crushing the bones through a 70 μm cell
strainer. Erythrocytes were lysed as above and cells were resuspended in FACS
buffer for further analysis. Liver was minced into small pieces and digested in 2 mL
PBS containing Mg2+ and Ca2+ (Sigma-Aldrich) with 1 mg/mL collagenase IV
(Worthington), 60 U/mL DNAse I (Roche), 2.4 mg/mL Dispase II (Roche), and 3%
FCS (Sigma-Aldrich) for 30 min at 37 °C while shaking. After digestion, cells were
passed through a 100 µm strainer and centrifuged for 3 min at 50 g at 4 °C, to pellet
hepatocytes. The supernatant was collected and recentrifuged for 7 min at 320 × g
at 4 °C. Pelleted cells were resuspended in FACS buffer for further analysis.
Cell isolation for cell sorting and functional analyses. Cell isolation from spleen
was performed as above but FACS buffer without sodium azide was used for all
functional and RNA profiling experiments. For sorting of cDC2 CD11c+ cells were
enriched from splenic single-cell suspensions by positive selection using anti-
CD11c magnetic beads and LS columns (Miltenyi) according to the manufacturer’s
instructions. For OT-II cell isolation, the spleen was mechanically disrupted
through a 70 µm strainer and washed once with FACS buffer without sodium azide.
OT-II cells were then enriched from total splenocytes using the EasySep™ Mouse
Naive CD4+ T Cell Isolation Kit (Stemcell Technologies) according to the man-
ufacturer’s instructions. Erythrocytes were not lysed prior to OT-II cell enrichment,
following the manufacturer’s recommendations.
Flow cytometry. For staining of surface epitopes, cells were incubated first in 50 μL
with purified anti-mouse CD16/32 (FcBlock) for 10 min at 4 °C, before additional
antibodies were added to a final staining volume of 100 μL in a 2×Mastermix. Cells
were stained at 4 °C for 20 min then washed twice and resuspended in FACS buffer
for analysis. CCR6 staining was performed at 37 °C for 45 min before staining with
additional antibodies. For intracellular staining, cells were first stained with anti-
bodies against surface epitopes in the presence of fixable viability dye eFluor™ 780
(Thermo Fisher Scientific) and then washed with FACS buffer. Intracellular
staining for cytokines was performed using intracellular Fixation & Permeabili-
zation Buffer Set and intranuclear staining was performed with the Foxp3 tran-
scription factor staining set (both Thermo Fisher Scientific) according to the
manufacturer’s instructions. A pre-fixation step with 2% paraformaldehyde at RT
for 15 min was performed after surface epitope staining to preserve TOMATO
signal during intranuclear staining. Dead cells were excluded from analysis by 4′,6-
diamidino-2-phenylindole staining (Sigma-Aldrich) for live samples or fixable
viability dye eFluor™ 780 (Thermo Fisher Scientific). Data were collected on an LSR
Fortessa (BD Biosciences) using BD FACSDiva Software (BD BioSciences, Version
8) and data analysis was performed using FlowJo software (Tree Star, Inc.). Cell
sorting was performed on an Aria III Fusion (BD Biosciences). Cells counts were
quantified using CountBright™ Absolute Counting Beads (Thermo Fisher Scien-
tific). Mean fluorescence intensity was calculated as the geometric mean of the
indicated fluorescent parameter using FlowJo software (Tree Star, Inc.). Antibodies
used for flow cytometry are provided in Supplementary Data 4.
Immunofluorescence microscopy. Spleens were fixed overnight at 4 °C in par-
aformaldehyde, then dehydrated in P-buffer (0.2 M Na2HPO4 and 0.2 M NaH2PO4
at an 81 : 19 analogy), containing 30% sucrose overnight at 4 °C as described145,
transferred to Tissue-Tek O.C.T. (Sakura), and frozen on dry ice. Twelve-
micrometer-thick frozen sections were cut on a cryostat at −20 °C (Leica
CM3050S), rehydrated in PBS, and permeabilized with Acetone (Sigma-Aldrich).
Afterwards, the sections were circled with a PAP Pen (Kisker Biotech GmbH) and
blocked for 1 h at RT in the dark with blocking buffer containing 10% goat serum
in PBS. Antibodies were diluted in blocking buffer and sections were incubated for
2 h at RT in the dark with the antibody mixture. Finally, stained sections were
washed with PBS, mounted with ProLong™ Diamond Antifade Mountant (Thermo
Fisher Scientific), cured at RT for 24 h in the dark, and stored at 4 °C until imaging.
Confocal microscopy was performed at the Core Facility Bioimaging of the Bio-
medical Center with an upright Leica SP8X WLL microscope, equipped with
405 nm laser, WLL2 laser (470 - 670 nm), and acusto-optical beam splitter. Three-
dimensional tile scans were acquired with a 20 × 0.75 objective, image voxel size
was 180 nm in x/y direction and 0.5 in z direction. The following channel settings
were used: BV421 (excitation 405 nm; emission 415–470 nm), AF488 (500;
510–542), TOMATO (553; 563–591), AF594 (592; 605–640), and AF647 (650;
656–718). Recording was done sequentially to avoid bleed-through. BV421, AF488,
AF594, AF647, and TOMATO were recorded with hybrid photo detectors. Tile
scans were merged in LAS X (Leica, Version 3.4.1.17670). Images were imported in
Fiji146 to create maximum projections, adjust brightness/contrast, and to add scale
bars. Antibodies used for microscopy are provided in Supplementary Data 4.
Pulse labeling of yolk sac progenitors. For labeling of yolk sac-derived macro-
phages, heterozygous Csf1rMer-iCre-Mer mice were crossed with homozygous
RosaYFP reporter mice. Pregnant females were injected at E8.5 with a single dose of
75 μg per gram body weight 4-hydroxytamoxifen (4′OHT, Sigma-Aldrich) sup-
plemented with 37.5 μg per gram body weight progesterone (Sigma-Aldrich)41. The
spleen and liver of F1 mice were analyzed at embryonic day 18.5, as well as at 2 and
4 weeks after birth by flow cytometry.
RNA isolation, library construction, and RNA-seq analysis. CD11c+ cells were
enriched from splenocytes of adult and 1-week-old Clec9acre/creRosaTOM mice. cDC2
were identified as live, single, autofluorescence-negative, CD11c+MHCII+CD11b+
cells, and divided based on TOMATO expression into TOM+ cDC2 and TOM−
DC2. Spleens from 1-week-old mice were pooled to increase the yield of sorted cells.
Total RNA was isolated using column-based PicoPure™ RNA Isolation Kit (Thermo
Fisher Scientific). RNA quality was assessed using a 2100 Bioanalyzer (Agilent) and
samples with RNA Integrity Number > 8 were used for cDNA synthesis by using
ultra-low input RNA SMART-seq v4 kit (Clontech) according to the manufacturer’s
instructions. cDNA was transferred to AFA Fiber Pre-Slit Snap-Cap 6 × 16mm
microTUBEs (Covaris) and sheared by sonication. Sheared cDNA was cleaned using
ethanol precipitation and sonication efficiency was determined using the 2100
Bioanalyzer. A maximum of 10 ng sheared cDNA was used to generate libraries for
RNA-seq with the MicroPlex Library Preparation kit v2 (Diagenode). The libraries
were amplified until a DNA concentration above 5 ng/µL was reached as determined
by Qubit 2 DNA quantification (Thermo Fisher Scientific). Amplified libraries were
cleaned using AMPure XP beads (Beckman Coulter) as described in the SMART-seq
v4 kit (Clontech) protocol and the final concentration, as well as the purity of the
libraries were assessed by using the 2100 Bioanalyzer. Sequencing was performed
on an Illumina HiSeq1500 sequencer with 50 base pair single-end reads and a
sequencing depth of 20 million reads per sample. For analysis, RNA-seq reads were
mapped to the mouse genome (mm10) using STAR147. Expression of genes in
transcripts per million was calculated with RSEM148. RNA-seq analysis was per-
formed in R (Version 3.5.3) with R-Studio (R-Studio, Inc., Version 1.1.383). Differ-
ential gene expression analysis and PCA was performed using DESeq2 (Version
1.22.2). Genes with average gene counts < 1 were discarded and log2 FC shrinkage was
performed using the Apeglm package149. Heatmaps were generated using pheatmap
(Version 1.0.12) and graphs were plotted with ggplot2 (Version 3.0.2). Tables con-
taining differentially expressed genes were created using Microsoft Excel
version 16.34.
scRNA-seq and data processing. MHCII+ cells from splenocytes of 9-day-old
female Clec9acre/creRosaTOM mice were sorted after gating out CD19+ B cells and
autofluorescence+F4/80hi macrophages. To increase cell yield, spleens from three
mice were pooled. Sorted cells were pelleted, resuspended at 1 × 103 cells/μL in PBS
containing 0.04% bovine serum albumin, and loaded onto the Chromium Con-
troller (10X Genomics). Samples were processed for single-cell encapsulation and
cDNA library generation using the Chromium Single Cell 3′ v3 Reagent Kits (10X
Genomics). The constructed library was sequenced on an Illumina HiSeq2500
(Rapid Run) sequencer with 28 (read 1)+ 91(read 2) base pair paired-end reads
and a sequencing depth of 320 million reads in total. Sequencing data were pro-
cessed using 10X Genomics Cell Ranger v3.0.2 pipeline. Sequencing reads were
mapped to the mouse genome (mm10) using STAR147 after spiking in the
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sequences of iCRE (GenBank ID: AY056050.1), the predicted transcript of the
unrecombined Rosa locus and Tomato sequence (GenBank ID: AY678269.1). Cell
Ranger’s count pipeline was run under default parameters. The output of Cell
Ranger’s count pipeline was a gene-barcode matrix consisting of ~1788 cellular
barcodes with 179,245 mean reads per barcode. This matrix was inserted to the
R (Version 3.5.3) software package Seurat (v3.0.2)86,87 for all downstream analyses.
Cells expressing <200 genes, having >7.5% of mitochondrial associated genes
and genes detected in <3 cells were removed from further analysis according to
the software suggestions. In addition, cells were scored based on their cell cycle
score and the differences between G2M and S phase cells were regressed. The
SCtransform package was used to normalize, scale, and find the variable features
of the dataset before PCA. Genes associated with the top 40 PCs were used
for graph-based cluster identification (resolution 1.3) and subsequent dimension-
ality reduction using UMAP. Identification of cluster defining markers and dif-
ferential expression analysis were performed using the FindAllMarkers and
FindMarkers commands of the Seurat package. To score single cells based on
their Tomato expression, we calculated the ratio of normalized Tomato reads
per cell to normalized reads per cell of the predicted transcript of the unrecom-
bined Rosa locus (Ratio Tom/unrec. Rosa). Cells with a ratio above 0.5
or below −0.5 were denoted Tom+ or Tom−, respectively. The selected
thresholds included more than 90% of the total cells in each cluster. Tables con-
taining differentially expressed genes were created using Microsoft Excel
version 16.34.
For trajectory analysis using Palantir, we selected clusters 0, 3, 6, 7, 11, and 14,
and generated diffusion maps as described93. We provided a defined starting point
in cluster 11 and used Palantir to characterize potential pseudo-time trajectories
from this point. The terminal states found in the analysis were automatically
calculated by the Palantir algorithm.
Cytospins and Hemacolor staining. TOM+ cDC2 and TOM− DC2 were sorted
from CD11c+ enriched splenocytes from 11-day-old Clec9acre/creRosaTOM mice as
live, single, autofluorescence-negative, CD11c+MHCII+CD11b+ TOM+ or TOM−
cells. Cells (2 × 104) were spun onto a microscope slide in a Shandon Cytospin 2 for
5 min at 8000 r.p.m. and stained with Hemacolor® rapid staining kit (Merck).
Microscopy was performed at the Core Facility Bioimaging of the Biomedical
Center using a Leica DM 2500 LED microscope with a ×100 magnification.
Bone marrow FLT3L cultures. Bone marrow cells from adult Clec9acre/+RosaTOM
(CD45.2) were isolated as described above.
After lineage depletion using negative selection (lineage: CD3, TER119, Ly6G,
CD19), CLPs were sorted as live, single, lin−CD115−CD117intCD135+CD127+
B220−TOMATO− cells. CLPs (104) were seeded in 300 μL complete medium
(RPMI supplemented with 10% FCS, penicillin/streptomycin, 1% non-essential
amino acids, 1% sodium pyruvate, 1% L-glutamine, 0.05 mM β-mercaptoethanol)
in a 48-well plate together with 1.5 × 105 total bone marrow cells isolated from
congenic B6.SJL (CD45.1) mice. As controls, total bone marrow cells from
Clec9acre/+RosaTOM and B6.SJL congenic mice were seeded at a 1 : 1 ratio. FLT3L
(purified from supernatant of CHO-flk2 cell line, a kind gift from Dr. Anne Krug,
Institute for Immunology, Biomedical Center, Munich) was added to all wells at a
concentration of 50 ng/mL. Culture wells were left unperturbed for 7 days and then
the culture output was analyzed by flow cytometry.
In vitro T-cell proliferation. DCs were sorted from CD11c+ enriched cells from
spleen of 2-week-old and adult Clec9acre/creRosaTOM mice, as live, single, auto-
fluorescent-negative, CD11c+MHCII+CD11b+ TOMATO+, or TOMATO− cells.
In some experiments, DCs were further subset based on ESAM and RORγt
expression, as indicated. In experiments comparing cDC2 from SPF and GF mice,
cDC2 were sorted from CD11c-enriched splenocytes as live, single, auto-
fluorescence-negative, CD11c+MHCII+CD11b+ cells. Sorted cells were incubated
in the wells of a V-bottom 96-well plate with 10 μg/mL chicken OVA peptide
(OVA323–339, InvivoGen) for 3 h in complete medium (prepared as indicated
above). After washing two times to remove any residual OVA323–339 DCs were
resuspended in complete medium, serially diluted, and co-cultured at the indicated
ratios with naive CTV-labeled OT-II cells from adult mice. Naive OT-II cells were
isolated as described above and labeled with CTV (Thermo Fisher Scientific). First,
OT-II cells were resuspended in PBS at 20 × 106 cells/mL and an equal volume of
CTV working solution was added to a final concentration of 5 mM. Cells were
incubated for 20 min at 37 °C in the dark and were mixed at the midpoint of
the incubation. An excess of pre-warmed complete medium was added and after a
5 min incubation, cells were washed with PBS. Cultures were supplemented with
20 ng/mL IL-12 (PeproTech) and 10 μg/mL anti-IL-4 (Biolegend) for Th1; 5 ng/mL
TGF-β, 10 μg/mL anti-IL-4, and 10 μg/mL anti-IFN-γ for Treg; 5 ng/mL TGF-β,
20 ng/mL IL-6, 10 μg/mL anti-IL-4, and 10 μg/mL anti-IFN-γ (all Biolegend) for
Th17 conditions. After 3.5 days of culture, supernatant was collected from each
well and cells were restimulated with 10 ng/mL phorbol 12-myristate 13-acetate
(PMA) (Calbiochem) and 1 μg/mL ionomycin (Sigma-Aldrich) for 5 h. After 2 h,
brefeldin A (5 μg/mL, Biolegend) was added for the remaining 3 h. Cytokines
and Foxp3 expression were detected by intracellular staining. Cytokine secretion
in culture supernatants was quantified using LEGENDplexTM Mouse Th Cytokine
Panel (Biolegend) according to the manufacturer’s instructions. For co-culture
experiments with OVA, DCs were sorted as above resuspended in complete
medium in the wells of a V-bottom 96-well plate, serially diluted and co-cultured
at the indicated ratios with CTV-labeled naive OT-II cells in the presence of
20 μg/mL OVA (Hyglos). After 4 days of culture, cytokine production was assessed
as above.
Antigen targeting. Antigen targeting was performed as described25,107. To
establish targeting specificity 2-week-old Clec9acre/+RosaTOM mice were injected
intraperitoneally (i.p.) with 10 μg αDCIR2-OVA or 10 μg OVA coupled isotype
control antibody. Mice were killed 12 h later and splenocytes were isolated by
mechanically disrupting the spleens through a 70 µm strainer and washing once
with PBS containing 1% FCS. Splenic single-cell suspensions were then enriched
for CD11c+ cells by positive selection using anti-CD11c magnetic beads and LS
columns (Miltenyi). PBS containing 1% FCS was used throughout the procedures
of isolation, enrichment and preparation of cells for sorting. TOM+ cDC2 and
TOM− DC2 were sorted as CD11c+B220−Ly6G−Ly6C−CD90.2-CD11b+
TOMATO+ or TOMATO− cells and cDC1 were sorted as CD11chighB220−Ly6G−
Ly6C−CD90.2-CD24+XCR-1+ cells. Sorted DCs were co-cultured with CTV-
labeled naive CD90.1 OT-II cells in complete medium. After 3.5 days, supernatant
was collected from each well and OT-II proliferation analyzed by flow cytometry.
For targeting experiments with adjuvant, 2-week-old and adult, Clec9acre/+Rosa-
TOM mice were injected i.p. with 10 μg of αDCIR2-OVA plus 0.2 μg/g body weight
of CpG-B ODN 1826 (Sigma-Aldrich). DC populations were sorted and co-
cultured with CTV-labeled naive CD90.1 OT-II cells as above. After 3.5 days, OT-
II cells were restimulated with PMA/ionomycin for 5 h in the presence of Brefeldin
A and cytokine production and Foxp3 expression assessed by flow cytometry
as described above. T-cell proliferation, cytokine production after restimulation,
and quantification of secreted cytokines in culture supernatants were assessed
as above.
TOMATO stability in vitro. TOM+ cDC2 and TOM− DC2 from 1-week-old
Clec9acre/creRosaTOM mice were sorted as above. Cells (2.5 × 103) were seeded in
200 μL complete medium together with 105 total splenocytes from CD45.1 con-
genic mice. Cultures were supplemented with 50 ng/mL murine recombinant GM-
CSF (PeproTech) and 200 ng/mL murine recombinant FLT3L (R&D Systems).
After 24 h, cells were collected and analyzed by flow cytometry.
In vitro phagocytosis. CD11c-enriched splenocytes (5 × 104) from 2-week-old and
adult Clec9acre/+RosaTOM mice cells were cultured with beads (FluoSpheres®,
Polystyrene Microspheres, 1.0 μm, yellow–green fluorescent (505/515)), Invitro-
gen) at a 50 : 1 bead to cell ratio for 2 h at 37 °C in humidified atmosphere con-
taining 5% CO2 in complete medium. To inhibit phagocytosis, cells were pre-
treated with 10 µg/ml cytochalasin D (Sigma-Aldrich) for 1 h at 37 °C. After
incubation, antibody staining for surface epitopes was performed as described
above and phagocytosis of beads by cDC2 was quantified by flow cytometry.
In vitro stimulation and cytokine production. TOM+ cDC2 and TOM− DC2
from 2-week-old Clec9acre/+RosaTOM mice and TOM+ cDC2 from adult
Clec9acre/+RosaTOM mice were sorted as above. Then, 0.7 × 106 cells/mL were
stimulated in a total volume of 50 μL complete medium in 96-well V-bottom
plates with 0.5 μg/mL CpG-B ODN 1826 (Sigma). After 18–20 h, cytokine
secretion was quantified using LEGENDplexTM Mouse Inflammation Panel and
LEGENDplexTM Mouse Cytokine Panel 2 for IL-12p40 (both from Biolegend)
according to the manufacturer’s instructions.
Statistical analysis. Statistical significance was calculated in Prism 7 software
(GraphPad) using two-tailed t-test with Welch’s correction (unless otherwise sta-
ted) or two-tailed paired t-test. For multiple comparisons, one-way analysis of
variance with Tukey’s test (unless otherwise stated) was performed. A p-value <
0.05 was considered significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that the data supporting the findings of this study are available
within the paper and its Supplementary Files. Raw data are available from the authors
upon reasonable request. Datasets related to bulk and single-cell sequencing experiments
that were generated and analyzed for the current study have been deposited and made
publicly available in the Gene Expression Omnibus under the accession number
GSE151595. The sequences of iCRE and Tomato used for the single-cell RNA sequencing
analysis are publicly available and can be found under the GenBank IDs AY056050.1 and
AY678269.1, respectively. Source data are provided with this paper.
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Supplementary Figure 1. Clec9cre mice faithfully trace cDCs in early life. (A, B) Splenic cDC2 
(CD11c+MHCII+CD11b+) from Clec9acre/+RosaTOM or Clec9acre/creRosaTOM mice of the indicated 
ages were analyzed for ESAM expression. Fluorescence minus one (FMO) controls used to set the 
gates are shown. (C-E) Splenic cDC2 from Clec9acre/creRosaTOM (C) and Clec9acre/creRosaYFP mice 
(D) were analyzed for TOMATO and YFP expression at the indicated ages (n=9, PND2; n=10, 
PND7-8; n=12, PND14-15; n=4, PND19-22; n=6, 4 weeks; n=5, adult (C) and n=3, E17.5; n=8, 
PND1; n=3, PND2; n=8, PND10; n=6, PND15-17; n=4, PND23; n=5, PND32; n=5, adult (D)). 
(E) Splenic ESAMhigh and ESAMlow cDC2 from Clec9acre/+RosaTOM (left) and Clec9acre/creRosaTOM 
(right) mice were analyzed for TOMATO expression at the indicated ages (n=9, PND7-8; n=6, 
PND14-15; n=10, PND19-22; n=5, 4 weeks; n=5, adult for left plot and n=6, PND2; n=2, PND7-
8; n=12, PND14-15; n=4, PND19-22; n=6, 4 weeks; n=4, adult for right plot). Each dot represents 
one mouse, horizontal bars represent mean, error bars represent SD, grey rectangles indicate 
weaning. (F, G) Spleens from one- and two-week-old Clec9acre/creRosaTOM mice were analyzed by 
flow cytometry as indicated, to profile TOMATO expression in lymphoid and myeloid 
populations. (F) Representative gating strategy. (G) t-Distributed Stochastic Neighbor Embedding 
(tSNE) of splenocytes from PND7 and PND14 Clec9acre/creRosaTOM mice. Cells were clustered 
independent of TOMATO. Manually gated populations were overlaid on the tSNE plot and 
indicated by color. Blue-to-red gradient indicates increasing intensity of TOMATO expression. 




Supplementary Figure 2. Identification of cDC progenitors in early life. (A) Representative 
gating strategy for the identification of cDC progenitors in bone marrow (upper row) and spleen 
(lower row) of adult mice. (B) Frequency of cDC progenitors as identified in (A) in the bone 
marrow of wild type mice at the indicated ages (n=6, MDP and CDP PND2; n=3, pre-cDC PND2; 
n=5, adult). Each dot represents one biological replicate, horizontal bars represent mean, error bars 
represent SD. (C, D) Bone marrow (C) and spleen (D) from wild type mice of the indicated ages 
were analyzed by flow cytometry. Lin- cells were gated, pre-cDCs were identified as indicated and 
stained with anti-DNGR-1 (red) or isotype-matched control antibody (grey). Lineage: CD3, B220, 
NK1.1, CD4, CD8 , TER119. (E, F) Bone marrow (E) and spleen (F) of Clec9acre/creRosaTOM 
mice was analyzed by flow cytometry at the indicated ages. (E) CLPs (lin-CD11b-CD115-
CD117intSca-1intCD135+CD127+), MDPs (lin-CD11c-MHCII-CD11blow CD115+ CD135+ 
CD117high), CDPs (lin-CD11c-MHCII-CD11blowCD115+CD135+CD117low) and pre-cDCs (lin-
MHCII-CD11blowCD11c+CD135+CD172aint) were analyzed for TOMATO expression. The lin-
CD11b-CD117intCD115-CD135+ fraction of bone marrows that contains CLPs was used to assess 
TOMATO expression in PND14 and adult mice (n=8, PND7; n=3, PND14; n=10, adult; n=4, CLP 
PND7 and adult). (F) TOMATO expression was analyzed in splenic pre-cDCs (lin-MHCII-
CD11blowCD11c+CD43+CD135+CD172aint) and CD11b+ cDCs (n=6, PND7; n=5, PND14; n=8, 
adult). Each dot represents one mouse, horizontal bars represent mean, error bars represent SD. 
Lineage: CD3, B220, NK1.1, CD4, CD8 , TER119. (G) TOM- and TOM+ CD11b+ cDC2 cells 
were sorted from spleens of one-week-old Clec9acre/creRosaTOM mice and cultured in vitro with 
congenic CD45.1 filler splenocytes in the presence of FLT3L and GM-CSF. After 24 hours, TOM- 
and TOM+ cells were analyzed for TOMATO labeling. FACS plots show TOMATO labeling in 
CD11b+ cDC2 before sorting (left), sort purity of TOMATO- and TOMATO+ fractions (right upper 
plots) and TOMATO labeling after 24 hours in culture (right bottom plots). Data are representative 
of two independent experiments with at least 2 biological replicates each. Source data are provided 
as a Source Data file. 
  

Supplementary Figure 3. Fate mapping reveals a lymphoid contribution to cDC2 in early life 
and TOM- DC2 morphologically resemble TOM+ cDC2. (A) Csf1rMer-iCre-Mer dams were mated 
with male RosaYFP mice and injected with 4OH-tamoxifen on E8.5. Spleen and liver from offspring 
mice were analyzed by flow cytometry two (n=17) or four weeks (n=13, n=9 for liver) after birth. 
The percentage of YFP+ cells in the indicated populations is plotted. (B) Unfractionated bone 
marrow and 104 CLPs (lin-CD11b-CD115-CD117intCD135+CD127+B220-TOMATO-) from adult 
CD45.2+ Clec9acre/+RosaTOM mice were cultured with FLT3L for 7 days in the presence of 
CD45.1+ congenic bone marrow filler cells. Left: CD11c+MHCII+ cells were identified by FACS 
and divided into CD24+ cDC1 and CD172a+ cDC2 equivalents. Numbers indicate mean 
frequency±SD. Middle: Expression of CD24 on cDC2 equivalents. Right: The frequency of 
TOMATO positive cells in cDC2 equivalents derived from bone marrow and CLP is shown. Data 
are representative of two independent experiments (n=3). Statistical analysis was performed using 
two-tailed t test. (C, D) Bone marrow (C) and spleen (D) from Rag1creRosaYFP mice at the indicated 
ages was analyzed by flow cytometry. (C) CLPs (lin-CD11b-CD115-CD117intSca-
1intCD135+CD127+), MDPs (lin-CD11c-MHCII-CD11blow CD115+ CD135+ CD117high ), CDPs (lin-
CD11c-MHCII-CD11blowCD115+CD135+CD117low), pre-cDCs (lin-MHCII-
CD11blowCD11c+CD135+CD172aint), as well as TER119+ erythroid cells were analyzed for YFP 
expression (n=6, PND2-3; n=5, PND7-9; n=8, adult; lineage: Ly6G, CD3, B220, NK1.1, CD8 ). 
(D) cDC2 from spleen of Rag1creRosaYFP mice on PND7-9 were divided into ESAMhigh and 
ESAMlow populations and analyzed for YFP expression (n=6). (E) Male Cxcr4creER mice were 
mated with female RosamTmG mice. Pregnant dams were injected with tamoxifen on E12.5. On 
E18.5 spleen and brain from offspring mice were analyzed by flow cytometry for GFP expression 
(n=6). Each dot in (A-E) represents one mouse, horizontal bars represent mean, error bars represent 
SD. **** p<0.0001. (F) Cytopsin analysis of splenic TOM+ cDC2 and TOM- DC2 of 11-day-old 
Clec9acre/creRosaTOM mice. Scale bar 5µm. Data are representative of two independent 
experiments. Source data are provided as a Source Data file. 
  

Supplementary Figure 4. RORγt+TOM- DC2 in early life are distinct from ILCs and exhibit 
phenotypic profile that resembles ESAMhi cDC2. (A) TOM- DC2 and TOM+ cDC2 from 8-day-
old and TOM+ cDC2 from adult Clec9acre/creRosaTOM mice were sorted and analyzed by mRNA 
sequencing. k-means clustering of differentially expressed genes (log2 FC >1 and padj <0.05) 
between TOM+ cDC2 from young mice, TOM- DC2 from young mice and TOM+ cDC2 from adult 
mice. Significance of differentially expressed genes was tested using default commands of 
DESeq2. (B) Splenic ILCs, identified as lin- (CD3, B220, NK1.1) CD11b-CD90.2+CD127+, from 
one-week-old Clec9acre/creRosaTOM mice were analyzed for expression of CD11c, MHCII and 
RORγt. Plots are representative of three biological replicates. (C) TOM+ cDC2 (red), ROR t-TOM- 
DC2 (black) and ROR t+TOM- DC2 (blue) from one-week-old Clec9acre/+RosaTOMRorceGFP mice 
were identified and analyzed for surface expression of the indicated markers. (D) ROR t-CD11b+ 
DCs (black) and ROR t+CD11b+ DCs (blue) from one-week-old RorceGFP mice were identified 
and compared for expression of indicated surface markers. (C, D) Data are representative of n=2.  
  

Supplementary Figure 5. TOM+ cDC2 and TOM- DC2 in early life are transcriptionally 
identical. (A) Sort strategy for MHCII+ cells from spleens of 9-day-old Clec9acre/creRosaTOM mice 
for single cell RNA-seq. (B) Heatmap showing expression of genes used for cluster identification. 
(C) Heatmap displaying expression of the top 15 cluster defining genes. (D-G) Heatmaps 
displaying the expression of (D) core CD8- DC genes, (E) core migratory DC genes, (F) genes 
characteristic for ESAMhigh and ESAMlow cDC2, as well as genes characteristic for T-bet+ and T-
bet- cDC2 (G) among cells of indicated clusters.(B-G) Expression is shown in logN values scaled 
by row. (H) Palantir pseudo-time analysis of differentiation potential and branch probabilities from 
cluster 11 (upper row). Start point and terminal states are indicated. The positioning of clusters 0, 
3, 6, 7, 11 and 14 used for Palantir analysis is shown in tSNE embedding of the diffusion map 
(lower row). (I) Spleen from two-week-old and adult RorccreRosaRFP mice were analyzed by flow 
cytometry. CD11c+MHCII+CD11b+ cDC2 were identified and analyzed for the expression of 
RORγt and RFP. Numbers represent mean ± SD (n=7, two-week-old; n=4, adult). Source data are 
provided as a Source Data file. 
  

Supplementary Figure 6. TOM+ cDC2 and TOM- DC2 can prime naïve T cell proliferation 
comparable to cDC2 from adults. (A, B) Sort-purified TOM- DC2 and TOM+ cDC2 from 8-day-
old and TOM+ cDC2 from adult Clec9acre/creRosaTOM mice were analyzed by mRNA sequencing. 
Heatmaps showing expression of selected pattern recognition receptors (log2TPM values) (A) and 
genes involved in Th17 and Treg differentiation (log2TPM values, scaled by row) (B). (C) TOM+ 
cDC2 from two-week-old and adult Clec9acre/+RosaTOM mice were analyzed by flow cytometry for 
PD-L1 and CD38 expression (n=4-7). (D-F) TOM- DC2 and TOM+ cDC2 from two-week-old and 
TOM+ cDC2 from adult Clec9acre/+RosaTOM mice were sorted, pulsed with OVA323-339 and co-
cultured with CTV-labelled OT-II cells as indicated. 3.5 days later OT-II cells were analyzed for 
cytokine expression (D) and cell division (E). (F) Cytokine levels in supernatants of OT-II cells 
co-cultured with the indicated DC2 populations under Th0 conditions. Data in (D-F) are pooled 
from four independent experiments. (G) Sort-purified ROR t-ESAMhighTOM- DC2 and 
ESAMhighTOM+ cDC2 from two-week-old Clec9acre/+RosaTOMRorc-eGFP mice were co-cultured 
with CTV-labelled OT-II cells in Treg or Th17 conditions for 3.5 days. The percentage of cytokine 
or Foxp3 positive proliferated OT-II cells is shown (n=5). (H) CD11c-enriched splenocytes from 
two-week-old (n=6) and adult (n=4) Clec9acre/+RosaTOM mice were cultured with yellow 
fluorescent beads at the indicated bead to cell ratio in vitro for 2 hours +/- cytochalasin D. Bead 
uptake was quantified by flow cytometry in TOM+ cDC2 (Autofluoresence-
CD11c+MHCII+CD11b+TOMATO+) and TOM- DC2 (Autofluoresence-
CD11c+MHCII+CD11b+TOMATO-). (I) Sort-purified splenic CD11c+MHCII+CD11b+ cDC2 
from SPF or GF mice were co-cultured with CTV-labelled OT-II cells as indicated. 3.5 days later 
proliferated OTII cells were analyzed for cytokines and Foxp3 expression (n=3). (J) PD-L1 and 
CD38 expression on splenic cDC2 from SPF and GF mice (n=3). Each dot represents individual 
biological replicates (E-H) or mice (I-J), horizontal bars represent mean, error bars represent SD. 
Comparison of TOM- DC2 and TOM+ cDC2 was performed using two-tailed paired t test. 
Comparison of two-week-old and adult groups was performed using one-way ANOVA. Statistical 
analysis in (I-J) was performed using two-tailed t test. Only statistically significant comparisons 
are indicated. Source data are provided as a Source Data file.  
  

Supplementary Figure 7. Early life cDC2 show distinct responsiveness to CpG and induce 
distinct T cell responses upon targeted antigen delivery compared to adult life cDC2. (A) 
TOM+ cDC2 and TOM- DC2 from two-week-old and TOM+ cDC2 from adult Clec9acre/+RosaTOM 
mice were sorted and stimulated with CpG-B. Cytokine production was analyzed 18-20h later 
(n=4, with IL-27 detected in 3 out of 4 replicates from two-week-old TOM- DC2, 2 out of 4 
replicates from two-week-old TOM+ cDC2, while it was not detected in supernatants from adult 
TOM+ cDC2). Each dot represents one biological replicate. (B) Two-week-old and adult 
Clec9acre/+RosaTOM mice were injected i.p. with anti-DCIR2-OVA antibody plus CpG-B. After 12 
hours DC populations were sorted and co-cultured with OT-II T cells for 3.5 days. The indicated 
cytokines were quantified in supernatants from co-cultures (n=10, two-week-old; n=8, adult; IL-
22 and IL-13 were detected in 7 out 8 adult replicates). Each dot represents one biological replicate 
from two independent experiments, horizontal bars represent mean, error bars represent SD. 
Statistical analysis was performed using two-tailed paired t test (comparing TOM- DC2 and TOM+ 
cDC2 groups) or one-way ANOVA (comparing two-week-old and adult groups). No statistically 
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